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ABSTRACT 
EFFECT OF SODIUM CHLORIDE ADDITION DURING DIAFILTRATION ON THE 
SOLUBILITY OF MILK PROTEIN CONCENTRATE 
 
Scott Joseph Gualco 
 
 
There is considerable interest among food manufacturers to incorporate protein 
into food products in both developed and developing countries. Dairy proteins are 
excellent choices for many different applications, as they are known to have several 
nutritional and functional benefits. Membrane filtration techniques are often utilized as 
the preferred method of fractionation, due to the high throughput and continuous nature 
of the process. One such product produced from membrane filtration of skim milk is 
called milk protein concentrate. This product is valued for its high protein content, but it 
has historically exhibited poor solubility when reconstituted into water, which severely 
restricts the food applications for which it is suitable. There is some existing evidence 
that milk protein concentrates which contain elevated levels of sodium exhibit higher 
solubility upon reconstitution into water. The main objective of this thesis project was to 
demonstrate the effect of sodium chloride, added to diafiltration water utilized during the 
manufacturing process, on the solubility of milk protein concentrate.  
It was observed that the addition of sodium chloride into diafiltration water at 
levels of 50 mM, 100 mM, and 150 mM had a beneficial effect on the solubility of milk 
protein concentrate across a variety of reconstitution conditions. For example, when milk 
protein concentrate was mixed for 1 h on a stage mixer at 23 °C ± 1 °C, a significant 
increase (p < 0.001) in mean solubility was observed when at least 50 mM NaCl had been 
incorporated into DF water. The incorporation of 50 mM NaCl into DF water 
 v
significantly increased (p < 0.001) the mean solubility of milk protein concentrate from 
59.81 % to between 64.34 % and 71.78 %. The addition of 100 mM NaCl significantly 
increased (p < 0.001) the solubility to between 88.80 % and 96.24 %, and the addition of 
150 mM NaCl significantly increased (p = 0.005) the solubility to between 92.79 % and  
100 %.  
Minerals analysis of dry powders revealed a significant increase (p < 0.001) in 
levels of sodium. The addition of 50 mM NaCl into DF water was associated with a 
significant increase (p < 0.001) in powder Na content to between 2.48 mg/g and 7.44 
mg/g. The addition of 100 mM NaCl into DF water was associated with a significant 
increase (p = 0.002) in powder Na content to between 5.80 mg /g and 10.75 mg/g, and the 
addition of 150 mM NaCl into DF water was associated with a significant increase (p = 
0.001) in powder Na content to between 9.57 mg/g and 14.53 mg/g. A significant 
difference (p < 0.001) in magnesium level was also detected. Differences in calcium 
content were not found to be statistically significant (p = 0.016) at α = 0.01. 
Preliminary observations of milk protein concentrate upon reconstitution were 
made using a confocal laser scanning microscopy method. This method showed evidence 
of possible differences in powder particle rehydration and affinity for lipid association 
between powder particles manufactured at different treatment levels. As the level of NaCl 
incorporated into DF water increased, particle structures upon rehydration appeared more 
porous, and the incidence of lipid material that was not associated with powder particles 
appeared to increase. Overall, this study demonstrates the importance of sodium content 
in determining the solubility of milk protein concentrate. 
Keywords: milk protein concentrate, solubility, sodium, calcium 
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1. INTRODUCTION 
As the demand for high-protein food products increases, food manufacturers have 
desired to incorporate protein into many different food systems. Dairy proteins are 
excellent choices for a variety of food applications because they have several benefits 
from a nutritional and functional perspective. Membrane filtration is one of the most 
efficient ways of separating dairy proteins on an industrial scale. One relatively new 
product is produced from membrane fractionation of skim milk, and this product retains 
the technologically and nutritionally important dairy proteins. The retained fluid can be 
incorporated in liquid form into a food product, or can be dried to powder form to 
facilitate storage, transportation, and incorporation at a later time. The fluid and dried 
powdered forms contain the same proteins in the same proportions as are present in skim 
milk, and have been utilized in recent years as a functional ingredient in the food 
industry. The dried form is commonly referred to as milk protein concentrate (MPC). 
Researchers are striving to understand and improve the functional characteristics 
of MPC as the market demand for this ingredient increases. This high-protein dairy 
powder has historically exhibited poor solubility when reconstituted into water, which 
severely restricts the food applications for which it is suitable. MPC must be dissolved in 
water before it can express most desirable functional properties. Existing studies have 
indicated possible connections between mineral content and solubility of MPC. To 
further investigate these links, we propose a study examining the connection between 
MPC solubility and an MPC manufacture process utilizing the incorporation of NaCl at 
various levels. This study will also investigate the changes in MPC physical 
characteristics that occur as a function of varying the NaCl levels utilized during this 
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manufacture process. This may provide a better understanding of the relationship 
between MPC manufacture process, MPC composition, MPC physical characteristics, 
and solubility. 
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2. LITERATURE REVIEW 
 
2.1. Brief Outline  
This literature review aims to establish a common foundation of knowledge in the 
area of milk protein concentrates (MPCs) with respect to solubility, a key functional 
property that is poorly expressed in MPCs containing greater than 70% protein. This 
review will first examine the highly variable composition of MPCs available both 
domestically and internationally, while paying special consideration to correlations 
between select mineral constituents and solubility. The effect of manufacture process on 
solubility will be discussed, along with the chemistry governing interactions between 
calcium, sodium, and proteins in the MPC system. Finally, a series of experiments are 
proposed to more thoroughly investigate the observed links between composition, 
manufacture process, and solubility of the resulting MPC. 
2.2. Definition of Milk Protein Concentrate 
MPC can be defined as a group of products with varying bovine milk protein 
content produced from the ultrafiltration (UF) of skim milk and subsequent water 
removal (Puhan, 1990). UF may include one or more diafiltration (DF) steps to remove 
lactose, minerals, and water. Further water removal may involve reverse osmosis, 
vacuum evaporation, and spray drying. The resulting powder expresses unique physical, 
chemical, and functional characteristics when dissolved in solution, due to both the high 
concentration of proteins present and the thermal conditions imposed upon these proteins 
during processing (Tong, 2007). A typical MPC manufacture process is illustrated in 
Figure 1. 
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Figure 1: Typical MPC manufacture process from raw milk acquisition to powder 
storage, from Anonymous (2010b)  
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Neither the Food and Drug Administration nor the Codex Alimentarius 
Commission defines MPC. As such, Chapter 4 of the Harmonized Tariff Schedule of the 
United States (HTSUS) is most frequently cited as the quality standard to which U.S. 
food manufacturers hold all MPCs. According to Chapter 4 of the HTSUS, MPC is 
classified as “any complete milk protein (casein plus lactalbumin) concentrate that is 40 
percent or more protein by weight.” Two categories of imports are classified under the 
HTSUS. Moreover, in 2001 nearly all MPC utilized in the U.S. food industry was 
imported from New Zealand, Australia, Ireland, Germany, and the Netherlands, and MPC 
manufacturers needed only to meet the HTSUS standard that fits the category of import 
(Bailey, 2003). 
MPC is most often manufactured using ultrafiltration and subsequent water 
removal processes. However, because the HTSUS only loosely defines MPC by 
composition, the HTSUS definition is tolerant of both dairy-derived protein products 
produced through other manufacturing processes and dairy-derived protein products with 
a high degree of composition variability. Laboratory analysis has confirmed large 
discrepancies in composition amongst MPCs from U.S. market suppliers, along with vast 
differences in MPC functionality (Floris et al., 2007). It was suggested that these 
differences in composition were due to variations in processing conditions. However, 
there is insufficient published data to correlate MPC manufacturing process and 
composition of the resulting powdered product with expression of its functional 
properties important to food manufacturers. 
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2.2.1. MPC Composition 
MPC is commercially available at various protein concentrations, and these 
products are labeled as MPCX, with X referring to the percent protein in that particular 
product. For example, MPC containing 40% protein is labeled MPC40, and MPC 
containing 80% protein is labeled MPC80. MPCs containing more than 85% protein are 
classified as milk protein isolate (MPI) (Tong, 2007). 
Table 1: Composition of various MPC products by protein content (Anonymous, 
2001). 
Product Origin Protein % Fat % Ash % Lactose % 
MPC42 AU 42.0 2.0 8.0 45.5 
MPC42 NZ 42.0 1.0 7.5 45.5 
MPC50 AU 49.8 1.5 8.0 35.5 
MPC56 AU 55.8 1.5 8.5 30.5 
MPC56 NZ 56.0 1.2 8.0 31.0 
MPC70 AU 69.8 2.0 8.5 15.5 
MPC70 NZ 71.0 1.0 7.0 17.0 
MPC75 AU 74.8 2.0 8.5 10.5 
MPC80 AU 79.8 2.5 8.5 5.5 
MPC85 AU 84.8 2.5 8.5 0.5 
MPC90 NZ 86.7 1.6 7.1 1.0 
Source: Adapted from (Anonymous, 2001). 
2.2.1.1. Variation in MPC Composition and Solubility 
Although MPC is most often produced using a combination of UF, DF, and spray-
drying processes, there currently exists no standardized procedure for its manufacture. In 
addition to ultrafiltered milk products, HTSUS classification includes concentrates 
obtained by dry blending nonfat dry milk (NFDM) with whey protein concentrate (WPC) 
and/or casein (CN) products, or mixing condensed liquid skim milk with liquid WPC and 
subsequently spray-drying to achieve a dry protein product (Durant, 2002).   
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The wide variations in solubility between MPCs obtained from different sources 
has been documented. A study examining 37 different MPC products from 10 different 
countries found no correlation between protein content and solubility, save for a small 
subset of MPCs in the range of 82% to 86% protein (de Castro-Morel and Harper, 2002). 
Detailed proximate analysis indicates that vast differences exist in MPC composition and 
functionality amongst MPCs obtained from different manufacturers, even amongst MPCs 
concentrated to similar protein levels (Floris et al., 2007). Table 2 illustrates observed 
differences in protein, K, Ca, and Na content, along with solubility as determined by the 
Nitrogen Solubility Index (NSI). 
This report contains a number of key observations that may provide insight for 
MPC manufacturers who desire to deliver products of consistent or improved quality. 
Samples 60X11x and 60X13 (Table 2), both highly soluble MPCs containing greater than 
80% protein, possess higher Na content than other MPCs, indicating that they may have 
been produced using processes involving Na addition as an intermediary step prior to, 
after, or during the ultrafiltration or diafiltration steps. Samples 60X11 and 62X13 (Table 
2) also contain relatively low amounts of Ca when compared to other samples, which 
indicates an intermediary step in which Ca was removed from the product, or at least an 
intermediary step designed to transfer calcium from colloidal phase to ionic phase so that 
it could be removed during the UF and DF processes.  
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Table 2: Composition data relating solubility of various MPCs to K, Ca, and Na 
content (Floris et al., 2007). 
Sample 
code Protein % Origin mg/g K mg/g Ca mg/g Na 
Solubility 
(NSI %) 
20A1 69.2 US 7.62 19.29 2.14 76 
21A2 76.3 US 3.73 21.85 2.10 68 
22A3 84.0 US 1.61 23.43 1.35 28 
23A4 56.9 US 10.29 17.04 2.95 81 
24A5 57.4 US 10.29 17.11 2.94 77 
25A6 68.3 US 7.24 19.04 1.97 72 
26A7 71.0 US 6.90 19.82 1.92 74 
27A8 54.6 US 11.05 16.21 3.02 75 
28A9 79.0 US 3.96 23.88 1.22 55 
51X02 80.7 world 3.35 23.28 1.21 57 
52X03 77.5 world 4.18 22.75 1.11 64 
53X04 59.8 world 9.55 18.10 2.39 72 
54X05 72.5 world 5.05 21.48 1.54 60 
55X06 79.5 world 4.56 21.63 1.25 72 
57X08 80.1 world 3.39 22.12 0.79 53 
58X09 60.0 world 9.95 18.62 2.54 74 
59X10 78.1 world 4.24 22.05 0.95 57 
60X11 80.2 world 1.79 12.94 12.83 79 
61X12 85.3 world 1.67 22.06 0.29 62 
62X13 80.6 world 1.92 12.65 13.70 80 
63X14 79.8 world 2.95 23.54 0.69 56 
64X15 59.8 world 11.51 14.44 2.52 68 
65X16 70.0 world 9.26 14.87 1.74 72 
66X17 80.6 world 7.11 16.00 0.91 68 
68X19 80.8 world 3.76 24.19 1.13 59 
69X20 67.1 world 8.43 21.78 2.05 82 
70X21 69.2 world 7.98 20.48 1.99 87 
71X22 59.0 world 10.88 18.89 2.74 88 
72X23 81.3 world 3.84 22.88 1.33 58 
72X24 80.1 world 3.95 25.50 1.59 63 
74X25 69.0 world 8.27 21.51 1.84 72 
Source: Adapted from Floris et al. (2007). 
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It is possible that samples with low Ca content were manufactured using a skim 
milk acidification process prior to UF and DF. Such an acidification step may result in a 
shift in the location and state of calcium, from colloidal calcium phosphate to ionic 
calcium (Walstra and Jenness, 1984). Ionic calcium may later be removed by UF and DF 
processes. However, any pretreatment must take care to avoid separation of casein and 
whey components, and thus it is not desirable to obtain a complete isoelectric casein 
precipitation. More likely, an acidification process is utilized whereby skim milk is 
partially acidified to later aid in the removal of Ca (and later addition of selected 
minerals), but isoelectric precipitation is prevented from occurring by carefully 
controlling skim milk pH. 
Unfortunately, since the manufacture process of each MPC examined in NIZO 
study is unknown, it is not possible to investigate any connections between manufacture 
process and solubility utilizing this data. Additionally, the study cannot provide 
information about the nature of processing variation that may occur during manufacture. 
2.2.1.2. Correlation Between Mineral Composition and MPC Solubility 
There is some evidence that increasing either Na or K content may improve the 
solubility of MPC, and both method and time of mineral addition may have significant 
impact on the solubility of the resulting powder. Carr et al. (2002) demonstrated that 
addition of monovalent salt to either skim milk (prior to the UF process) or final retentate 
(prior to spray-drying) could yield an MPC with enhanced solubility, though no 
explanation for the observed increase in solubility was reported. Dybing et al. (2007) 
discussed some principles of mineral manipulation in context of UF, and noted 
acidification of milk prior to UF could lower Ca content of MPC (most likely by shifting 
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Ca equilibrium towards the ionic phase, where it would then permeate through the 
membrane during the UF process).  
An MPC manufacture process involving skim milk acidification was described in 
great detail by Moran et al. (2001). First, pasteurized skim milk was treated with an 
edible acid to obtain a pH between 5.9 and 6.5. Second, the skim milk was concentrated 
via UF to at least 15 % total solids. Third, the pH of UF retentate was adjusted to between 
4.9 and 6.3 by the addition of edible acid. Finally, the retentate was dried by evaporation 
and spray-drying to obtain an MPC containing up to 70 % total solids. This MPC could 
more easily be incorporated into process cheese than such an MPC that did not undergo a 
manufacturing process involving acidification, and the reduced-calcium properties of this 
MPC were found to favorably impact the texture and functionality of the resulting 
processed cheese. A few disadvantages to this process, such as possible protein 
precipitation along with changes in retentate viscosity, UF flux, and Na contamination of 
permeate, were documented.  
It is not known which, if any, of these processes are currently utilized to 
manufacture MPC products available in the U.S. A survey of MPCs available from 
commercial suppliers indicates that at least one supplier advertises an instantantized MPC 
with improved solubility characteristics (Anonymous, 2010a), and at least one supplier 
advertises MPC tailored for yoghurt applications (Anonymous, 2007). Upon request, 
most suppliers will attempt to tailor MPCs towards various food applications, suggesting 
that some data correlating composition or manufacture parameters to MPC functionality 
is held internally. 
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2.2.1.3. Implications of Observations Linking Mineral Composition and 
MPC Solubility 
In milk, strong structural stability of proteins is imparted by electrostatic 
interactions between amino acid chains and ions in solution. Caseins contain several 
potential sites for ionic bonds between casein molecules, and it is believed that these sites 
play major roles in micelle sub-unit interactions (Farrell, 1988). Milk is sensitive to 
changes in ionic strength and pH; for instance, as pH approaches the isoelectric point of 
casein, inter- and intra-protein electrostatic interactions are increased to a point where 
casein precipitation occurs (Mulvihill and Fox, 1989b). Furthermore, there is great 
interest among researchers and technologists to best predict and utilize the ionic 
equilibria in milk to manufacture dairy products (Fox and Brodkorb, 2008). 
The equilibria between ionic colloidal salts of milk can be altered by many factors 
(Fox and McSweeney, 1998). For example, acidification of milk brings about the 
progressive solubilization of colloidal calcium phosphate, as well as other colloidal salts, 
from casein. This solubilization is complete between pH 4.6 and 4.9. The addition of 
alkali is known to have the opposite effect. At roughly pH 11, nearly all calcium in milk 
can be found in the colloidal phase. Changes in temperature cause large shifts in the 
solubility of calcium phosphate (Fox and McSweeney, 1998). The solubility of calcium 
phosphate increases with decreasing temperature. Low-temperature (in the range of 20 °C 
to 3 °C) shifts in this equilibria are reversible, but reversibility decreases upon thermal 
treatment of milk.  
Ionic equilibria play an important role in the properties of fluid milk, and it 
follows that ionic equilibria of dairy powders produced from processes utilizing milk may 
have a powerful ability to alter the solubility of those powders. Changes in ionic 
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equilibria are known to impact electrostatic interactions and hydrophobic interactions, 
two important factors dictating the solubility of a protein (Walstra et al., 2006). 
The solubility of dairy proteins is also known to decrease upon storage, and this 
phenomenon has been shown to occur in MPC upon storage at high temperature (Anema 
et al., 2006). One possible mechanism for the observed decrease in MPC solubility upon 
storage involves the Maillard reaction. It was noted that significant lactosylation occurred 
in MPC85 samples, particularly on κ-CN, that had been stored for 7 days at 50 °C (Figure 
2). Cross-linking of the proteins at the interface of the MPC85 powder were also 
implicated as a possible reason for the impaired solubility of the MPC upon storage. 
These findings were largely consistent with the findings of Mimouni et al. (2010), who 
provided field emission scanning electron micrograph evidence of intermicellar bridging 
still intact during rehydration. 
 Figure 2: Mass spectrum of 
days of storage at 50 
Figure 3: Details of the surface of rehydrated 
magnifications (x50,000
D indicate the presence of intermicellar 
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κ-casein A in untreated MPC85 (A) and MPC85 after 7 
°C (B) Source: Adapted from Anema et al.
MPC85 powder particles at 2 
 [C] and x100,000 [D]). The white arrows 
bridges (Mimouni et al., 2010)
 
 (2006) 
 
in panels C and 
. 
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2.2.2. Proposed Model of Protein Aggregation During MPC Manufacture 
The hairy layer of κ-casein chains impart casein micelle stability in the colloidal 
milk system through both electrostatic and steric repulsion, and it follows that if the hairy 
layer is removed, or if the hairy layer collapses, then a sufficient decrease in electrostatic 
repulsion occurs that can result in casein aggregation (Cho et al., 2003). Micelles 
depleted of κ-casein are also more prone to aggregation that those with intact κ-casein 
hairs on the micelle exterior (Walstra and Jenness, 1984). Casein aggregation can occur 
only under conditions in which it results in a lower free energy, which furthermore is due 
to a decrease in enthalpy (Walstra et al., 2006). When aggregation occurs, it causes a 
decrease of entropy, which in turn causes an increase in free energy (Equation 1), which 
simultaneously counteracts aggregation. 
 
     
Equation 1: Gibbs free energy equation for constant temperature, where ∆G is the 
change in Gibbs free energy, ∆H is the change in enthalpy, T is the absolute 
temperature, and ∆S is the change in entropy 
 
The model of heat-induced coagulation of milk proposed by Walstra et al. (2006) 
describes two distinct series of reactions that may cause casein coagulation. The first, 
which is highly dependent on Ca2+ activity, is colloidal in nature and is not strongly 
dependent on temperature. The first series of reactions involves the formation of Ca salt 
bridges when colloidal interactions (also determined by the location of κ-casein and pH 
of the milk system) dictate that caseins come into close proximity with one another. The 
second series of reactions can be described by the formation of chemical cross-links. 
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These covalent interactions are strongly temperature-dependent. Covalent interactions 
may result in cross-links between or within peptide chains. Possible cross link 
formations, which may severely inhibit protein solubility, are shown below (Table 3).  
It follows that, as caseins (along with whey proteins) are progressively 
concentrated during the UF process, and if distances between micelles are also decreased 
(Erdem, 2006) (and further discussed in Section 2.4.3.1), possibly also by way of 
decreasing electrostatic interactions due to mineral depletion and a net decrease in ionic 
strength, then the hairy layers of κ-casein on separate micelles may be more likely to 
come into contact with one another.  
Table 3: Possible Reactions of Side Chain Groups of Amino Acid Residues Linked 
in the Peptide Chain (|) of Proteins at High Temperature 
Reactant Direction Product 
|__CH2__S- + -S__CH2__| → |__CH2__S--S__CH2--| + 2e- 
Cysteine  Cystine 
   
|=CH2 + HS__CH2__| → |__CH2__S__CH2__| 
Dehydroalanine, Cysteine  Lanthionine 
   
|__(CH2)4__NH3+ H2C=| + OH- → |__(CH2)4__NH__CH2__| + H2O 
Lysine,     Dehydroalanine  Lysoalanine 
   
|__CH2__COOH + H2N__(CH2)4__| → |__CH2__CO__NH__(CH2)4__| + H2O 
Aspartic Acid,       Lysine  Isopeptide 
   
|__CH2__S__S__(CH2) __|  |__CH2__S- 
 +          + 
             |__CH2__S-          |__CH2__S__S__CH2__| 
Source: Adapted from Walstra and Wouters et al. (2006) 
 
When two micelles closely approach (due to Brownian motion) the protruding κ-
casein hairy layers may overlap, even though steric repulsion between micelles occurs at 
 16
a distance of roughly 20 nm. It is believed that cross-linking between reactive groups on 
κ-casein chains may occur, and that the number of linkages formed increases as the hairy 
layer interpenetration depth increases. Ca may play an integral role in forming initial 
short-lived bonds, which may be salt bridges between negatively charged groups. An 
excess of Ca ions may increase the probability of Ca bridge formation, particularly at κ-
casein (despite only containing 1 to 3 PO4 / mol) which may accelerate the rate at which 
Ca bridges between micelles may form. 
At high temperatures, such as those in a typical spray-drying process, more long-
lasting covalent bonds may form between amino acids if the necessary reaction radius has 
been penetrated, creating a strong network of many bonds termed a “junction.” (Walstra 
et al., 2006). This heat also has the effect of gradually dissolving inorganic phosphate, 
causing the net negative electric charge of the casein micelles to decrease, favoring casein 
micelle aggregation. It is at this point that water is removed, leaving behind dried powder 
particles in which this junction remains intact. This junction may inhibit rates of water 
transfer when the final powder is introduced to water, leading to poor solubility of MPCs 
(Mimouni et al., 2010) as discussed in Section 2.2.1.1. The model proposed above may 
explain why an alteration in the ionic strength of the milk serum, involving the removal 
of Ca from retentates produced through a UF and DF process, may result in the creation 
of high protein powders which are more highly soluble than those that have not 
undergone a Ca removal process, as was observed previously (Dybing et al., 2007). 
Yet, the question of how Na or K addition into an ultrafiltered retentate could 
yield a material, which upon subsequent diafiltration and spray-drying, which is more 
highly soluble than one which has not undergone Na addition, has not yet been fully 
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addressed. Caseins are unique proteins from a structural standpoint in that they contain 
repeating segments of serine phosphates (Fox and McSweeney, 1998). Caseins bind 
calcium at the ratio of about 0.016g Ca per g casein, or 0.4 g Ca per L milk (Demott, 
1969). In addition, casein may bind Na and K at neutral pH, and this binding also occurs 
at phosphoserine groups of caseins. It is possible that the increased Na present in samples 
60x11 and 62x13 and increased K in samples 23A4, 24A5, and others (Table 2) 
represents a state similar to that of sodium or potassium caseinates, which generally have 
better solubility than calcium caseinates. This is likely due to several factors, including a 
decreased net ionic strength (HadjSadok et al., 2008), increased electrostatic interactions, 
and decreased susceptibility to aggregate formation in sodium caseinate solutions as 
compared to calcium caseinate solutions. The role of Na in dictating the ionic strength of 
the milk solution, and subsequent changes that may be caused by ionic strength 
manipulation, will be discussed in Section 2.6.3. 
2.3. Assessing the Current State of Solubility of MPCs with ≥ 70 % Protein 
Though MPC has a variety of uses in dry-blending applications, a prerequisite for 
the expression of the majority of this ingredient's functional properties is ensuring the 
dispersion and solubilization of MPC. It can be generally stated that, although wide 
variation in MPC solubility has been previously observed, upon reconstitution at 20 °C of 
MPC containing ≥ 70 % protein, a portion of the solids remains undissolved and settles to 
the bottom of the container. Reconstitution of MPC containing ≥ 70 % protein is also 
typically characterized by poor dispersability of powder particles and impaired rate of 
hydration, which adversely impacts gelling, foaming, and emulsifying properties (Havea, 
2006). It is also recognized that increased MPC storage temperatures result in a decrease 
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in solubility over time (Anema et al., 2006, Havea, 2006, Jimenez-Flores and 
Kosikowski, 1986, Mistry and Pulgar, 1996). In addition, it is clear that increasing the 
temperature of reconstitution results in a decreased amount of undissolved solids (Mistry 
and Hassan, 1991b, Mistry and Pulgar, 1996). 
A variety of analytical work has been performed to understand the nature of 
insolubility of MPC containing ≥ 70 % protein. Havea (2006) noted the existence of only 
negligible differences between sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) patterns of MPCs (Figure 4), regardless of large differences 
in their solubilities. He also documented the presence of small amounts of disulphide-
linked protein aggregates present on top of, and within, the stacking gel. 
 
Figure 4: SDS-PAGE patterns of different MPC solutions observed by Havea 
(2006); lane 1: MPC85 with 53 % solubility; lane 2: MPC85 with 44 % solubility; 
lane 3: MPC85 with 41 % solubility; lane 4: MPC85 with 32% solubility, lane 5: 
MPC 85 with 96% solubility, lane 6: MPC with 98% solubility; protein 
concentration in samples ~ 1 g/kg, sample load = 10 µl. Gel image from Havea 
(2006) 
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He concluded that, based upon observed differences in alkaline-PAGE and SDS-
PAGE electrophoretograms (Figure 5), hydrophobic association of casein molecules 
(with some apparent interaction with minor whey proteins) was present with the 
formation of insoluble material. It was also apparent from SDS-PAGE and Two 
Dimensional (2D) SDS-PAGE that disulfide bound aggregates were composed of β-
lactoglobulin (β-LG) and κ-casein (κ-CN), as high-molecular weight protein aggregates 
moved to those respective locations in 2D SDS-PAGE, and resulted in more intense β-
LG and κ-CN bands, respectively, in SDS-PAGE. Lastly, these disulfide bound 
aggregates most likely existed in a range of sizes, as they were present in both 
supernatant phases and sediment phases after centrifugation (700 x g, 10 min). There was 
no evidence to suggest that disulfide bound aggregates were responsible for the formation 
of insoluble particles. 
 
 
Figure 5: Alkaline-PAGE (lanes 1-3), SDS-PAGE (lanes 4-6), and reduced SDS-
PAGE (lanes 6-9) patterns of 5% (w/w) MPC solution (41% solubility)  as 
observed by Havea (2006); Lanes 1,4, and 7: MPC solution, lanes 2, 5, and 8: 
sediment; lanes 3, 6, and 9: supernatant; protein concentration in samples ~ 1 g/kg, 
sample load = 10 µl. Gel image from Havea (2006) 
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Havea's findings were consistent with those of McKenna (2000), who investigated 
the formation of insoluble material in MPC. Observations utilizing transmission electron 
microscopy (TEM) indicated that insoluble material consisted of particles up to roughly 
100 µm in diameter. It was documented that these particles appeared to associate via 
some type of protein-protein interactions, and that an outer "skin" layer began to form on 
particles of MPC that were stored at 20 °C or higher, possibly inhibiting the movement of 
water into and between the particles. 
It was also observed that CN dissociation from micelles can occur at pH 7.1 in 
heated reconstituted skim milk  (Anema and Klostermeyer, 1997). Free CN, with a large 
amount of hydrophobic residues, may interact to form non-covalent linkages with non-
dissociated CN during drying. It is probable that the formation of insoluble particles 
occurs during the drying process, but there is currently no data relating changes in casein 
micelle size and casein micelle mineral depletion that co-occur during the UF process, 
with the formation of such insoluble particles. 
There is some data suggesting that significant changes in casein micelle size 
distribution occur during UF, which could induce a state in which hydrophobic 
interactions are more likely to occur upon drying (Srilaorkul et al., 1991). A kinetic 
approach suggested that heat-induced structural modifications of milk proteins are related 
to the concentration factor of the UF treatment, and found that the protein system in skim 
milk was reorganized to a progressively more compact structure via hydrophobic bonds 
as UF progressed. Heat treatment of this retentate may further induce a more "closed" 
casein structure, as surface hydrophobic sites of milk proteins bound with 1-
anilinonaphthalene-8-sulfonate (ANS) became progressively unavailable for hydrophobic 
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bonding (Erdem, 2006). Despite this work, there is still limited knowledge of how 
micelles are affected by the MPC manufacturing process, and the potential effect of 
mineral modifications on both the retentate and dried powder. 
It is important to view MPC solubility not only from the viewpoint of protein-
protein or protein-water interactions, but also from a physical dispersion standpoint. 
Several authors have studied the rehydration characteristics of dairy powders using 
nuclear magnetic resonance relaxometry (NMR-R) methods, which provide data on the 
rehydration kinetics during powder reconstitution. It was found that, for native 
phosphocaseinates (NPCS), NMR data indicated changes in CN micelle structure, which 
most likely resulted from changes in protein-protein interactions that influenced 
hydration characteristics (Schuck et al., 2002). Other workers have utilized turbidity 
sensors to monitor the dairy powder rehydration process. These sensors are advantageous 
because they can distinguish between several phases of dairy powder rehydration, such as 
wetting (the process of a powder absorbing water when first contacting the water 
surface), sinking (the process of a powder sinking into the water), dispersing (the process 
of the powder separating into single particles throughout the water), and solubilizing (the 
process of rapid association with water and dissolution into water) (Freudig et al., 1999).  
Use of turbidity sensors with NPCS solutions showed a clear ability to monitor 
the rehydration process, but further studies applying this approach to other dairy powders 
have not yet been done. It is likely that, if the introduction of sodium or potassium to 
skim milk retentate that has been produced via UF and DF processes changes the density 
or porosity of the resulting protein network of the MPC, changes in MPC rehydration and 
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rates of water transfer to the interior of the particles may be detected via the use of such 
turbidity sensors. 
2.3.1. Methods of MPC Solubility Analysis 
Solubility is defined as the property of a solid, liquid, or gaseous chemical solute 
to dissolve in a liquid solvent to form a homogeneous solution. Because MPC is a 
complex mixture of proteins, lipids, carbohydrate, minerals, and moisture derived from 
skim milk (which is itself not homogenous), dissolved MPC can never be considered 
truly homogenous. Therefore, it is prudent to consider more applicable definitions of 
solubility in context of MPC. 
Mulvihill and Fox (1989a), define protein solubility as “the amount of protein in a 
sample that goes into solution or into colloidal dispersion under specified conditions that 
is not sedimented by low centrifugal forces." Existing standard methods of dairy powder 
solubility analysis conform closely to this definition, but often measure all solids that 
resist centrifugation, as protein material does not sediment to the exclusion of all other 
molecules. For example, the solubility index (SI) for nonfat dry milk, developed by the 
American Dairy Products Institute (ADPI), measures the amount of product sediment 
after the application of low centrifugal forces under specified conditions. This method is 
also used to measure the solubility of dry whey, dry buttermilk, and dry whole milk 
powder. The insolubility index (ISI) is a measurement of the ability of a powder to 
dissolve in water, defined as the volume of sediment in ml after centrifugation. It is 
typically used to analyze the solubility of skim milk, whole milk, and sweet buttermilk 
powder, but it may also be applied to other soluble, dried dairy products (Federation, 
1988).  
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In literature related to MPC, solubility is defined using a multitude of different 
methods, though most methods cited or stated in literature conform to the definitions 
stated previously. For purposes of comparison of the effect of storage temperature on 
solubility, Anema et al. (2006) defined MPC solubility as: 
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Figure 6: Method used for determination of MPC solubility (Anema et al. 2006)  
 
Solubility was calculated according to the equation in Figure 6 after mixing a 5% 
w/w MPC85 solution in MilliQ water with a propeller-blade attached to an overhead 
stirrer (while maintaining the temperature of the solution at 30 °C, for a total of 30 min), 
withdrawing a subsample of MPC solution, and obtaining the supernatant by 
centrifugation at 700 x g for 10 min. It was found that the solubility of MPC85 decreased 
exponentially with storage temperatures, and that insolubility of an MPC85 system may 
involve interactions in or between casein micelles that reduce the solubility of these 
macromolecular complexes. 
For purposes of comparing the effect of processing methods involving 
monovalent salt addition on the solubility of MPC, the term "enhanced solubility" was 
defined only as "a product which on reconstitution into a 5% w/v solution provides less 
sediment on centrifugation for 10 minutes at 700 x g relative to the corresponding 
product" (Carr et al., 2002). It was observed that an increase in the cation to protein ratio 
of 0.035 to 0.100 moles per 100 g protein had a beneficial effect on the solubility of the 
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MPC, and the resulting MPC would be advantageous in the preparation of beverages and 
cheese manufacture. 
Lack of a standardized MPC solubility analysis method compounds the difficulty 
in comparing data across multiple studies, as the method and temperature of 
reconstitution greatly impact the amount of material able to enter solution and resist 
centrifugation or sedimentation. Therefore, multiple solubility methods should be 
considered when conducting any experiment that aims to assess the effect of a 
manufacture process, or changes in that process, on the solubility of the resulting MPC. 
This minimizes the chance that one particular test “favors” MPC of a certain 
composition, particle structure, or rehydration characteristic. 
2.3.2. Advances in Assessing MPC Solubility 
In recent years, a number of workers have explored novel methods of 
characterizing MPC solubility. Such methods aim to analyze key characteristics that may 
rapidly and efficiently predict the solubility of MPC without the need of carrying out a 
formal solubility test, such as those discussed previously in section 2.3.1. The two 
methods described below have potential future uses in the quantification of MPC 
solubility. 
The first method utilized fourier transform infrared (FTIR) spectroscopy in an 
attempt to correlate differences in MPC nitrogen solubility with changes in FTIR spectra 
(Kher et al., 2007). This work was able to correlate changes in nitrogen solubility of 
individual MPCs during storage with changes in spectra, and show sufficient evidence 
that second derivative spectroscopy and principle components analysis (PCA) in the 
amide I and II regions (1700 to 1400 cm-1) and the fingerprint region (1800 to 700 cm-1) 
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could discriminate between MPCs which suffered loss of nitrogen solubility on storage, 
and MPCs which maintained consistent nitrogen solubility on storage. 
The second method attempted to characterize the solubility of MPC using focused 
beam reflectance measurements (FBRM), which provides the ability to monitor changes 
in chord length over time under a variety of suspension concentrations (Fang et al., 
2010). A characteristic dissolution profile for different MPC powders was able to be 
established, but it was recognized that further investigation must be conducted to confirm 
FBRM as a method suitable for MPC solubility analysis, especially given that MPCs vary 
widely in composition and dissolution characteristics. 
Although both techniques could potentially be used in the future to better 
standardize and characterize the solubility of high-protein dairy powders, at present day 
they have not been adequately tested, and neither has been proven to assess the solubility 
of MPC in a way that can be traced across previous studies. Therefore, any current 
assessment of manufacture processes on the solubility of the resulting MPC should be 
conducted using existing methods of solubility analysis, such as those discussed 
previously in section 2.3.1. 
2.4.  Possible Changes in Casein Micelles During MPC Manufacture 
2.4.1. Caseins 
The casein micelles can be described as supramolecules, systems containing 
several molecular entities organized by noncovalent intermolecular binding interactions. 
Casein micelles represent roughly 80 percent of the total protein in bovine milk and other 
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commercial dairy species, and are the primary sources of calcium, phosphate, and protein 
for the mammalian neonate.  
Table 4 lists characteristics that contribute to the biological purpose of milk and 
its ability to be utilized as a food ingredient. 
Table 4: Average characteristics of casein micelles from bovine milk 
Characteristic Value 
Diameter 120 nm (range: 50 - 500 nm) 
Surface Area 8 x 10-10 cm2 
Volume 2.1 x 10-15 cm3 
Density (hydrated) 1.0632 g cm3 
Mass 2.2 x 10-15g 
Water content 63% 
Hydration 3.7 g H2O g-1 protein 
Voluminosity 44 cm3 g-1 
Molecular Mass (hydrated) 1.3 x 109 Da 
Molecular Mass (dehydrated) 5 x 108 
No. of Peptide Chains 5 x 103 
No. of Particle per ml Milk 1014 to 1016 
Surface of Micelles per ml Milk 5 x 104 cm3 
Mean Free Distance 240 nm 
Source: Adapted from (Fox and McSweeney, 1998) 
The stability and structure of casein micelles during processing is known to have 
strong implications on the properties of the final food product. Casein micelle structure 
has been the focus of exhaustive research (Dalgleish and Parker, 1980, Fox, 1989, Fox 
and McSweeney, 1998, Horne, 1998, Kruif, 1999, Sawyer, 1969a, Walstra and Jenness, 
1984, Waugh and von Hippel, 1956). It is generally accepted that casein micelles exist as 
roughly spherical, porous entities, 50 nm to 500 nm in diameter, and there are several 
different models of casein micelle structure. These models fall into the general categories 
described as coat-core, internal structure, or subunit models (Fox and Brodkorb, 2008). 
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To date, the most accepted model is the submicelle model proposed by Walstra in 1984, 
which describes the casein micelles as composed of roughly spherical subunits called 
submicelles. 
2.4.1.1. Effect of Temperature on Casein Micelles 
The caseins are susceptible to temperature-induced association, which is largely a 
function of their high hydrophobic residue content, presence of highly charged segments, 
and cross-linking via organic phosphate groups. For example, αs1-CN associates in a 
series of consecutive steps, which are dependent upon ionic strength and pH, but 
independent of temperatures below 30 °C. The association of αs2-CN is dependent upon 
ionic strength, but is also relatively independent of temperatures below 30°C. However, 
the association of β-CN, in addition to being dependent on ionic strength, is highly 
temperature dependent (Fox, 1989). 
A shift in temperature not only causes changes in milk protein association, but it 
also alters the ion-binding abilities of the individual caseins. Calcium-binding of the 
caseins is influenced by temperature, pH, and ionic strength (Dalgleish and Parker, 1980, 
Dickson and Perkins, 1971, Horne, 1998). At Ca2+ concentrations ordinarily found in 
milk, Ca2+ is bound to phosphoseryl residues, but at at high Ca2+ concentrations, binding 
to aspartyl or glutamyl residues may occur. This causes a reduction in protein charge 
along with significant changes in conformation, causing protein association and 
eventually precipitation to occur.  
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2.4.2. The Role of κ-CN on Micelle Structure and Stability 
The isolation of κ-CN by Waugh and von Hippel (1956) drove casein micelle 
research towards the investigation of this particularly hydrophilic protein. κ-CN, a 
mixture of disulfide-bonded polymers, stabilizes and regulates the size of casein micelles, 
which can be considered a colloidal protein complex containing Ca+2 and inorganic P. 
Although it consists of only between 12 % to 15 % of the entire casein micelle system, κ-
CN’s hydrophobicity and solubility in the presence of Ca2+ contrasts to the relative 
hydrophobicity and susceptibility to Ca2+ -induced coagulation exhibited by the other 
casein variants. Not only is κ-CN insensitive to the presence of relatively high 
concentrations of Ca2+, it can also stabilize nearly 10 times its weight of  αs1, αs2, and β-
CN against Ca2+ -induced precipitation. Thus, the location of κ-CN in relation to the other 
micellar proteins, and its ability to stabilize the casein micelle in the presence of Ca2+, 
play a critical role in the structure of the casein micelle and the micelle’s stability in the 
relatively calcium-rich milk system (Mulvihill and Fox, 1989a). 
2.4.3. Ultrafiltration 
If an increase in the degree of Ca-dependent colloidal interactions between κ-
casein hairy layers is at least partly responsible for the formation of observed covalent 
bonds between proteins under conditions of heat treatment, then it is imperative that a 
clear understanding of how UF favors these interactions is needed. This cannot take place 
unless the basic principles of the UF process are first discussed. 
UF describes a variety of membrane filtration processes in which hydrostatic 
pressure forces a fluid against a semipermeable membrane. Solids and solutes of high 
molecular weight are retained, while water and low molecular weight solutes pass 
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through the membrane into the permeate stream. In bovine milk, the general separation of 
components is illustrated by Figure 7. The efficiency of a membrane process is 
determined by both the membrane’s selectivity, governed by its reflection, and the 
permeate flux. The rejection (R*) of a particular solute x is described by the equation 
(Figure 8). 
 
Figure 7: Flow of the components removed from ultrafiltered milk, from 
Anonymous (2001) 
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Figure 8: Description of rejection R* of a solute x, where qw = flux  
(kg•m-2 •s-1) of a solvent through the membrane, and qx = flux (kg•m-2 •s-1) of solute 
x, c* = concentration (kg solute / kg water) of x at pressure side of membrane 
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In ideal filtration situations, R* = 1 for all retained components, and R* = 0 for all 
components which permeate through the membrane. However, most components will 
have R* values between 1 and 0. Several factors in general are known to affect R*, 
including the type of membrane utilized, molecular weight of the solute, viscosity of the 
solute, concentration factor, and transmembrane pressure. With milk in particular, pH and 
temperature, which not only dictate solution viscosity but also alter the interactions 
between minerals and proteins, have an effect on both rejection and permeate flux, which 
is important in gauging the efficiency and speed of the UF process. 
The permeate flux is described as the quantity q of liquid which passes through 
the membrane per unit time and surface area, and is defined by the equation (Figure 9): 
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Figure 9: Description of the permeate flux of a membrane, where q = total permeate 
discharge, B = permeability coefficient of the membrane, h = effective thickness of 
the membrane, 4p = transmembrane pressure, and η = viscosity of the permeating 
liquid 
 
There are several additional factors which effect the permeate flux during skim 
milk UF. For instance, protein molecules typically adsorb onto the membrane surface 
over the course of the UF process and reduce the effective pore width, reducing flux. In 
addition, at high flux values, a gel layer is compressed across the membrane surface 
which enhances membrane selectivity. High levels of calcium phosphate in retentate 
promote gel formation, and thus removal of calcium (for example by electrodialysis) is 
known to increase flux rates. 
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At typical operating pressures of 20 psi to 80 psi, the turbulent flow of the 
membrane surface prevents build up of particles and excessive membrane fouling (Pabby 
et al., 2009). UF membranes contain pores in the range of 0.1 to 0.001 µm. The typical 
UF membrane utilized by the dairy industry is a pressurized system containing a spiral 
wound module with negatively charged polyethersulfone membrane with a nominal 
molecular weight cut-off of 10 kDa. UF applications in the dairy industry include, but are 
not limited to, production pre-concentrated milk for cheese making, production of milk 
protein and whey concentrates and isolates, and acquisition of lactose and mineral rich 
permeates. It was estimated that over 300,000 square meters of membrane were installed 
in the dairy industry worldwide as of 1998 (Cheryan, 1998). 
2.4.3.1. The Effect of UF and DF on Casein Micelle Size Distributions 
The effect of UF on casein micelle structure is a topic of emerging research. 
Along with the previously discussed work of Erdem (2006), who observed the increasing 
hydrophobicity of the concentrated milk system during UF using the ANS hydrophobic 
probe, a number of authors have contributed observations to the area of casein micelle 
size changes as a result of UF. In highly concentrated UF milk retentate, caseins are 
allowed to interact over short distances, and this has shown to influence the size 
distribution of micelles. During UF, the distance between casein micelles was shown to 
decrease from approximately 120 nm to approximately 10 nm (Walstra and Jenness, 
1984). Unfortunately, data relating casein micelle size to the UF process is not consistent 
across all studies. Some studies reported that casein micelle size appeared to be 
unchanged, while others reported increased or decreased sizes.  
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Karlsson et al. (2007) reported no observable changes in casein micelle size when 
UF retentate was observed under TEM, using three different preparation techniques, 
though it was must be noted that any TEM preparation (and virtually any microscopy 
preparation) may itself interfere with sample size. Singh (2007), utilizing electron 
microscopy, reported an increase in micelle size during the course of UF. It was also 
noted that micellar swelling occurred during DF, an increase in nonmicellar material was 
observed, and that the non-micellar material appeared to link together intact micelles, 
which is consistent with the findings of Srilaorkul et al. (1991). Meanwhile, Erdem 
(2006) observed decreases in micelle size as a result of UF. The most recent study was 
performed by Martin et al. (2010), who reported that casein micelles were not altered 
during the manufacture of MPC. This conclusion was reached by applying photon 
correlation spectroscopy (PCS) using the Cumulant method, also described in Martin et al 
(2007), to raw skim milks, UF/DF retentates, and concentrated UF/DF retentates. It was 
observed that differences in micelle size between these materials were less than 3 nm, 
and that this difference was not significant relative to the accuracy of the measurements. 
In addition, it was found that MPC reconstituted in water at 60 °C exhibited micelle sizes 
in the range of 210 nm to 197 nm within 30 minutes after reconstitution, to 197 nm to 
195 nm after 1 h reconstitution, which is similar to size observed in skim milk in the 
same study and other studies of skim milk casein micelle size (Griffin and Anderson, 
1983, Holt et al., 1973).  
These results show that, in the determination of submicron particle sizes, PCS 
methods and other light-scattering techniques may be advantageous over microscopy 
methods because they do not require a sample preparation step that may alter sample 
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properties, and future work would benefit from the application of PCS to the study of 
ultrafiltered skim milk for this reason. The results of Martin et al. (2010), obtained by 
PCS methods, were consistent with those obtained through TEM by Karlsson et al. 
(2007) using three different sample preparation steps. Both studies were also consistent 
with (McKenna, 2000), who utilized electron microscopy and reported no change in 
casein micelle size distribution under conditions of UF. This body of work is also in 
agreement with the work of Montero (2010), who utilized dynamic light scattering (DLS) 
to observe the size of casein micelles at conditions up to 5X UF and noted no statistically 
significant difference in the size of casein micelles. Despite the earlier microscopy-based 
work of (Walstra and Jenness, 1984)  and Singh (2007), the general agreement of PCS, 
TEM, and DLS methods indicates that casein micelle size is probably not affected to a 
significant degree as a result of UF. It is clear from the above research that microscopy-
based methods alone, with the possible exception of TEM, cannot be used to draw 
accurate conclusions about the effect of UF on casein micelle size. 
2.4.4. Evaporation and Spray-drying 
The purpose of evaporation is to remove as much water as is practically possible 
without decreasing the quality of the final MPC. After UF (and, optionally, DF) the 
retentate is evaporated to remove additional water, and then spray-dried. 
Spray drying is a method of producing a dry powder from a fluid by rapidly 
drying with hot air. All spray-driers contain an atomizer (spray nozzle) which disperses 
the liquid into droplets of uniform size, most commonly between 100 µm and 200 µm. 
The dried product is then collected in a drying chamber, and moisture-laden air is 
separated from dry powder using a cyclone separator. 
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Although the varying physical attributes (and to a lesser extent, the chemical 
attributes) of the resulting MPCs are relatively well documented, there has been little 
work examining the specific effects of spray-drying on casein micelles in milk, and even 
fewer studies have examined the specific effects of spray-drying on casein micelles in UF 
concentrated milk (Singh, 2007).  
2.4.4.1. Influence of Spray-drying on Characteristics of Powder Particles 
Valued technological properties of dairy powders are dictated by interactions 
between particles and water, such a rehydration and solubilization (Gaiani et al., 2005, 
Gaiani et al., 2007), particles and air (oxidation) (Keogh et al., 2001), and particle-
particle interactions (flowability and stickiness) (Kim et al., 2005). These interactions are 
influenced by the chemical composition of powder particles, their morphological and 
physical properties, and their surface composition and structure. All of these 
characteristics can be altered by adjusting the various parameters of the spray-drying 
process. 
A number of authors have published work providing insights to the changes in 
morphological properties which can occur due to variations in processing conditions and 
storage, which were found to influence surface composition and lipid distribution in 
several studies (Buma, 1971, Kim et al., 2002). With the application of X-ray 
photoelectron spectroscopy (XPS) to particle analysis, spray-drying conditions have 
recently been implicated as having profound effects on particle surface composition and 
topology. In a study performed on commercial native micellar casein (NMC) and 
commercial native whey isolate (NWI) powders, Gaiani et al. (2010) found that as outlet 
air temperature increased from 70 °C to 150 °C, the percentage lipids on the particle 
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surface decreased from 5.3 % to 0 %. When NMC contained lactose (added prior to 
drying), the percentage lipids on the particle surface decreased from 8.9 % to 0 % as 
spray-drying outlet air temperature increased from 70 °C to 150 °C.  
The surface composition of native whey isolate (NWI) powders containing whey 
proteins were found to vary strongly with spray-drying outlet temperature. Lipid surface 
content of NWI particles decreased from 33.8 % to 10.6 % as spray-drying temperature 
increased from 70 °C to 150° C. When NMC contained lactose (added prior to drying), 
the lipid surface content of particles decreased from 27.6 % to 3.8 % as spray-drying 
outlet temperature increased from 70°C to 150°. Powders containing an 80/20 mix of 
casein to whey were also found to be affected by spray-drying outlet temperatures; lipid 
surface content of these casein/whey mixtures decreased from 10.1 % to 0 %. These 
results indicate that spray-drying outlet temperature is a critical factor which can 
influence the surface composition of powder particles in NMC, NMC containing lactose, 
WMI, and WMI containing lactose. It can be expected that spray-drying outlet 
temperature may impact the surface composition of MPC powder particles in a similar 
fashion, but given the relatively large amounts of lipids in some MPCs compared to the 
NMC and WMI powders studied previously, there is not sufficient data to hypothesize 
how proteins, lipids, and lactose may redistribute upon spray-drying at different outlet 
temperatures. Therefore, because the manufacture of MPC on large-scale commercial 
level requires the use of a spray-dryer, care should be taken to control such variables as 
inlet and outlet temperatures, feed rates, and ambient air conditions to minimize variation 
in overall MPC quality. 
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2.4.5. Possible Surface Formation Mechanisms 
Previous research has suggested two main theories of surface formation of a 
drying droplet exiting the spray-drier nozzle. The first theory, supported by the work of 
Fäldt and Bergenstahl (1994) and Nijdam and Langrish (2005), contends that protein 
preferentially absorbs to the air/liquid interface on droplets, and that fat droplets must 
thusly migrate to the interior of the droplet. This theory is based on XPS measurements to 
analyze the chemical composition of spray-dried dairy based model emulsions. The work 
of Fäldt (1995) demonstrated that solutions containing surface-active components (such 
as proteins) tend to dominate the surface of a spray-dried powder particle. This 
observation was explained by a scenario in which the high surface activity of protein will 
absorb preferentially to the air/liquid interface of a droplet during atomization of liquid 
feed into hot air. 
The second theory, supported by the work of Kim et al. (2003) and Kentish et al. 
(2005), based on slab drying experiments with a food model system containing water, 
sucrose, and sodium caseinate, takes into account the differences in binary diffusion 
coefficients of the spray-dried molecules. Because the binary diffusion coefficient in an 
aqueous solution can vary significantly between high molecular weight components and 
low molecular weight components, the transport velocity of each component towards the 
center of the droplet may be very different. It was observed that segregation of 
components does occur during spray-drying, and that the surface of powder particles 
could be expected to be enriched with components possessing the lowest diffusion 
coefficients (proteins and lipids). It was noted by Gaiani et al. (2010) that, at spray-drying 
outlet temperatures above 110 °C, the diffusion of components could be interrupted by 
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the solidification of the outer surface of the powder particle, and the subsequent 
immobilization of components trapped in that layer, before the system attains 
equilibrium. 
Though these two theories shed some light onto the mechanisms of particle 
formation and the composition and structure of the resulting powder particles, further 
research must be conducted to understand the interactions of kinetic forces on particle 
formation (Kim et al., 2003). Little is known about the dynamic interactions which 
proceed during formation of droplets. In particular, the methods used by previous authors 
could be adapted towards the analysis of MPC, with little modification required, in order 
to further investigate the rehydration and solubility mechanics of these powders. 
2.5. Other Milk Proteins 
An understanding of the fundamental characteristics of milk proteins is integral 
when discussing the UF and DF of skim milk and the spray-drying of the resulting 
retentate; therefore this section will establish a common ground from which applied 
topics relevant to MPC manufacture can be explored. 
2.5.1. Whey 
The whey protein fraction consists of β-LG, α-lactalbumin (α-LA), and bovine 
serum albumin (BSA). The main whey protein is β-LG, which is 50% of the whey 
fraction and 12% of t otal milk protein  (Fox and McSweeney, 1998). β-LG contains two 
disulfide bonds and one free sulfhydryl group that is located within its structure. This 
sulfhydryl group is revealed upon thermal denaturation, and it becomes available to react, 
particularly with κ-CN. The interaction between κ-CN. and β-LG involves both a 
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sulphydryl-disulphide interchange mechanism and non-covalent interaction (Sawyer, 
1969b). Interactions between κ-CN. and β-LG are fundamental to all thermally-induced 
modifications of the functionality of milk proteins (Cho et al., 2003). The role of heat-
induced κ-CN. and β-LG interactions in the formation of MPC insolubility is still under 
investigation. 
α-LA comprises 20% of the whey protein in milk, and 3.5% of the total milk 
protein (Fox and McSweeney, 1998). α-LA contains four disulfide bonds. BSA exists in 
low concentrations; it is normally found in bovine blood, but transfers to milk in small 
amounts (Fox and McSweeney, 1998). 
2.6.  Minerals 
Minerals are relatively minor constituents in bovine milk, but the ionic 
equilibrium they contribute to plays a significant role in determining the structure of the 
casein micelles. Bovine milk ordinarily contains salts in the quantities listed in Table 5. 
The total ionic strength of milk varies between 0.067 and 0.080. Ionic strength affects the 
electrical double layer thickness, which is about 1.1 nm in milk serum (Walstra et al., 
2006).  
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Table 5: Distribution of milk salts in bovine milk 
 
 
 
Species 
 
 
 
Concentration 
(mg/L) 
 
Soluble 
 
Colloidal 
(%) 
 
%       Form 
Sodium 500 92              Completely Ionized 8 
Potassium 1450 92              Completely Ionized 8 
Chloride 1200 100            Completely Ionized — 
Sulphate 100 100            Completely Ionized 57 
Phosphate 750 43              10% bound to Ca and Mg 
                  51% H2PO- 
                  39% HPO42-  
Citrate 1750 94              85% bound to Ca and Mg 
                  14% Citr3- 
                     
    1% HCitr2-  
Calcium 1200 34              35% Ca2+ 
                  55% bound to citrate 
                  10% bound to phosphate 
66 
Magnesium 130 67              Probably similar to calcium 33 
 Source: Adapted from Fox and McSweeny (1998) 
 
2.6.1. Calcium 
Ca plays an important technological role in the production of most dairy products, 
and it is of particular interest in MPC manufacture for reasons discussed previously in 
sections 2.2.1.3 and 2.2.2  Calcium in milk exists in three forms: Assuming a total Ca 
content ≈ 32 mM, roughly 22 mM (69%) exists in the colloidal phase and roughly 10 mM 
(31%) exists in the soluble phase. Only 2 mM of soluble Ca exist as ionic Ca (Walstra 
and Jenness, 1984). Ca distribution in milk is 2 to 2.5 times higher in the colloidal phase 
than in the soluble phase (De la Fuente, 1988, Rajput and Bhavadassan, 1983). The 
remainder of soluble Ca is associated to citrate, phosphate, and casein monomers. In the 
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colloidal phase, Ca may interact with phosphoesters, carboxyl groups of casein micelles, 
or colloidal phosphate and citrate associated with casein micelles (Philippe et al., 2003). 
2.6.2. Importance of CCP in Casein Micelle Stability 
Approximately 6% (w/w) of dry casein is composed of various minerals, of which 
calcium phosphate is the largest constituent (Fox and McSweeney, 1998), and it is a key 
structural element of the casein micelle. CCP, with its positive charge, binds to negatively 
charged phosphoserine residues and reduces the caseins’ negative charge to a level at 
which hydrophobic interactions dominate (Horne, 1998). CCP may be solubilized at low 
temperatures and by acidification. 
2.6.3. Sodium 
Casein micelle stability can be altered by the presence or absence of several key 
cations, notably calcium, potassium, phosphorus, magnesium, and sodium. The effect of 
NaCl on properties of casein micelles in both unconcentrated and concentrated milk has 
been explored in the scientific literature. Addition of 50 mM to 100 mM NaCl to 
unconcentrated milk reduces the milk’s pH, primarily caused by increased dissociation of 
ion pairs when net ionic strength increases, and the displacement of casein-bound H+ by 
Na+, which results in increasing serum-phase H+ (van Hooydonk et al., 1986). The 
addition of NaCl has also been shown to increase micelle hydration, which is thought to 
increase the heat stability of milk (Creamer, 1985). 
The addition of 100 mM to 400 mM NaCl to concentrated bovine milk (18 % and 
27 % total solids) is also associated with a number of changes, such as an increase in the 
amount of ionic calcium and soluble calcium present, and a decrease in zeta potential. 
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However, no net change in casein micelle size was detected. It was also noted that NaCl 
addition increased the heat coagulation time of concentrated milk (18% and 27% total 
solids), and decreased the extent of heat-induced dissociation of micellar κ-CN as 
determined by SDS-PAGE (Huppertz and Fox, 2006). A decrease in heat-induced 
dissociation of micellar κ-CN is expected to result in an increase in the heat coagulation 
time of milk. 
2.6.3.1. Sodium’s Role in Determination of Milk System Ionic Strength 
Milk can be considered a dilute aqueous solution with an ionic strength of roughly 
0.073 M. In an ideal solution, ionic strength is defined as a function of the concentration 
of all ions in solution (Equation 4); however, milk is not an ideal solution and thus 
activities must be used to calculate ionic strength (Equation 2, Equation 3). 
. *  6. . 
Equation 2: Relationship describing ion activity of substance x, a = activity 
(mol/L), γ = activity coefficient, m = concentration (mol/L) 
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Equation 3: Free ion activity coefficient of an ionic species in water at room 
temperature when ionic strength < 0.1 M, γ = activity coefficient, z = valency of ion 
i in Equation 4, I = ionic strength of solution. 
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Equation 4: Ionic strength of a solution, I = ionic strength ci = molar concentration 
of ion i, zi = charge number of ion i 
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Addition of NaCl to the milk solution causes an increase in the ionic strength of 
the milk solution, which in turn causes a decrease in ion activity coefficients (Equation 
3). The result is that, in general, the solubility of milk salts increases (Walstra et al., 
2006), a phenomenon which some MPC manufacturers may exploit to modify the 
mineral content of retentate during the ultrafiltration process. In particular, the solubility 
of calcium phosphate (Equation 5) increases as NaCl is added to milk; increasing I results 
in a decrease in the activity coefficient of Ca+2 and HPO4-2, given that dissociation KD 
remains constant (Equation 6). 
CaL2LHPO4-2  CaHPO4 
Equation 5: Chemical equation describing the equilibrium of calcium phosphate in 
milk 
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Equation 6: Dissociation constant for calcium phosphate in milk 
 
The ionic strength of the milk solution also plays a strong role in determining the 
extent of electrostatic repulsion between particles. These particles have negative surface 
charge; therefore counterions (cations in milk) tend to group near the particle surface, 
while co-ions (anions in milk) migrate toward the interstitial space between particles. 
Particle surfaces contain high concentrations of counterions, with the concentration of 
counterions gradually decreasing as the distance away from the particle surface becomes 
greater. The accumulated counterions at the particle surface, along with the gradient of 
decreasing counterion concentration, is known as the electrical double layer. If two 
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charged particles overlap, their electrical double layers may also overlap, causing the 
repulsion of the two particles.  
However, the addition of NaCl to concentrated milk is known to result in an 
increase in ionic strength, which would have the effect of reducing the electric shielding 
parameter 1/k (Equation 7) and collapsing the electrical double layer. 
 
1/$ Y 0.30/√> 
Equation 7:Approximation of the Debye length as provided by Walstra et al.(2006), 
1/k = the nominal thickness of the electric double layer, I = ionic strength (mol/L), 
 
Therefore, if the solubility of MPC may be improved by the addition of Na to 
retentate, depletion of Ca from retentate during the MPC manufacture process, several 
events may be occurring simultaneously that greatly impact ionic strength, electrostatic 
interactions, the electrical double layer, and ultimately the interaction free energy 
between colloidal milk particles. Because the interaction free energy between colloidal 
milk particles cannot yet be estimated with accuracy in a given system (Walstra et al., 
2006), it is critically important that future studies obtain qualitative data on the ion 
concentrations and activities present within retentate products; if this data is obtained, the 
role ionic strength plays in protein aggregation upon spray-drying of MPC retentate can 
be better understood. 
2.7. Summary of Literature 
Milk protein concentrate (MPC) can be defined as a range of products with 
varying bovine milk protein content produced from the ultrafiltration of skim milk and 
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subsequent water removal. The manipulation of processing parameters has allowed 
manufacturers to create a wide variety of MPC products with varying protein, lactose, fat, 
and mineral concentrations. Large discrepancies between MPC composition (particularly 
with respect to key cations) from manufacturer to manufacturer, along with literature 
demonstrating intent to manipulate mineral content to improve functionality, indicate that 
(1) manufacturing process and equipment is highly varied, and (2) manufacturers employ 
different intermediary steps with the intent of replenishing or depleting minerals. Of key 
interest is solubility of MPC, which has been found to vary widely, despite its importance 
in dictating the expression of most other functional properties. Prior research has shown a 
relationship between Na and K content and solubility of MPC, with some evidence that 
Ca content also plays a role, and that these relationships would be well worth further 
investigation. 
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3. Justification, Hypothesis, and Objectives 
An extended review of the patent and scientific literature hints at two critical 
factors that likely influence the solubility of MPC80. The calcium content of the skim 
milk retentate prior to spray-drying is the first critical factor implicated by several 
workers in the art (Carr et al., 2002, Dybing et al., 2007), who collectively describe 
processes for the Ca depletion of retentate by acidification, Na addition, and/or ion 
exchange, leading to the production of cold-water soluble MPC80 with improved 
solubility. Additionally, workers in the art of cheese making reference the use of such 
calcium-depleted MPC in patent literature relating to the manufacture of process cheese 
(Moran et al., 2001). The second critical factor is the Na content of MPC. Using sodium 
to fortify either the skim milk starting material or the product obtained by UF/DF has 
been demonstrated to significantly improve the solubility of MPC. 
Despite evidence of the effect of Ca depletion and Na addition on the solubility of 
MPC, there exists no study in the scientific literature examining the relationship between 
an MPC manufacture process designed to replace Ca with Na, and proximate 
composition of retentate intermediates obtained during the manufacture process. 
Additionally, there are no studies which link manufacturing process of an MPC 
replenished in Na content, Na and Ca content of retentates and powder, particle size, 
particle structure, solubility, and changes in hydrophobicity upon powder reconstitution. 
There is also no mention of an MPC manufacture process that incorporates sodium 
addition into DF water, which may be a convenient application in industry which 
prevents the contamination of UF permeate with high Na content. 
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This thesis project intends to examine the effect of Na addition into DF water on 
the solubility of MPC. The relationships between MPC composition, solubility, structure, 
and particle size will be examined. Once these relationships have been elucidated, steps 
can be taken to control the content of key minerals during the manufacturing process, 
with the intention of producing more highly soluble MPCs. 
MPC can be defined as a product with varying bovine milk protein content 
produced from the ultrafiltration and subsequent diafiltration of skim milk. 
Unfortunately, many MPC powders concentrated to 70% protein or above exhibit poor 
water solubility, and the solubility of these powders varies greatly from manufacturer to 
manufacturer. This suggests inconsistencies in manufacturing process and parameters. A 
review of the current scientific literature hints at several critical factors, including powder 
Na content, that likely influence the solubility of MPC. There exists no study in the 
scientific literature examining the relationship between MPC processing method, 
solubility, composition, Ca content, and Na content with particle structure and size 
distributions both of the dry powder and during reconstitution. The experiment proposed 
is designed to address the current needs of the scientific literature. Data produced by such 
a study could be utilized by MPC manufacturers to produce MPCs of consistently high 
solubility, and by the research community in future work exploring the interactions 
leading to protein aggregation and insolubility in spray-dried MPC. 
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The hypotheses of this study were: 
1.     MPC manufactured utilizing increasing levels of Na in DF water will 
contain increasing levels of Na and will also show increased solubility 
upon reconstitution into DI water. 
2.     MPC manufactured utilizing increasing levels of Na in DF water will 
exhibit smaller particle sizes, and differences in particle structures 
during reconstitution will be observed between MPCs manufactured at 
different treatment levels. 
The objectives of this study were: 
1. To develop a method of replenishing MPC retentate of Na content by 
adding NaCl  into DF water, and to show evidence that this method 
yields an MPC with improved solubility upon reconstitution into water. 
2. To show that, at increasing levels of NaCl addition into DF water, 
progressively more Na is present in retentate and final powder, while 
decreasing levels of Ca are present in retentate and final powder. 
3. To show evidence of changes in particle size and structure that exist 
between Na-replenished MPC and MPC that has not been replenished 
with Na upon reconstitution into water. 
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4. MATERIALS AND METHODS 
4.1. Experimental Design 
The model of the randomized complete block is: 
yij = µ + τi + βj + εij 
Definitions of terms are as follows: 
τi = main effect of the ith sodium chloride treatment level 
βj = main effect of jth block 
εij = random error term 
i = 1, 2, 3, 4  
1 = 0 mM (0 %) 
2 = 50 mM (0.29 %) 
3 = 100 mM (0.58 %) 
4 = 150 mM (0.88 %) 
j = 1, 2, 3 
1 = batch 1 
2 = batch 2 
3 = batch 3 
 
Data from previous pilot plant trials was used to approximate statistical power. 
Three preliminary trials were performed using the manufacture method described in 
section 4.2; one trial utilized NaCl treatment level 1, one trial utilized NaCl treatment 
level 2, and one trial utilized NaCl treatment level 3. From these preliminary trials, it was 
determined that only one treatment level could be reliably tested per day, and that one 
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batch of skim milk should be utilized to produce each of the four treatments (to attempt to 
minimize any batch effect). This dictated the incorporation of a blocking factor into the 
experiment design. These three preliminary trials indicated approximately 10.0% 
difference in solubility between the most effective treatment level and control samples. 
Additionally, it was observed that the standard deviation for MPC solubility was 
approximately 2.6 %. 
Statistical power is defined as the probability that a test with the specified 
assumptions will correctly reject the null hypothesis when the alternate hypothesis is true, 
and is defined by the series of equations in Appendix A. 
Using Minitab v15.1 it was calculated that, with four treatment levels, 88.0 % 
power was obtained by completing each treatment three times (Figure 10). This indicated 
that the experiment had an 88.0 % chance of detecting a 10 % difference in solubility if it 
truly exists. The actual order of trials performed in this experiment is also shown (Table 
6). 
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Figure 10: Power curve for one-way ANOVA for MPC manufacture. x axis is 
maximum detectable difference in % solubility 
 
Table 6: Actual order of MPC trials performed 
Block Day Treatment (% NaCl in DF H2O)  Treatment Level 
1 1 0.00 1 
1 2 0.29 2 
1 3 0.58 3 
1 4 0.88 4 
2 5 0.58 3 
2 6 0.88 4 
2 7 0.29  2 
2 8 0.00 1 
3 9 0.88 4 
3 10 0.00 1 
3 11 0.29 2 
3 12 0.58 3 
 
 
 4.2. MPC Manufacture
Milk was stored, collected,
to Figure 11. Three batches of 56
Producer's Dairy Foods, Inc. (Fresno, CA)
block, and milk was stored a 
four trials (one trial at each of the four treatment levels)
day. One trial consisted of 140 kg
tank attached to an R12 Pilot Plant
with dual 10 KDa cut-off
(model MT3B-3838, approximate length = 1.2 m,
 
Figure 11: Storage 
 
Block 1
560 kg skim milk 
(4 C)
Day 1 - 140 kg 
skim milk 
transfered to 
R12
Day 2 - 140 kg 
skim milk 
transfered to 
R12
Day 3 - 140 kg 
skim milk 
transfered to 
R12
Day 4 - 140 kg 
skim milk 
transfered to 
R12
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 and distributed for MPC manufacture trials
0 kg of pasteurized skim milk were
 and stored at 4 °C. One batch was utilized per 
maximum of one week before use. One block consisted of 
, and one trial was conducted per 
 skim milk being transferred to the retentate holding 
 (Niro Inc, Hudson, WI) (Figure 11
 (nominal) spiral-wound polyether sulfone (PES) membranes 
 Snyder Filtration, Vacaville, CA).
and distribution of skim milk for MPC manufacture trials
Block 2
560 kg skim milk 
(4 C)
Day 1 - 140 kg 
skim milk 
transfered to 
R12
Day 2 - 140 kg 
skim milk 
transfered to 
R12
Day 3 - 140 kg 
skim milk 
transfered to 
R12
Day 4 - 140 kg 
skim milk 
transfered to 
R12
Block 3
560 kg skim milk 
(4 C)
Day 1 - 140 kg 
skim milk 
transfered to 
R12
Day 2 - 140 kg 
skim milk 
transfered to 
R12
Day 3 - 140 kg 
skim milk 
transfered to 
R12
Day 4 - 140 kg 
skim milk 
transfered to 
R12
 according 
 obtained from 
) cross-flow unit 
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Prior to each day’s trial, the R12 equipment was flushed with soft H2O for 30 
min, then shut down and allowed to empty completely. Once one day’s skim milk was 
transferred to the R12 as per Figure 11 , the UF and DF manufacture process was 
conduced according to Figure 12. UF commenced at 5.9 °C ± 1.2 °C. During UF, 
temperature was allowed to increase such that, by the end of the UF process, the 
temperature was 19.7 °C ± 1.5 °C. DF H2O was prepared by transferring 117 kg soft H2O 
(GE SmartWater, Fairfield, CT) to a jacketed kettle (60 gallon capacity, serial number 
50347, Will-Flow Corp., Charlevoix, Michigan) with an overhead mixer (P/N 123856, 
Form Factor 1.33, Lightnin, Rochester, NY) holding at 26.7 °C, and mixing for 15 min 
after addition of non-iodized NaCl (Evaporated Food Grade Salt, United Salt Corp., 
Houston, TX). Each UF and DF step was monitored by weighing the permeate and 
proceeding when permeate removal weight equaled 117 kg (representing a retentate 
concentration factor of 4.2). Temperature and pH were recorded during the manufacture 
process. One trial was conducted per day. At the end of each trial, membranes were 
cleaned by washing with soft H2O for 30 min at 35 °C, caustic solution (Chlorinated 
Mechanical and CIP Cleaner for Protein Soils) (Ecolab, St. Paul, MN) for 1 h at 49 °C, 
soft H2O for 30 min at 35 °C, acidic solution (HD PL-10 Plus Acid Detergent for Pipeline 
and Bulk Tank Equipment) (Ecolab, St. Paul, MN) for 1 h at 48 °C, followed by soft H2O 
for 30 min at 35 °C, in preparation for the next day’s trial.  
Immediately after the DF3 process was completed, retentate was collected, 
weighed, and spray-dried using a Niro Filterlab (Hudson, WI) with consistent inlet feed. 
Inlet temperature was 208.7 ± 19.7 °C. Outlet temperature was 82.0 °C ± 0.8 °C. The 
powder was collected, weighed, and split into two batches; one batch was stored at 22 °C 
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± 3 °C and was used for all forthcoming described experiments, and the other batch was 
stored at 4 °C in plastic airtight containers for later analysis. 
During the manufacture, samples (200 ml) of skim milk, as well as products 
obtained by UF and DF, were withdrawn and stored for later analysis. Skim milk was 
withdrawn after loading skim milk into the holding tank of the R-12 Pilot Plant and the 
skim milk in the holding tank had been mixed thoroughly (prior to initiation of the UF 
process). Products of UF and DF were sampled by collecting the continuously flowing 
product out of the retentate return as it returned to the retentate holding tank, immediately 
after the required amount of permeate had been removed. All samples were preserved by 
adding 0.02 % NaN3 (EMD Chemicals, Gibbstown, NJ) and storing at 4 °C.  
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Figure 12: Schematic of a single MPC manufacture trial; x = no NaCl (treatment 
level 1), 0.29 % NaCl (50 mM ) (treatment level 2), 0.58 % NaCl (100 mM) 
(treatment level 3), or  0.88 % NaCl (150 mM) (treatment level 4) in DF H2O. 
Retentate (DF3) yields varied between 11 and 13 kg; dry MPC yields varied 
between 0.9 kg and 1.3 kg. 
 
 
 
 
Skim Milk
140 kg
5.9 °C ± 1.2 °C
Ultrafiltration
19.7 °C ± 1.5 °C
Diafiltration 1
26.3 °C ± 1.6 °C
Diafiltration 2
29.9 °C ± 1.3 °C
Diafiltration 3
30.5 °C ± 1.3 °C
Spray-Drying
Inlet: 208.7 ± 19.7 °C
Outlet: 82.0 °C ± 0.8 °C
117 kg soft 
H2O 26.6°C   
(x % NaCl) 
Remove 117 kg permeate 
Remove 117 kg permeate 
Remove 117 kg permeate 
Remove 117 kg permeate 
117 kg soft 
H2O 26.6°C   
(x % NaCl) 
117 kg soft 
H2O 26.6°C   
(x % NaCl) 
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4.3. Solubility Analysis 
4.3.1. Laboratory Stage Mixer 
Solutions of MPC (5% w/w) were made by placing an octagonal magnetic stir bar 
(8 x 38mm) in a 250 ml beaker, weighing 95.0 g DI H2O in the beaker, placing 5.0 g 
MPC in a weigh dish, transferring the MPC to the DI H2O, and hand-mixing (100 
clockwise revolutions with a thin spatula), prior to reconstitution using a laboratory stage 
mixer (R010 Power, IKA Works, Wilmington, NC). Each was allowed to reconstitute at 
960 rpm (speed setting #8) at 23 °C ± 1.0 °C for 1 h and 3 h. One complete block was 
tested at a time, and two replicates of each treatment were tested at a time. Aliquots (13 
ml) of these samples were transferred to a series of 15 ml falcon tubes and centrifuged at 
700 x g for 10 min at 23 °C. The supernatant was separated from the pelleted material by 
withdrawing supernatant into a pipette. Percent solubility was calculated as supernatant 
total solids (TS) divided by bulk solution TS, multiplied by 100. TS was determined 
using CEM LabWave 9000 (CEM Corp, Matthews, NC) using parameters of 100% 
power and 4 min drying time, after running duplicate samples under vacuum oven drying 
(AOAC 927.05) to verify accuracy of LabWave 9000 measurements. Measurements were 
conducted in duplicate. A diagram of this experiment is shown in  
Figure 13. 
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Figure 13: Diagram of laboratory stage mixer solubility experiment 
 
4.3.2. Insolubility Index 
One-hundred ml of water (24 ˚C ± 0.2 ˚C) was poured into the mixing jar (bottom 
diameter = 7.11 cm, blade diameter = 5.08 cm) (Waring Commercial Blender [Model 
34B197, 120 Volts AC, 50 Hz to 60 Hz, 7.0 Amps], Torrington, CT). An aliquot of MPC 
(5 g) was placed into the mixing jar. The analysis then proceeded according to 
Insolubility Index: GEA Niro analytical method A 3 a (Anonymous, 2010c). Three drops 
of Antifoam B Emulsion (Sigma-Aldrich, St. Louis, MO) were added, and mixing 
commenced at 3800 rpm for 90 sec. The solution was allowed to sit for 15 min. After 15 
min. elapsed, the solution was stirred with a thin spatula and transferred to two 50 ml 
centrifuge tubes. Centrifugation took place at 910 rpm for 5 min. A pipette was used to 
dispose of all sediment-free liquid more than 5 ml above the sediment layer. The 
centrifuge tubes were then filled with DI water to the 50 ml mark, the sediment was 
dispersed with a thin spatula, and centrifugation again took place at 910 rpm for 5 min. 
 
Centrifugation 
(700 x g) 
Labwave 
9000 
 
Stage mixer and 8 beakers Transfer 13 ml to falcon tubes                 Centrifugation       Obtain TS of supernatant 
 
Beaker 
95g DI H2O 
5g MPC 
Stir (100 x clockwise revolutions 
Either 1 hour or 3 hours 
total mixing time 
Obtain TS of bulk solution 
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The amount of sediment remaining was reported in ml. Measurements were conducted in 
duplicate. 
4.3.3. Solubility Using Modified Method of Anema et al. (2006) 
Solutions of MPC (5% w/w) were made in a 400 ml beaker by weighing 95.0 g 
DI H2O in the beaker, placing 5.0 g MPC in a weigh dish, transferring the MPC to the DI 
H2O, and hand-mixing (100 clockwise revolutions with a thin spatula). This solution was 
placed into a 30 °C water bath. Mixing immediately commenced at 600 rpm (speed 
setting #5) using a propeller-blade (blade diameter = 4.4 cm) attached to an overhead 
stirrer (StedFast Stirrer [Model SL600], Fisher Scientific, Tustin, CA).  After 30 min., 
samples of MPC solutions were then withdrawn, and the supernatant was obtained by 
centrifugation at 700 x g for 10 min. Percent solubility was calculated as supernatant total 
solids TS divided by bulk solution TS, multiplied by 100. TS was determined using CEM 
LabWave 9000 (CEM Corp, Matthews, NC) using parameters of 100% power and 4 min. 
drying time. Measurements were conducted in duplicate. 
4.3.4. Solubility in pH-adjusted Environments 
Solutions of MPC (5% w/w) were made by placing an octagonal magnetic stir bar 
(8 x 38mm) in a 250 ml beaker, weighing 95.0 g DI H2O in the beaker, placing 5.0 g 
MPC in a weigh dish, transferring the MPC to the DI H2O, and hand-mixing (100 
clockwise revolutions with a thin spatula), prior to reconstitution using a laboratory stage 
mixer (R010 Power, IKA Works, Wilmington, NC). Each was allowed to reconstitute at 
960 rpm for 10 min. to allow for dispersion of material. pH of all samples were recorded. 
While mixing, 1% NaOH solution was used to adjust pH of samples treatment levels 1 
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through 3 to pH of treatment level 4. Samples were allowed to mix at 23 °C ± 1.0 °C until 
3 h total mixing time was achieved. Samples were checked at 30 min. intervals to ensure 
consistency in pH, and readjusted with 1% NaOH if necessary. Aliquots (13 ml) of these 
samples were transferred to a series of falcon tubes and centrifuged at 700 x g for 10 min 
at 23 °C. The supernatant was separated from the pelleted material by withdrawing 
supernatant into a pipette and transferring to a 15 ml falcon tube.  Percent solubility was 
calculated as supernatant TS divided by bulk solution TS, multiplied by 100. TS was 
determined using CEM LabWave 9000 (CEM Corp, Matthews, NC) using parameters of 
100% power and 4 min. drying time. Measurements were conducted in duplicate. Figure 
14 diagrams this experiment. 
In a separate experiment, solutions of MPC (5% w/w) were made by placing an 
octagonal magnetic stir bar (8 x 38mm) in a 250 ml beaker, weighing 95.0 g DI H2O in 
the beaker, placing 5.0 g MPC in a weigh dish, transferring the MPC to the DI H2O, and 
hand-mixing (100 clockwise revolutions with a thin spatula), prior to reconstitution using 
a laboratory stage mixer (R010 Power, IKA Works, Wilmington, NC). Each was allowed 
to reconstitute at 960 rpm for 10 min. to allow for dispersion of material. pH of all 
samples were recorded. While mixing, 1% HCl solution was used to adjust pH of samples 
treatment levels 2 through 4 to pH of treatment level 1. Samples were allowed to mix at 
23 °C ± 1.0 °C until 3 h total mixing time was achieved. Samples were checked at 30 
min. intervals to ensure consistency in pH, and readjusted with 1% HCl if necessary. 
Aliquots (13 ml) of these samples were transferred to a series of falcon tubes and 
centrifuged at 700 x g for 10 min at 23 °C. The supernatant was separated from the 
pelleted material by withdrawing supernatant into a pipette. Percent solubility was 
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calculated as supernatant total solids TS divided by bulk solution TS, multiplied by 100. 
TS was determined using CEM LabWave 9000 (CEM Corp, Matthews, NC) using 
parameters of 100% power and 4 min drying time. Measurements were conducted in 
duplicate. Figure 14 diagrams this experiment. 
 
 
Figure 14: Solubility of experiment testing solubility in pH-adjusted environments 
 
4.4. Chemical Composition of MPCs Manufactured by Na Addition to DF H2O 
4.4.1. FTIR Analysis 
The protein, casein, lactose, fat, and total solids content of skim milks and 
products obtained by UF and DF was analyzed with Milkoscan FT2 (Foss, Eden Prairie, 
MN) utilizing Foss Integrator software package version 1.5.0 (Foss, Eden Prairie, MN). 
Measurements were conducted in duplicate. Prior to run, instrument was zeroed with 
Winescan™/Grapescan™ Zero Liquid Salt (Foss Analytical A/S, Eden Prairie, MN). 
Instrument was soaked with Foss-Soak (Foss Analytical A/S, Eden Prairie, MN) 
containing enzyme, surfactant, and sodium carbonate. Instrument was cleaned with S-470 
 
Beaker 
95g DI H2O 
5g MPC 
Stir (100 x clockwise 
revolutions) 
Centrifugation 
(700 x g) 
Labwave 
9000 
 
Stage mixer and 8 beakers    Transfer 13 ml to falcon tubes     Centrifugation       Obtain TS of supernatant 
pH adjustment (30 min. 
intervals), 3 hours total 
mixing time 
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Cleaning Agent (Foss Analytical A/S. Eden Prairie, MN). Instrument was calibrated with 
DQCI Services: Dairy Quality Control California Milk Standards (product #110300) 
(DQCI, Mounds View, MN). 
4.4.2. Nitrogen Analysis 
The protein content of skim milks, products obtained by UF and DF, and MPCs 
were analyzed using Elementar rapid N cube (Elementar Analysensysteme GmbH, 
Hanau, Germany). Prior to sample run, instrument was blanked three times with O2 and 
prepared for calibration with two L-aspartic acid (Sigma-Aldrich, St. Louis, MO) samples 
weighing 100 mg ± 10 mg each, utilizing the “RunIn” method. Instrument was calibrated 
using “aspartic acid” method, using three L-aspartic acid samples weighing 100 mg ± 10 
mg each. Daily correction factor was checked to be between 0.95 and 1.05 before 
proceeding; if daily correction factor was lower or higher, then blanking and calibration 
were repeated until daily correction factor was between 0.95 and 1.05. Volume of tin 
capsule used for sample delivery of skim milk, UF, and DF products was 4.75 mm * 11 
mm (Elementar Americas, Mt Laurel, NJ). Weight of sample delivery was 100 mg ± 10 
mg, utilizing “100 mg” delivery method. Tin capsule with sample was flushed with Ultra 
High Purity (UHP) O2 (Airgas West, San Luis Obispo, CA) for 3 sec. prior to closure of 
tin capsule. Sample delivery of dry MPCs was conducted by utilizing Elementar-supplied 
tin foil dimension 50 mm * 50 mm (Elementar Americas, Mt Laurel, NJ). Weight of 
sample delivery was 100 mg ± 10 mg, utilizing “100 mg” method. Protein was calculated 
using protein correction factor 6.38, by rapid N Software v.3.2.6 (Elementar 
Analysensysteme GmbH, Hanau, Germany) according to the Dumas method (AOAC 
993.13). Measurements were conducted in duplicate. 
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4.4.3. Minerals Analysis 
The concentration of Ca, Na, K, and Mg in skim milks and products obtained by 
UF and DF was determined by the Institute for Integrated Research on Materials, 
Environment and Society (IIRMES) (Long Beach, CA). Samples (10 ml) were 
transferred to a series of 15 ml falcon tubes, assigned a 5-digit code at random, and 
shipped overnight from California Polytechnic State University San Luis Obispo to 
IIRMES. Samples were held at 4 °C during transit. Upon receiving, samples were frozen 
and stored for later analysis. 
Prior to minerals analysis, samples were removed from frozen storage and placed 
in a 50 °C water bath for 30 min to return sample flowability. Microwave-assisted acid 
digestion was utilized to obtain complete sample digestion, followed by sonication and 
heating at 65 °C for 2 h. 100 µl of digested, heated, and sonicated sample was placed in a 
15 ml conical vial, along with 200 µl Rh/Tm solution. Minerals analysis was conduced 
using Hewlett Packard 4500 ICP-MS (Agilent Technologies, Santa Clara, CA) according 
to EPA 200.8m; the concentration of Ca, Na, K, and Mg in MPCs was analyzed 
according to EPA 6020m. Instrument Calibration Standard 2 Claritas PPT® from Spex 
Certiprep (Metuchen, NJ) was used to generate a standard response curve for Ca, Na, Mg, 
and K. Certified Reference Material (CRM) (cat. #018) from Environmental Resource 
Associates (ERA) (Arvada, CO) was used to generate a standard response curve for Ca. 
CRM (cat. #025) from ERA was used to generate a standard response curve for Mg. 
Measurements were conducted in triplicate. 
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4.5. Physical Properties of MPCs Manufactured by Na Addition to DF Water 
4.5.1. Particle Size Diameter Distribution Analysis of MPC 
Particle size diameter distribution of dry MPC was determined using Coulter LS 
230 with Dry Powder Module (Beckman Coulter, Brea, CA). The instrument was 
allowed to adjust for electrical offsets and align the laser prior to measuring background. 
Background was measured for 60 sec. Sample loading was measured for 60 sec. 
Obscuration was held between 4% and 7% during the runtime by adjusting speed of the 
auger attached to the feed mechanism. Voltage measurements from the detectors were 
converted to particle size diameter distributions by Beckman Coulter LS Software v.3.29 
August 2003 (Brea, CA) utilizing the Fraunhofer model of light scattering. A complete 
particle size distribution from 0.4 µm to 2000 µm, for each powder, was obtained in 
triplicate. 
4.5.2. Particle Size Distribution Analysis of MPC During Reconstitution 
Solutions of MPC (5% w/w) were made by placing an octagonal magnetic stir bar 
(8 x 38mm) in a 250 ml beaker, weighing 95.0 g DI H2O in the beaker, placing 5.0 g 
MPC in a weigh dish, transferring the MPC to the DI H2O, and hand-mixing (100 
clockwise revolutions with a thin spatula), prior to reconstitution using a laboratory stage 
mixer (R010 Power, IKA Works, Wilmington, NC). Each was allowed to reconstitute at 
960 rpm at 23 °C ± 1.0 °C for 3 h, prior to particle size diameter distribution 
measurement using Coulter LS230 with Fluid Module (Beckman Coulter, Brea, CA). At 
initial start-up, and thereafter once per hour, the instrument was allowed to adjust for 
electrical offsets and align the laser prior to measuring background. Background was 
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measured for 60 sec. Sample loading was measured for 60 sec. Sample was loaded until 
obscuration was between 10 % and 12 %. Pump speed was set to 51 (medium speed), and 
sonication was not used. Voltage measurements from the detectors were converted to 
particle size diameter distributions by Beckman Coulter LS Software v.3.29 August 2003 
(Beckman Coulter, Brea, CA) utilizing the Fraunhofer model of light scattering. A 
complete particle size distribution from 0.4 µm to 2000 µm, for each sample, was 
obtained in triplicate. The fluid module was flushed with water for 15 min. between each 
sample. 
4.5.3. Confocal Laser Scanning Microscopy (CLSM). 
An Olympus FV1000 confocal laser scanning biological microscope (Olympus 
America Inc., Center Valley, PA, USA) was used to examine the structure of MPC 
protein aggregates dissolved in solution, and possible changes in lipid surface coverage 
(Fillery-Travis et al., 2000) of protein aggregates occurring with treatment level. In a 50 
ml falcon tube, 1 g powder was weighed to the nearest 0.0001 g. 30 ml DI H2O was 
added, and the solution was vortexed 1 min. to mix. 100 ul was transferred to a microfuge 
tube. To the microfuge tube, 2 µl of Nile Red (NR), (9-diethylamino-5H- 
benzo[R]phenoxazine-5-one) dye (1 mg/ml in acetone) was added, and the tube was 
vortexed to mix. Then, 5 µl Fast Green (FG) (disodium2-[[4-[ethyl-[(3-
sulfonatophenyl)methyl]-amino]phenyl]-[4-[ethyl-[(3-
sulfonatophenyl)methyl]azaniumylidene]-cyclohexa-2,5-dien-1-ylidene]methyl]-5-
hydroxybenzenesulfonate) dye (1 mg/ml in nanopure H2O) was added to the microfuge 
tube, and the tube was vortexed to mix. 25 µl of the sample + dye mixture was added to a 
microscope slide. Quickly, 50 µl 0.5 % warm agarose solution was added to the slide and 
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mixed gently using the micropipette tip. A UPLAPO20x objective lens and UPLFL60XO 
oil-immersion objective lens were used. NR excitation was performed with the 543nm 
HeNeG laser. FG excitation was performed with the 633nm HeNeR laser. A 3D image 
was obtained by setting a defined z-section prior to scanning the sample. 
4.5.4. Statistical Analyses 
The statistical analyses of solubility on the laboratory stage mixer for both one 
hour and three hour reconstitution time were conducted using the GLM command in 
Minitab (v.16.1, Minitab Inc., State College, Pennsylvania). Block was a random effect. 
Treatment was a fixed effect. All statistical tests were performed at a significance level of 
α = 0.01 in order to compensate for the large number of tests throughout the analysis. 
Initial models were run to check for a statistically significant (α = 0.01) interaction; if no 
statistically significant interaction was found, the interaction term was dropped and the 
model was rerun. Tukey’s method was used to compare treatment means. In addition 
histograms of residuals, normal plot of residuals, plots of residuals versus fits, and plots 
of residuals versus order were used to test model adequacy. Lavene’s test was used to 
check for unequal error variance between treatments. The statistical analysis of ISI was 
conducted using the GLM command in Minitab (v.16.1) as described above. The 
statistical analysis of solubility according to the method of Anema et al. (2006) was 
conducted using the GLM command in Minitab (v.16.1) as described above. The 
statistical analysis of solubility in pH adjusted environments was conducted using the 
GLM command in Minitab (v.16.1) as described above. The statistical analysis of protein 
content of dry MPC, as determined by Elementar rapid N, was conducted using the GLM 
command in Minitab (v.16.1) as described above. The statistical analysis of moisture 
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content of dry MPC was conducted using the GLM command in Minitab (v16.1) as 
described above. The statistical analysis of MPC particle size upon reconstitution was 
first conducted by analyzing the d90 and mean as described above. Then, d90 was 
subtracted from d10 to create a new variable (d80), treating NaCl as a quantitative variable, 
and using the GLM command in Minitab (v.16.1) as described above. The statistical 
analysis of the right tail of MPC particle size distribution upon reconstitution was 
analyzed by the following method: the d50 was subtracted from the d90 to create a new 
response variable, and the GLM command in Minitab (v16.1) was used, treating NaCl as 
a quantitative variable. 
The regression analyses for solubility on the laboratory stage mixer for both one 
hour and three hour reconstitution time were performed using the General Regression 
command in Minitab (v16.1); NaCl concentration was the predictor. The regression 
analysis for solubility according to the method of Anema et al. (2006) and ISI were 
performed using the General Regression command in Minitab (v16.1); the mean-centered 
NaCl concentration was the predictor to reduce multicollinearity. 
The statistical analysis of Ca, Na, K, and Mg in skim milks and products obtained 
by UF and DF, on both wet basis and total solids basis, was conducted using SAS (v.9.1, 
SAS Institute, North Carolina). The difference in Ca, Mg, K, and Na content at DF1, 
DF2, and DF3 process levels from UF process levels, on wet basis, was analyzed using 
distinct PROC MIXED statements, with process as a random effect, utilizing 
autoregressive model 1 (ar1) variance-covariance structure for Ca, Mg, and K analysis, 
and unstructured variance-covariance structure for Na. LSMEANS and Tukey’s 
comparisons in all PROC MIXED statements were used to aid in analysis interpretation. 
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On total solids basis, the difference in Ca, Mg, K, and Na content at DF1, DF2, and DF3 
process levels from UF process levels was analyzed using distinct PROC MIXED 
statements, with process as a random effect, utilizing SAS (v.9.1), and variance-
covariance structures were as follows: (ar1) for Ca and Mg, and variance components for 
Na and K.  A statistical analysis comparing the FOSS and FTIR obtained protein data 
was conducted using SAS (v.9.1). The statistical analysis of the ratio of Ca to Mg in the 
DF3 product on dry basis was conducted using the general regression command in 
Minitab (v16.1); the mean-centered NaCl concentration was the predictor to reduce 
multicollinearity. 
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5. RESULTS AND DISCUSSION 
5.1. Temperature and pH of products obtained by MPC manufacture 
MPC was manufactured according to the method outlined in section 4.1. It is 
known that the temperature of UF and DF processes can affect the mineral distribution of 
retentates manufactured by UF and DF retentates. The pH and temperature of each 
material obtained after the completion of each step in the MPC manufacture process, by 
block, treatment, and sample, are displayed in Appendix B, along with the accompanying 
statistical analyses. Because it is known that temperature and pH affect several important 
qualities of retentate, including the ratio of bound Ca to ionic Ca and retentate viscosity, 
that may have an impact on the solubility of the final powder, it was imperative to record 
the temperature of the skim milk, as well as that of the products obtained by the various 
UF and DF steps during manufacture. The changes in pH and temperature are 
summarized by Figure 16 and Figure 17. 
At α = 0.01, there was a statistically significant difference (p < 0.001) in pH due 
to process level, and there was also a statistically significant (p = 0.002) interaction 
between process and treatment. The MPC manufacture process, particularly diafiltration, 
is known to deplete soluble minerals from the retentate, including the hydrogen ion which 
directly contributes to the pH of the system. The general trend towards basic, rather than 
acidic, retentates is consistent with what is expected during the DF processes. As 
hydrogen ions are removed, the pH should increase according to the equation (Figure 15). 
In contrast, the downward trend observed in the pH of the UF process is likely due to two 
factors. The first is that mean temperature increased from SM to UF, which may drop pH; 
the second is that the UF process by itself is not known to efficiently remove soluble 
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minerals. A much higher degree of mineral removal has been observed during the DF 
processing steps. If this is the case, then a progressive concentration of hydrogen ions 
during UF may occur, leading to a drop in pH. 
 
  log" 
Figure 15: pH, defined as the negative log of hydrogen ion activity in a solution 
 
As determined by the test of effect slices, there was also a statistically significant 
(p < 0.001) difference in pH within the DF3 process. This may be attributable to 
differences in the final concentration factor and protein content of the retentate, though 
this was not explicitly tested in the analysis. 
 
 
Figure 16: Mean pH (unadjusted for temperature) of products obtained as the result 
of the UF and DF manufacturing processes, by NaCl treatment level 
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At α = 0.01 there was a statistically significant (p < 0.001) difference in 
temperature due to process, but no statistically significant difference due to treatment (p = 
0.138). Tests of effect slices indicated that mean temperature was not statistically 
significantly different within each process level. 
 
 
Figure 17: Mean temperature (°C) of products obtained as the result of the UF and 
DF manufacturing processes 
 
The lack of statistically significant effect slices (save for pH within the DF3 slice 
as mentioned above) suggests that the manufacture process took place in a consistent 
fashion with respect to pH and temperature. Though it is clear that both pH and 
temperature changed throughout the manufacture as a whole, the lack of statistically 
significant effect slices indicates that the process was consistent across all treatment 
levels, and thus any observed differences in samples cannot be easily attributed to pH or 
temperature of manufacture. Treatment level, then, is implicated as the driver of any 
differences observed between samples. 
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5.2. Solubility of Manufactured MPCs 
5.2.1. One Hour Reconstitution 
The data collected according the method outlined in section 4.3.1, pertaining to 
one hour reconstitution time, is shown in Appendix C. The statistical analysis of 
solubility on the laboratory stage mixer for one hour reconstitution time was conducted 
using the GLM command in Minitab according to Section 4.5. The interaction between 
block and treatment was not statistically significant at α = 0.01, and thus the model was 
rerun without the interaction term. There was a statistically significant difference in mean 
solubility due to the effect of NaCl treatment (p < 0.001). Tukey’s simultaneous 
comparisons state that each treatment level was statistically significantly different from 
each other (Figure 18).  
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Figure 18: Mean solubility after one hour on laboratory stage mixer, results 
averaged across all blocks and replicates; different superscripts denote solubility 
results that are statistically significantly different from each other according to 
Tukey’s simultaneous tests (Appendix C) 
 
These results indicate that the addition of NaCl during DF steps significantly 
increased the solubility of the manufactured MPC when it was reconstituted for one hour. 
With 99 % confidence, the addition of 50 mM NaCl into DF water significantly increased 
(p < 0.001) the mean solubility of MPC by between 4.53 % and 11.97 %. The addition of 
100 mM NaCl significantly increased (p < 0.001) the solubility by between 29.00 % and 
36.44 %. The addition of 150 mM NaCl significantly increased (p = 0.005) the solubility 
by between 33.00 % and 40.44 %. 
The largest increase in solubility at 1h mixing time was observed between MPC 
manufactured 50 mM NaCl in DF water and MPC manufactured at 100 mM NaCl in DF 
water. Therefore, it is recommended that, if a food manufacturer desires to mix MPC for 
one hour at 22 °C, MPC manufactured utilizing at least 100 mM NaCl in DF water would 
have significant advantages over those manufactured at lower levels tested. If the 
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absolute highest solubility is desired, then a significant increase in solubility can be 
obtained by moving to an MPC manufacture process that incorporates 150 mM NaCl in 
DF water. 
A regression analysis was performed to further elucidate the connection between 
NaCl addition to DF water and the resulting increase in solubility. The tests associated 
with this analysis are located in Appendix C. With 99% confidence, the addition of 1 mM 
NaCl to DF water resulted in an increase in solubility between 0.23% and 0.31%. The 
relationship between MPC solubility at 1 hour and NaCl concentration in DF water is 
described by the following equations. The equation for block 1 is: solubility_1hr  =  
78.6238 + 0.26925(conc-75). The equation for block 2 is: solubility solubility_1hr  =  
79.01 + 0.26925(conc-75). The equation for block 3 is: solubility_1hr  =  80.05 + 
0.26925(conc-75). A scatterplot of solubility vs. NaCl concentration is shown (Figure 
19). It must be noted that predictions at or near 150 mM may be above 100 %. Therefore, 
this regression model should be used for descriptive purposes, and not for prediction at 
the highest levels. 
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Figure 19: Scatterplot for solubility vs NaCl concentration (mM) at 1h 
 
That data above is consistent with observations that sodium addition to either 
skim milk or retentate obtained by UF/DF processes may yield a material which, upon 
spray-drying, exhibits a higher water-solubility than such spray-dried material that has 
not undergone such sodium addition (Carr et al., 2002, Moran et al., 2001). However, 
retentate manufactured by incorporating NaCl into DF water may have significantly 
lower levels of Ca present than retentate manufactured by incorporating NaCl into the 
final retentate; this will be explored in section 5.3.4.3. 
Differences in pH upon reconstitution were also observed (Figure 20). It appeared 
that samples with lower solubility also had a lower pH upon reconstitution, and samples 
with higher solubility also had a higher pH upon reconstitution. A regression analysis of 
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pH (1h) vs. solubility (1h) revealed that pH was a statistically significant predictor of 
solubility (p < 0.001) (Appendix C).  
 
Figure 20: Scatterplot of solubility (1h) and pH (1h) 
 
ANOVA, utilizing pH (1h) as response and treatment as fixed factor, indicated the 
existence of a statistically significant difference in pH due to the effect of NaCl treatment 
(p < 0.001) (Appendix C). With 99 % confidence, an increase from 0 mM NaCl to 50 
mM NaCl in DF water was associated with a statistically significant (p < 0.001) mean pH 
increase by between 0.18 and 0.22. From 50 mM NaCl to 100 mM NaCl, a statistically 
significant (p < 0.001) mean pH increase by between 0.21 and 0.25 was observed. Taken 
together, these analyses indicated that additional experiments should be performed to 
separate the effect of pH on solubility from the effect of NaCl treatment on solubility. 
The results of these experiments are described in Section 5.2.5 and Section 5.2.6. 
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5.2.2. Three Hours Reconstitution 
The data collected according the method outlined in section 4.3.1, pertaining to 
three hour reconstitution time, is shown in Appendix D. The statistical analysis of 
solubility on the laboratory stage mixer for one hour reconstitution time was conducted 
using the GLM command in Minitab according to Section 4.5.4. The interaction between 
block and treatment was not statistically significant at α = 0.01, and thus the model was 
rerun without the interaction term. There was a statistically significant difference in 
solubility due to the effect of NaCl treatment (p < 0.001). Tukey’s simultaneous 
comparisons are summarized below (Figure 21).  
 
 
Figure 21: Mean solubility after three hours on laboratory stage mixer, treatment 
averaged across all blocks and replicates; different superscripts denote solubility 
results that are statistically significantly different from each other according to 
Tukey’s simultaneous tests (Appendix D) 
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These results indicate that the addition of NaCl during DF steps significantly 
increased the solubility of the manufactured MPC when it was reconstituted for three 
hours. With 99 % confidence, the addition of 50 mM NaCl in DF water yielded a 
significant (p < 0.001) mean solubility increase by between 26.54 % and 34.13 %. The 
addition of 100 mM NaCl in DF water yielded a significant (p < 0.001) mean solubility 
increase by between 30.08 % and 37.66 %. The addition of 150 mM NaCl in DF water 
yielded a significant (p < 0.001) mean solubility increase by between 30.54 % and 38.12 
%. 
These results suggest that if a particular MPC is intended to be mixed for three 
hours at 22 °C, manufacturing the MPC using at least 50 mM NaCl in DF water may 
yield a significant improvement in solubility. The incorporation of 100 mM NaCl in DF 
water did not cause a significant improvement in solubility over that of 50 mM NaCl in 
DF water. However, if a food application demands the absolute highest possible MPC 
solubility (for example, a high-protein beverage containing MPC) , then a significant 
increase in solubility can be obtained by moving from a manufacture process 
incorporating 50 mM NaCl in DF water to one that incorporates 150 mM NaCl in DF 
water. No sensory studies were performed, so the sensory impact of the mean 4.0 % 
difference in MPC solubility (the difference between samples manufactured with 50 mM 
NaCl in DF water and 150 mM DF water, at 3h mixing time) cannot be discussed. 
However, future work may wish to explore the relationship between sensory perception 
and MPC solubility to determine the perceptibility of such differences in different food 
products. 
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A regression analysis was performed to further elucidate the connection between 
NaCl addition to DF water and the resulting increase in solubility. The tests associated 
with this analysis are located in Appendix D. The relationship between MPC solubility at 
3 hours and NaCl concentration in DF water is described by the following equations: The 
equation for block 1 is: solubility_3hr = 65.0903 + 4.94575 log2(conc+1). The equation 
for block 2 is: solubility_3hr = 64.2566 + 4.94575 log2(conc+1). The equation for block 
3 is: solubility_3hr = 64.2741 + 4.94575 log2(conc+1). The tests associated with this 
analysis are located in Appendix D, and the scatterplot of solubility at 3 hours vs. 
concentration is shown (Figure 22). 
After adjusting for differences between the blocks, doubling the NaCl 
concentration is associated with an increase of between 4.48% and 5.41% in mean 
solubility with 99% confidence. This model would allow solubility to increase past 100% 
at NaCl concentrations above 132.3 mM.  Therefore, any predictions above 132.3 mM 
are suspect and should be replaced with a value of 100%.  Despite these problems, this 
model fits the data better than a quadratic fit.  For comparison, the R2 of the log fit was 
97.9% versus 95.4% for the quadratic model.  The quadratic model also begins to show a 
decrease in solubility at the highest concentration levels, which is not supported by the 
data. 
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Figure 22: Scatterplot for solubility vs NaCl concentration (mM) at 3h 
 
Similar to the solubility experiment performed at 1h reconstitution (section 5.2.1), 
differences in pH upon reconstitution were also observed (Figure 23) in this experiment. 
It appeared that samples with lower solubility also had a lower pH upon reconstitution, 
and samples with higher solubility also had a higher pH upon reconstitution. A regression 
analysis of pH (3h) vs. solubility (3h) revealed that pH was a statistically significant 
predictor of solubility (p < 0.001) (Appendix D).  
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Figure 23: Scatterplot of solubility (3h) and pH (3h) 
 
Furthermore, ANOVA, utilizing pH (3h) as response and treatment as fixed 
factor, indicated the existence of a statistically significant difference in pH due to the 
effect of NaCl treatment (p < 0.001). With 99 % confidence, the addition of 50 mM NaCl 
in DF water significantly increased (p < 0.001) pH by between 0.20 and 0.29. The 
addition of 50 mM NaCl to DF significantly increased (p < 0.001) pH by between 0.26 
and 0.34. The addition of 150 mM NaCl in DF water significantly increased (p < 0.001) 
by between 0.30 and 0.39. 
Taken together, these analyses, along with analyses conducted in Section 5.2.1, 
indicated that additional experiments should be performed to separate the effect of pH on 
solubility from the effect of NaCl treatment on solubility. The results of these 
experiments are described in Section 5.2.5 and Section 5.2.6. Moreover, because the 
sensory characteristics and texture properties of many food products which incorporate 
MPCs are highly dependent on pH (for example, process cheese and high-protein 
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beverages) the differences in pH must be accounted for and controlled when utilizing 
MPCs manufactured with NaCl in DF water. 
5.2.3. Insolubility Index 
The data collected according the method outlined in Section 4.3.2 is shown in 
Appendix E. In this experiment, as well as all subsequent solubility experiments, n = 12 
(no internal replication was conducted). The statistical analysis of solubility according to 
ISI was conducted using GLM command in Minitab according to Section 4.5.4. At α = 
0.01, there was a statistically significant difference in solubility due to the effect of NaCl 
treatment (p < 0.001). Tukey’s simultaneous comparisons are summarized below (Figure 
24). 
This test examines the performance of MPC under conditions of low mixing time 
(30 sec) but high shear (in the form of blending at 3800 rpm for 90 sec.), followed by a 
period of potential particle settling. This differs from the methods used previously, which 
examined MPC under conditions of mixing at 960 rpm for 1h and 3h, because high shear 
rates may assist in breaking large particles, possibly facilitating the rehydration process. 
These results indicate that the addition of NaCl during DF steps significantly decreased 
the amount of sediment remaining after the ISI method was completed. With 99 % 
confidence, the addition of 50 mM NaCl in DF water significantly decreased (p < 0.004) 
mean sediment by between 5.53 ml and 0.50 ml. The addition of 100 mM NaCl in DF 
water significantly decreased (p < 0.001) mean sediment by between 10.00 ml and 4.97 
ml The addition of 150 mM NaCl in DF water significantly decreased (p < 0.001) mean 
sediment by between 12.00 ml and 6.97 ml, but the difference in mean sediment between 
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the 100 mM and 150 mM treatment levels was not found to be statistically significant (p 
= 0.029). 
 
 
 
Figure 24: Mean sediment (ml) recorded after performing ISI method, treatment 
averaged across all blocks and replicates; different superscripts denote ISI results 
that are statistically significantly different from each other according to Tukey’s 
simultaneous tests (Appendix E) 
 
These results suggest that the manufacture of MPC incorporating up to 100 mM 
NaCl in DF water may significantly reduce the amount of sediment present, after mixing 
under conditions of high shear and low time. To further reduce the amount of sediment 
remaining in a 5 % w/w solution of MPC, it may be possible to move from an MPC 
manufacture process incorporating 100 mM NaCl in DF water to one which incorporates 
150 mM NaCl in DF water, but the reduction may not be significant enough to warrant 
the increased consumption of NaCl and associated costs. 
A regression analysis was performed to elucidate the connection between NaCl 
addition to DF water and the resulting decreases in ml sediment. With 99% confidence, 
for every 1 mM increase in NaCl added to DF water, there was a decrease in the amount 
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of sediment between 0.076 ml and 0.056 ml. The tests associated with this analysis are 
located in Appendix E. The relationship between MPC solubility as determined by ISI 
and NaCl concentration in DF water is described by the following equations: The 
equation for block 1 is: ISI = 9.4875 - 0.0658333(concentration). The equation for block 
2: ISI  =  10.1875 - 0.0658333(concentration). The equation for block 3 is: ISI = 10.35 - 
0.0658333(concentration). It must be noted that predictions at or near 150 mM may be 
below 0 ml sediment. Therefore, this regression model should be used for descriptive 
purposes, and not for predictions at the highest levels. 
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Figure 25: Scatterplot for solubility according to ISI and NaCl concentration  
 
5.2.4. Solubility using method of Anema et al. (2006) 
The data collected according the method outlined in Section 4.3.3 is shown in 
Appendix F. The statistical analysis of solubility according to the method of Anema et al 
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(2006). was conducted using GLM command in Minitab according to Section 4.5.4. At α 
= 0.01, there was a statistically significant difference in solubility due to the effect of 
NaCl treatment (p < 0.001). Mean solubility and significant differences from Tukey’s 
simultaneous comparisons are summarized below (Figure 26) 
These results indicate that the addition of NaCl during DF steps significantly 
increased the solubility of the manufactured MPC under these mixing conditions when at 
least 100 mM NaCl was added. With 99 % confidence, the addition of 50 mM NaCl to 
DF water did not yield a significant increase in mean solubility (p = 0.060).  The addition 
of 100 mM NaCl to DF water significantly increased (p < 0.002) mean solubility of MPC 
by between 20.09 % and 59.08 %. The addition of 150 mM NaCl to DF water yielded a 
significant increase (p = 0.001) in mean solubility of MPC, but no significant differences 
(p = 0.128) were found between the 100 mM and 150 mM treatment levels. 
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Figure 26: Mean solubility (%) recorded after performing solubility method of 
Anema et al. (2006), treatment averaged across all blocks and replicates; different 
superscripts denote solubility results that are statistically significantly different 
from each other according to Tukey’s simultaneous tests (Appendix F). 
 
This test examines the performance of MPC under conditions of 30 min mixing 
time using an overhead stirrer, the most likely equipment to be used in a food 
manufacturing facility setting. The results suggest that if a 5% w/w MPC solution is 
mixed for 30 min. using an overhead stirrer at a speed of 600 rpm using a propeller blade 
4.4 cm in diameter, then in order to obtain a significant increase in MPC solubility, that 
MPC should be manufactured with at least 100 mM NaCl incorporated into DF water. 
MPC manufactured with 50 mM incorporated into DF water did not perform significantly 
better than MPC manufactured with no NaCl incorporated into DF water, and MPC 
manufactured with 150 mM NaCl incorporated into DF water did not perform 
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significantly better than MPC manufactured with 100 mM NaCl incorporated into DF 
water. 
A regression analysis was performed to further elucidate the connection between 
NaCl addition to DF water and the resulting increase in solubility. With 99% confidence, 
the addition of 1 mM NaCl to DF water resulted in an increase in solubility between 
0.28% and 0.42%. The tests associated with this analysis are located in Appendix F. The 
relationship between MPC solubility according to the method of Anema et al. (2006) and 
NaCl concentration in DF water is described by the following equations. The equation for 
block 1 is: solubility = 45.66 + 0.353667(concentration). The equation for block 2 is: 
solubility  =  45.215 + 0.353667(concentration). The equation for block 3 is: solubility  =  
44.905 + 0.353667(concentration).  
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Figure 27: Scatterplot for solubility according to the method of Anema et al. 
(2006).  
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5.2.5. After Adjustment to Treatment Level 4 (150 mM NaCl in DF water) pH 
A correlation between pH and solubility, and pH and NaCl treatment, was 
suggested by experiments discussed in sections 5.2.1 and 5.2.2. Therefore, the following 
experiments were conducted to determine the effect of pH adjustment on the solubility of 
MPC. At treatment 4 pH (7.68 ± 0.02), with 99 % confidence there is a significant 
increase (p < 0.001) in mean solubility, by between 23.16 % and 40.70 %, when MPC 
was manufactured with 150 mM NaCl in DF water. However, there were no significant 
differences in solubility between MPCs manufactured with 50 mM, 100 mM, or 150 mM 
NaCl incorporated into DF water. 
 
Figure 28: Mean solubility after adjustment to treatment level 4 pH, after 
reconstitution on laboratory stage mixer (3h); treatment averaged across all blocks; 
different superscripts denote solubility results that are statistically significantly 
different from each other according to Tukey’s simultaneous tests (Appendix G) 
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5.2.6. After Adjustment to Treatment Level 1 (0 mM NaCl in DF water) pH 
At treatment 1 pH (7.41 ± 0.02), there is a significant increase in solubility in 
MPC samples which were manufactured with NaCl incorporated into DF water. With 99 
% confidence, the addition of 50 mM NaCl in DF water significantly increased (p < 
0.001) the mean solubility of MPC by between 12.75 % and 28.28 %. The addition of 
100 mM NaCl in DF water significantly increased (p < 0.001) the mean solubility of 
MPC by between 25.87 % and 41.39 %. The addition of 150 mM NaCl in DF water 
significantly increased (p < 0.001) the mean solubility of MPC by between 27.83 % and 
43.36 % , but the difference between the 100 mM and 150 mM treatment levels was not 
significant (p = 0.617). 
 
 
 
Figure 29: Solubility after adjustment to Control pH, after reconstitution on 
laboratory stage mixer (3h); treatment averaged across all blocks and replicates; 
different superscripts denote solubility results that are statistically significantly 
different from each other according to Tukey’s simultaneous tests (Appendix H) 
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5.3. Proximate Analysis of Material Obtained During MPC Manufacture 
5.3.1. FTIR Analysis 
Proximate analysis (fat, protein, casein, lactose, TS) of skim milk and all products 
obtained by UF and DF are displayed in Appendix I: Proximate Analysis as Determined 
by FOSS Milkoscan FT2. A comparison between the Milkoscan FT2 data and protein 
data obtained by Elementar rapid N is conducted in section 5.3.2 
There are no previous studies reported in the literature involving the proximate 
analysis of skim milk and all products obtained by UF and DF by Milkoscan FT2. Yet, 
the instrument’s speed, lack of lengthy sample preparation requirements, simplicity of 
user operation, and ability to analyze several compositional constituents simultaneously 
have great potential use in the manufacture of retentate. The data is largely consistent 
with what is expected to occur during the MPC manufacture process; protein, casein, and 
fat are concentrated and thus consist of higher proportions of the total solids as the 
manufacturing process continues. Conversely, the majority of lactose is removed during 
the DF1, DF2, and DF3 manufacturing steps, which is consistent with previous 
observations (Mistry and Hassan, 1991a).  
The data shown provides evidence that Milkoscan FT2 equipment serves as a 
valuable aid during the MPC manufacture process. Its ability to provide near real-time 
analysis of a wide variety of constituents would be valuable to MPC manufacturers and 
would likely lead to the manufacture of retentate with more consistent protein, lactose, 
fat, and total solids. This, in turn, could lead to the manufacture of more consistent spray-
dried MPCs. 
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5.3.2. Elementar rapid N nitrogen analysis 
5.3.2.1. Protein Content of Skim Milk, UF, and DF Products 
Protein content of all skim milks, along with all products obtained from UF and 
DF, as obtained by elementar rapid N, are shown in Appendix J. Comparison of protein 
Milkoscan FT2 data with Elementar rapid N data reveal that the two methods are 
statistically significantly different from each other. This comparison is shown below 
(Figure 30). Output from statistical analysis is shown in Appendix K, and the data is 
further discussed in section 5.3.3. 
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Figure 30: Comparison of protein values obtained by Milkoscan FT2 and those obtained by rapid N. X axis represents sample 
measured, Milk Block 1 Treatment 1 representing Sample 1, and DF3 Block 3 Treatment 4 representing Sample 60. 
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5.3.2.2. Protein Content of Dried MPC 
Protein content of all dry MPCs, as determined by Elementar rapid N and 
collected according to the method outlined in Section 4.4.2, is shown in Appendix J. The 
statistical analysis of the protein content of all dry MPCs was conducted using the GLM 
command in Minitab according to Section 4.5.4. At α = 0.01, there was a statistically 
significant difference in protein content due to the effect of NaCl treatment (p = 0.003). 
Mean protein % and significant differences from Tukey’s simultaneous comparisons are 
summarized below (Figure 31). 
When more than 100 mM NaCl was added to DF water, there was a statistically 
significant decrease in protein content of dry MPC. From a mean protein content of 84.99 
% (control), the addition of 100 mM NaCl to DF water was associated with a decrease in 
protein content between 0.33 % and 6.47 %. From the control, the addition of 150 mM 
NaCl to DF water was associated with a decrease in protein content between 0.38 % and 
6.52 %. 
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Figure 31: Protein analysis of dry MPC by Elementar rapid N, treatment averaged 
across all blocks; different superscripts denote protein results that are statistically 
significantly different from each other according to Tukey’s simultaneous tests 
(Appendix J). 
 
5.3.3. Comparison of Milkoscan FT2 and Elementar rapid N protein analysis 
As no prior MPC studies have reported protein measurements of all UF and DF 
products obtained by FOSS Milkoscan FT2 equipment, protein measurements obtained 
by this method were compared with those obtained by Elementar rapid N. Protein data 
obtained by FOSS Milkoscan FT2 and Elementar rapid N were compared according to 
the statistical procedure outlined in section 4.5.4. The SAS output is displayed in 
Appendix K. Protein data obtained by both methods is displayed visually in Figure 30.  
At α = 0.01, there is a statistically significant difference (p < 0.001) between 
protein content as measured by the two analysis methods, though no additional analyses 
were performed to determine which of the two methods yielded the overall higher protein 
measurements. 
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There could be several reasons why the two measurement methods differed in a 
statistically significant fashion. The first reason stems is that the two analysis methods 
measure fundamentally different sample characteristics. The Elementar rapid N combusts 
the sample, traps the resulting vapor, and filters it through a drying chamber and 
reduction chamber before this passing vapor (which should only contain nitrogen at this 
point) to a detector. The resulting voltage measurements are then processed and 
converted to a raw nitrogen measurement, and then, according to the Dumas method, to a 
protein measurement. A slightly high protein measurement may result if either the sample 
contains a high amount of non-protein nitrogen, or the drying chamber or reduction 
chamber fail to trap virtually all vapor that is not nitrogen. Though the instrument was 
calibrated according to manufacture’s specification for the analysis of dairy products 
(section 4.4.2), it is not unfeasible that, like most precision laboratory equipment, 
instrument accuracy may degrade over time. The FOSS Milkoscan FT2, on the other 
hand, measures protein content by obtaining an FTIR spectra of the sample and probing 
this spectra in the amide I and amide II regions (1700 to1400 cm−1) and the fingerprint 
region (1800 to 700 cm−1). The Milkoscan FT2 instrument is calibrated for the analysis of 
dairy products by the use of standards as described in section 4.4.1. Despite the existence 
of standards for concentrated milk, there do not exist standards for milk concentrated by 
UF and DF processes (possibly because physical and chemical properties, such as fluid 
viscosity, color, and mineral content of the UF and DF processed samples can change 
depending upon the pH and temperature at which these concentration processes are 
carried out). 
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Despite the statistically significant differences observed in protein measurements 
obtained between the two processes, for the purposes of this experiment the protein data 
obtained by both seem to be in relative agreement. This study utilized FOSS Milkoscan 
FT2 data in an attempt to verify expected increases in protein concentration (on dry basis) 
that should occur as the UF and DF concentration processes took place, as the ability to 
obtain this information within minutes (and potentially in line if the correct equipment is 
engineered) could be a huge benefit to an MPC manufacturer However, it is clear that, 
from. rapid N protein data obtained, that FTIR application to the measurement of protein 
content in UF and DF retentates in a production environment, where product consistency 
is of utmost importance, may require additional study, as the both methods were not 
strictly in agreement with each other. 
5.3.4. Minerals analysis 
5.3.4.1. Mineral Content of Skim Milk, UF, and DF Products on Wet Basis 
Data obtained from minerals analysis (Ca, Mg, K, and Na) of skim milk and all 
products obtained by UF and DF, as determined by ICP-MS, as well as SAS output, are 
displayed in Appendix L, while the means for Ca, Mg, K, and Na are displayed below. 
Statistical analysis of the difference in Ca, Mg, K, and Na content at DF1, DF2, and DF3 
process levels from UF process levels was analyzed using distinct PROC MIXED 
statements as described in Section 4.5.4. At α = 0.01, there is no statistically significant 
difference in Ca level due to process (p = 0.199) or treatment (p = 0.188).  
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Figure 32: Mean Ca (mg/L) of skim milk and all products obtained by UF/DF 
processes on wet basis 
 
Although no significant differences in Ca content were found in this particular 
study, this data is generally consistent with what has been previously reported concerning 
the effect of mineral addition on the Ca system in milk (Dalgleish and Parker, 1980, 
Dickson and Perkins, 1971, Horne, 1998). According to the previously established work, 
as well as work which attempts to model ionic calcium as a function of ionic strength 
(Mekmene et al., 2009), as ionic strength of the milk solution increases, a larger 
percentage of total calcium will be found in the ionic phase. Ionic-phase minerals are 
then able to be removed by the UF/DF processes, which should lead to an overall lower 
level of Ca in the final UF/DF product. This general trend is illustrted by the plot of Ca 
(mg/ml) by treatment level and process (Figure 32). However, possible causes of failing 
to find a significant difference in Ca levels may involve temperature variations that 
occurred during UF and DF processes, as well as differences in the concentrations of 
products at similar processing levels. Future work should take care to control these two 
variables, as they may highly impact levels of Ca present. 
1000.0
1500.0
2000.0
2500.0
3000.0
3500.0
4000.0
4500.0
Milk UF DF1 DF2 DF3
C
a
 (
m
g
/L
) 0 mM NaCl
50 mM NaCl
100 mM NaCl
150 mM NaCl
 96
At α = 0.01, there is a statistically significant difference in Mg level due to 
process (p = 0.001) and Treatment (p = 0.004). In terms of difference in Mg content, 
Tukey’s comparisons state that, on average, the increase in Mg from UF to DF3 was 
statistically larger than the increase in Mg from UF to DF1. Also, on average, treatment 
level 1 had a significantly larger increase in Mg between UF and DF than treatment level 
4. 
Milk contains roughly 130 mg/L Mg, and of that amount roughly 33 % is found in 
the colloidal phase (Fox, 1989); yet, this association may shift as minerals are added to 
the milk system and overall ionic strength of the milk system increases (Walstra et al., 
2006). The observation that treatment level 1 had a significantly larger increase in Mg 
between UF and DF than treatment level 4 is generally consistent with previous 
observations relating an increase in ionic strength to increased solubility of milk salts 
(Mekmene et al., 2009). 
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Figure 33: Mean Mg (mg/L) of skim milk and all products obtained by UF/DF 
processes on wet basis 
 
At α = 0.01, there is a statistically significant difference in the difference in K 
content due to process (p < 0.001). As nearly roughly 92 % of K in milk exists in the 
ionized form (Fox, 1989), it would be expected to be removed during DF. The sharp 
drops in K during DF1 are consistent with this data, however, the K results presented 
here stand in contrast to data collected by Floris et al., (2007) who noted variation in K 
levels in MPCs collected domestically and internationally. Taken together, these 
observations suggest that, unless manipulated during the manufacture process, K levels 
will likely drop, and that K levels are not affected by the addition of NaCl into DF water 
during the MPC manufacture process. There is no statistically significant difference in K 
content due to treatment (p = 0.222), indicating that the level of NaCl treatment did not 
have a significant effect on the concentration of K present. 
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Figure 34: Mean K (mg/L) of skim milk and all products obtained by UF/DF 
processes on wet basis 
 
At α = 0.01, there is a statistically significant difference in Na content due to 
treatment (p < 0.001). The increase in Na content from UF to DF, on average, was 
significantly higher in treatments 2, 3, and 4 (50, mM, 100mM and 150 mM NaCl 
incorporated into DF water, respectively) than in treatment 1 (control), as well as 
significantly higher in treatment 4 than in treatment 2. This indicates that, as between 50 
mM NaCl and 150 mM NaCl were incorporated into DF water, progressively higher 
levels of NaCl were found in retentate. There was no statistically significant difference in 
Na content due to process (p = 0.052). 
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Figure 35: Mean Na (mg/L) of skim milk and all products obtained by UF/DF 
processes on wet basis 
 
5.3.4.2. Mineral Content of Skim Milk, UF, and DF Products on Dry Basis 
Data obtained from minerals analysis (Ca, Mg, K, and Na) of skim milk and all 
products obtained by UF and DF, as determined by ICP-MS, as well as SAS output, are 
displayed in Appendix L, while the means for Ca, Mg, K, and Na are displayed below. 
Statistical analysis of the difference in Ca, Mg, K, and Na content at DF1, DF2, and DF3 
process levels from UF process levels was analyzed using distinct PROC MIXED 
statements as described in Section 4.5.4. 
At α = 0.01, there was no statistically significant (p = 0.013) difference in Ca 
content. This result is consistent with Ca results for wet basis (section 5.3.4.1) all 
previous discussion concerning Ca results for wet basis also applies here. It should be 
noted that dry basis Ca analysis may more accurately reflect the differences in the true 
proportion of Ca to solid material, especially if the MPC manufacture process had not 
been balanced according to the weight of water removed. Mean Ca content on dry basis is 
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illustrated in Figure 36. No statistically significant interaction was found between process 
and treatment (p = 0.343). 
 
 
Figure 36: Mean Ca (%) of skim milk and all products obtained by UF/DF 
processes on dry basis 
 
At α = 0.01, there is a statistically significant difference in Mg level due to 
process (p = 0.001) but not due to treatment (p = 0.239). There was no statistically 
significant interaction between process and treatment (p = 0.023). Mean Mg content on 
dry basis is illustrated in Figure 37. This differs somewhat from the wet basis analysis, in 
which Mg levels were statistically significantly different due to both process and 
treatment. The differences observed in the wet basis analysis could have been due to 
differences in the final concentration factor achieved, though this was not explicitly 
tested.  
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Figure 37: Mean Mg (%) of skim milk and all products obtained by UF/DF 
processes on dry basis 
 
At α = 0.01, there is a statistically significant (p < 0.001) difference in K content 
due to process, but not due to treatment (p = 0.229) or process by treatment interaction (p 
= 0.174). Mean K content is illustrated by Figure 38. This result is consistent with the 
result for wet basis K content (section 5.3.4.1). 
At α = 0.01, there is a statistically significant (p < 0.001) difference in Na content 
due to treatment, but not process (p < 0.014) or process by treatment interaction (p = 
0.079). Mean Na content is illustrated by Figure 39. This result is consistent with the 
result for wet basis Na content (section 5.3.4.1). 
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Figure 38: Mean K (%) of skim milk and all products obtained by UF/DF processes 
on dry basis 
 
 
Figure 39: Mean Na (%) of skim milk and all products obtained by UF/DF 
processes on dry basis 
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equations. The equation for block 1 is: CaMgRatio = 16.3193 + 0.021788(conc-75) - 
0.000143511(conc-75^2). The equation for block 2 is: CaMgRatio = 15.1105 + 
0.021788(conc-75) - 0.000143511(conc-75^2). The equation for block 3 is: CaMgRatio = 
16.3922 + 0.021788(conc-75) - 0.000143511(conc-75^2). Minitab output is located in 
Appendix M, and a scatterplot of the ratio of Ca to Mg in DF3 on dry basis vs. NaCl 
concentration is shown (Figure 40). 
 
 
Figure 40: Scatterplot of the ratio of Ca to Mg in DF3 vs. NaCl concentration 
 
5.3.4.3. Mineral Content of Dry MPC 
Mineral content of all dry MPCs, as determined by ICP-MS and collected 
according to the method outlined in section 4.4.3, is shown in Appendix N. The statistical 
analysis of the mineral content of all dry MPCs was conducted using the General 
MANOVA command in Minitab according to section 4.5.4. Factors tested were Block 
and Treatment. Responses were Ca, Mg, and Na; because K was below detection limits in 
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all dry MPC, K values were considered to be zero and excluded from the analysis. At α = 
0.01, there was a statistically significant difference in mineral content due to the effect of 
Treatment according to both Wilks’ and Lawley-Hotelling (p < 0.001) criterion. 
Examination of univariate ANOVA for each mineral revealed statistically significant 
differences in Na content (p < 0.001) and Mg content (p < 0.001) due to treatment. Ca 
content was not statistically significantly different due to Treatment (p = 0.016). 
Averages across all blocks are shown (Figure 41). 
ANOVA indicated that there were significant differences (p < 0.001) in powder 
Na content at all treatment levels. With 99 % confidence, the addition of 50 mM NaCl in 
DF water significantly increased (p < 0.001) the mean Na content of MPC by between 
2.48 mg/g and 7.44 mg/g. The addition of 100 mM NaCl in DF water significantly 
increased (p < 0.001) the mean Na content of MPC by between 5.80 mg/g and 10.75 
mg/g. The addition of 150 mM NaCl in DF water significantly increased (p < 0.001) the 
mean Na content of MPC by between 9.57 mg/g and 14.53 mg/g. 
It is also observed that one of the MPCs manufactured during this experiment 
contain similar levels of Na as a typical sodium caseinate. Due to variations in alkali 
requirement during sodium caseinate manufacture, sodium caseinate sodium content may 
typically vary between 0.99 % to 1.75 % (Mulvihill, 1989). MPC manufactured at 
treatment level 2 contains a mean Na value of 0.50 %, treatment level 3 contains a mean 
Na value of 0.83 %, and treatment level 4 contains a mean Na value of 1.21 %, 
respectively, on average. This indicates that the manner in which MPCs were 
manufactured during this experiment may bear similarities with the exchange of Na for 
Ca which takes place in sodium caseinate manufacture as the acidified, calcium-depleted 
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curd is then washed and solubilized in a weak NaOH solution. There is potential for 
future work to verify the similarity of these two mechanisms. 
 
Figure 41: Ca, Mg, and Na analysis of dry MPC by ICP-MS, Treatment averaged 
across all blocks 
 
The amount of Na present in the final MPCs, and the solubility results reported in 
this study, are in agreement with values reported in patent literature. Carr et al. (2002) 
described a monovalent cation addition procedure in which the final powder, which 
exhibited enhanced solubility over powders which had not been replenished with a 
monovalent cation, contained between 0.013 and 0.300 mol Na per 100 g protein. The 
MPC manufactured at treatment levels 2, 3, and 4 contain concentrations of Na per 100 g 
protein falling between these values. The MPC manufactured at treatment level 2 
contains on average 0.026 mol Na per 100 g protein, the MPC manufactured at treatment 
level 3 contains on average 0.044 mol Na per 100 g protein, and the MPC manufactured 
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shown in Appendix N). Dry powder protein and sodium values used in these calculations 
were obtained by least squares means from the analyses titled “General Linear Model: Na 
versus block, treatment” in Appendix N. 
5.4. Moisture analysis 
The moisture content of dry MPC powder, as determined according to AOAC 
925.23, is shown in Table 7. The statistical analysis of the moisture content of dry MPCs 
was conducted using the GLM command in Minitab according to section 4.5.4. There 
was no significant difference in moisture content of MPC (p = 0.107). Therefore it can be 
concluded that the differences in solubility that were observed between the treatment 
levels cannot be attributed to differences in MPC moisture content. Minitab output from 
Tukey’s simultaneous comparisons is located in Appendix O. 
Table 7: Moisture content of dry MPCs; Treatment averaged across all blocks, 
different superscripts denote moisture results that are statistically significantly 
different from each other according to Tukey’s simultaneous tests. 
Sample 
Treatment (mM 
NaCl in DF H2O) Moisture (%) 
MPC 0 7.13a 
MPC 50 6.04a 
MPC 100 5.79a 
MPC 150 6.56a 
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5.5. Powder Particle Size 
5.5.1. Particle Size Distribution of Dry MPC Powder 
The particle size of dry MPC powder, as determined by Coulter LS230 with dry 
powder module, is shown below (Table 22). To determine the treatment effect on the size 
of the of powder particles, statistical analysis of d90 was conducted using the GLM 
command in Minitab according to section 4.5.4.  
At α = 0.01, there was no statistically significant difference in particle size (d90) 
due to the effect of NaCl treatment (p = 0.798) or mean particle size (p = 0.878) due to 
the effect of NaCl treatment. For complete detail, the full particle size distributions of 
MPC powders for each treatment level averaged across all blocks are displayed below 
(Figure 42, Figure 43, Figure 44, Figure 45). 
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Figure 42: Average particle size distribution of MPCs manufactured with no NaCl 
in DF water (treatment level 1) across all blocks. 
 
Figure 43: Average particle size distribution of MPCs manufactured with 50 mM 
NaCl in DF water (treatment level 2) across all blocks. 
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Figure 44: Average particle size distribution of MPCs manufactured with 100 mM 
NaCl in DF water (treatment level 3) across all blocks. 
 
Figure 45: Average particle size distribution of MPCs manufactured with 150 mM 
NaCl in DF water (treatment level 4) across all blocks. 
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The statistical analysis was unable to detect a difference in the dry MPC particle 
sizes (as expressed by both the d90 and mean) between MPCs manufactured at different 
treatment levels. This result suggests that NaCl addition to DF water may not impact dry 
MPC particle size. Currently, no other study has attempted to detect a difference in dry 
MPC particle size due to addition of sodium. 
5.5.2. Particle Size Distribution of MPC Powder During Reconstitution 
The particle size of MPC during reconstitution, as determined by Coulter LS230 
with fluid module, is shown in Appendix P. To determine the treatment effect on the size 
of of particles, statistical analysis of d90 and mean particle size were conducted using the 
GLM command in Minitab according to section 4.5.4. At α = 0.01, there was no 
statistically significant difference in d90 (p = 0.798) or mean particle size (p = 0.878) due 
to the effect of NaCl treatment. 
The full particle size distributions of MPC powders for each treatment level 
averaged across all blocks is also displayed below (Figure 46, Figure 47, Figure 48, 
Figure 49). 
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Figure 46: Average particle size distribution of particles during reconstitution 
resulting from the manufacture of MPC utilizing no NaCl in DF water (treatment 
level 2) across all blocks 
 
Figure 47: Average particle size distribution of particles during reconstitution 
resulting from the manufacture of MPC utilizing 50 mM NaCl in DF water 
(treatment level 1) across all blocks 
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Figure 48: Average particle size distribution of particles during reconstitution 
resulting from the manufacture of MPC utilizing 100 mM NaCl in DF water 
(treatment level 1) across all blocks 
 
 
Figure 49: Average particle size distribution of particles during reconstitution 
resulting from the manufacture of MPC utilizing 150 mM NaCl in DF water 
(treatment level 1) across all blocks 
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It is generally expected that, as the solubility of dairy powders increases, particle 
size will trend closer to that of native micelle size in milk. This study did not detect a 
difference in either d90 or mean particle size between the treatment groups. It is possible 
that powders were not reconstituted for a long enough time during this experiment to 
observe more significant decreases in particle size upon reconstitution or that the number 
of replicates was too small to detect a difference. It is also possible that observed 
increases in solubility are due to changes in particle structure, not necessarily a 
significant decrease in particle size. This possibility will be discussed in section 5.6.  
It is also possible that analysis of d90 or mean particle size, by themselves, do not 
accurately describe changes in particle size distribution that could be occurring as a 
function of the treatment. This is illustrated by a scatterplot of particle size averaged 
across blocks vs. NaCl treatment (Figure 50). The scatterplot shows that particle size 
distribution appears to narrow as NaCl treatment is increased. To assist in the analysis of 
MPC particle size distribution upon reconstitution, an analysis of the mid80 range (d90-
d10) was conducted using the GLM command in Minitab according to section 4.5.4. At α 
= 0.01, there was no statistically significant difference in mid80 range
 
(p = 0.017) due to 
the effect of NaCl treatment. Therefore, this study cannot conclude that significant 
changes in particle size occurred in MPC during reconstitution as a function of NaCl 
treatment up to 150 mM NaCl in DF water, the highest treatment level tested. 
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Figure 50: Scatterplot of particle size averaged across blocks vs. NaCl (mM in DF 
water) 
 
Further analysis was conducted to investigate possible changes in particle size of 
MPC during reconstitution. An analysis of the right tail of the particle size distribution, 
defined as (d90-d50), was conducted using the GLM command in Minitab as described in 
section 4.5.4. At α = 0.01, there was a statistically significant difference in (d90-d50) (p = 
0.008) due to the effect of NaCl treatment (Table 8). 
Despite the GLM finding a significant difference between the treatment levels, 
Tukey’s method of pairwise comparisons did not yield statistically significant differences 
between means. This may be due to differences in the nature of the two tests; the GLM is 
a slightly more powerful method than the method of Tukey’s pairwise comparisons. The 
significant F-test from the GLM indicates that (d90-d50) is significantly different between 
the treatments.  Since the Tukey intervals cannot detect which treatments are significantly 
different, we interpret that a significant difference exists between 0 mM NaCl and 150 
mM NaCl, the lowest and highest treatments. 
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Table 8: Average particle size distribution (d90-d50) of particles during reconstitution 
resulting from the manufacture of MPC; treatment averaged across all blocks; different 
superscripts denote particle size distribution (d90-d10) results that are statistically 
significantly different from each other according to Tukey’s simultaneous tests; although 
GLM results were significant (p = 0.008), Tukey’s simultaneous tests did not find 
significant differences between the means. 
Treatment (mM 
NaCl in DF H2O) 
Particle Size 
(d90-d50) 
0 82.6a 
50 66.2a 
100 36.2a 
150 35.3a 
 
5.6. Confocal laser scanning microscopy 
CLSM of reconstituted MPCS were taken according to the method outlined in 
Section 4.5.3. Figure 51 shows differences in MPC particle microstructure between MPC 
manufactured with no NaCl (top left), 50 mM (top right), 100 mM (bottom left), and 150 
mM (bottom right) NaCl incorporated into DF water. Upon reconstitution, MPC particles 
manufactured without NaCl addition to DF water appeared to contain a structural 
network of greater density than MPC particles manufactured with 50 mM or 100 mM 
NaCl incorporated into DF water. As NaCl treatment level increases, the particle 
structural network appeared to become more porous, as can be seen in Figure 51. 
If an increase in porosity is observed, then a decrease in particle density upon 
reconstitution should also be observed; however, no particle density measurements were 
conducted. It is recommended that future research further explore possible connections 
 between the manufacture of MPC utilizing the
porosity, and changes in particle density.
 
 
Figure 51: (Top Left) Confocal micrograph of MPC manufactured at block
level 1 (scale = 50 µm). (
2, treatment level 2 (scale = 50 µm
manufactured at block 3, treatment level 3
Confocal micrograph of MPC manufactured at block 3, treatment level 4
 
It was previously observed that the microstructure of fresh MPC85 powders after 
rehydration for 10 min. at 24 °C
(Mimouni et al., 2010).The micrographs
and 50 mM NaCl treatment (top right) 
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 addition of NaCl to DF water,
 
 
 
 
Top Right) Confocal micrograph of MPC manufactured at block 
). (Bottom Left) Confocal micrograph of MPC 
 (scale length = 20 µm). (Bottom Right) 
 displayed a “skin-like structure” on their surfaces
 in Figure 51, particularly the control (top left),
support that observation. In the micrograph 
 particle 
 
 
 3, treatment 
 (scale = 20 µm). 
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containing an MPC manufactured without NaCl in DF water (top left), there is a clear 
distinction between the particle material and the surrounding space. In contrast, in the 
MPC particle manufactured with 50 mM NaCl in DF water (top right), and 100 mM NaCl 
in DF water (bottom left), and 150 mM DF water (bottom right), the separation between 
the particle material and the surrounding space is less distinct. 
It was also previously observed that the microstructure of hydrated MPC85 
powder particles, under conditions of mixing at 24 °C for 80 min., became relatively 
porous, and these cavities are large enough to enable water to penetrate the particle 
interior (Figure 52, bottom right) (Mimouni et al., 2010). This observation was made by 
comparing MPC85 (of which no data pertaining to mineral content or solubility was 
reported) at different reconstitution times and temperatures, and at different storage 
times, using scanning electron microscopy. Together, the images captured by Mimouni et 
al. (2010)  demonstrate a similar progression as the one demonstrated in Figure 51, from 
a particle exhibiting a skin-like structure upon rehydration (Figure 52, top left), to a 
particle with an interior structure appearing more porous in nature (Figure 52, top right), 
to a particle that is breaking apart (Figure 52, bottom left). Though solubility data was not 
reported, MPCs stored 2 months at 20 °C (Figure 52, top left) should exhibit poorer 
solubility, according to Havea et al (2006) and Carr et al. (2002), than freshly made MPC 
reconstituted for 10 min. at 24 °C (Figure 52, top right) and 80 min (Figure 52, bottom 
left). It was concluded that the dissolution of powder particles occurred by a gradual 
process, in which the external particle surface and internal surfaces (when exposed by 
breaches in the external surface) were eroded by the penetration of water throughout the 
particle (Mimouni et al., 2010). 
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Figure 52: Field emission scanning electron micrographs of MPC after rehydration, 
all scales = 1 µm; (Top left) aged milk protein concentrate after 2 months storage at 
24 °C hydrated for 10 min. at 24 °C (scale = 1 µm), (Top right) freshly made MPC 
hydrated for 10 min. at 24 °C, (Bottom left) freshly made MPC hydrated for 80 
min. at 24 °C, (Bottom right) details of the surface of hydrated powder particles, 
white arrows indicate presence of intermicellar bridges. Images captured by 
Momouni et al (2010) 
 
Taken together, there exist observed similarities between the images in Figure 51 
and those in Figure 52; both sets of images depict MPC particles with a “skin-like layer”, 
followed by what appears to be a gradual dissolution (both from the exterior and interior) 
of the MPC particle, and both demonstrate an apparent change in the porosity of MPC. If 
the mechanisms of dissolution demonstrated in Figure 51 and Figure 52 are indeed 
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similar to each other, it would indicate that the addition of NaCl into DF water has 
accelerated the mechanism by which MPC dissolves. In other words, the forces which 
bridge micellar networks (described as intermicellar contacts and short bridges by 
Mimouni (2010)) may have been weakened by the addition of NaCl into DF water ,or 
that forces existed which counteracted the forces which favored the bridging of micellar 
networks. This assumes that that these intermicellar contacts and short bridges are a 
significant inhibitor of MPC dissolution, but the role of these physiochemical interactions 
has not yet been isolated or determined.  
The cause of this acceleration in the dissolution mechanism it is not known. 
Testing if the speed of the dissolution mechanism heavily depends upon the ionic 
strength of the MPC as it is reconstituted would require a measurement of important 
minerals during the reconstitution process, including determining the ratio of ionic phase 
minerals to colloidal phase minerals. If, however, the addition of NaCl to DF water 
during the manufacture significantly alters the mechanism by which the product is 
converted from liquid retentate to dry form, then high-resolution examination of the 
MPCs in dry form (utilizing TEM or SEM techniques) may indicate differences in the 
arrangement of material on the powder surface. To date, although TEM has been used to 
show changes in MPC morphology under storage conditions (Carr et al., 2002), direct 
evidence of physical differences (in dry form) between MPC manufactured with mineral 
addition and MPC manufactured without have not been reported. Particle size analysis of 
dry MPC, discussed in section 5.5.2, failed to find significant differences in dry MPC 
particle size due to effect of NaCl treatment. 
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In this study, the utilization of FG and NR in CLSM allows some observations to 
be made concerning the distributions of lipids and proteins on the surface of MPC 
powder particles. It was observed that MPC powders manufactured without the addition 
of NaCl into DF water had a high incidence of lipid material on MPC particle surfaces; 
and there appeared to be only small amounts of lipid material present that were not bound 
to particle surfaces. These observations are illustrated by Figure 53, which shows MPC 
powder particles manufactured without addition of NaCl into DF water. Both the 
intensity and concentration of lipid material on the surface of powder particles in Figure 
53 appear different than those in Figure 54, which show MPC powder particles 
manufactured at treatment level 2 (top left and top right) and treatment level 3 (bottom 
left and bottom right). 
  
 121
 
 
 
 
Figure 53: Top left and top right: confocal micrograph of powder manufactured at 
block 3, treatment level 1 (scale = 50 µm); (Top left) NR excitation only, (Top 
right) excitation of both FG and NR; Bottom left and bottom right: confocal 
micrograph of MPC manufactured at block 2, treatment level 1 (scale = 50 µm); 
(Left) NR excitation only, (Right) excitation of both FG and NR 
  
  
Figure 54: Top left and top right: c
block 2, treatment level 
excitation of only FG
manufactured at block 3, treatment level 3 (scale = 2
excitation, (Right) excitation of only FG
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onfocal micrograph of MPC manufactured
2 (scale = 20 µm); (Left) FG and NR excitation, (Right) 
; Bottom left and bottom right: confocal micrograph of MPC 
0 µm); (Left) FG and NR 
 
 
 
 
 at 
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A comparison of three-dimensional confocal micrographs (Figure 55) indicate 
that MPC manufactured with 150 mM NaCl in DF water appears to contain a very high 
incidence of lipid material that is not bound to any powder particle (left), in comparison 
with MPC manufactured without NaCl incorporated into DF water (right), in which the 
majority of lipid material appears to be associated with powder particles. 
 
 
Figure 55: Confocal micrographs of MPC manufactured at block 2, treatment level 
4, NR and FG excitation (left), and block 1 treatment level 1, NR and FG excitation 
(right) (length and width of cross sections in both images = 105.44 µm) 
 
Milk fat is believed to play a role in the behavior of powder during reconstitution 
(Farkye, 2006). It was previously observed in milk powder that the amount of free fat 
(defined as the fraction of total fat that is not protected by protein film, but is instead 
present as “pools” or “patches” instead of as globules on the powder particle surface) 
(Pisecky, 1997) was inversely related to the particle size (Buma, 1971). According to 
Zayas (1997), in high powder protein foods, fat binding is influenced by the size of the 
powder particles. However, these observations have not been tested in an MPC system. 
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There is some information relating the packed bulk density of milk powders with 
fat content;  a study by Tuohy (1989) suggested that increasing fat content of milk 
powder could yield a milk powder with decreased bulk density. If applicable to MPC, this 
would indicate that a decrease in the fat content of MPC could result in an improvement 
in the poor bulk density typically exhibited by these powders, but there are currently no 
studies to suggest these same assumptions are applicable. In addition, there is little to no 
information in the scientific literature on the role of milk fat on the dispersability, 
flowability, or bulk density of milk powders (Farkye, 2006), much less the role of milk 
fat on these properties in MPC. 
In dairy powders, it can be assumed that fat may exist in one of four states:: as 
surface fat (present as patches on the surface of particles), outer layer fat (consisting of 
fat globules that nearly touch the particle surface), capillary fat (fat globules that come 
into contact with the surface of micropores), and dissolution fat (fat globules that contact 
any openings after the particle’s outer layer has been dissolved) (Pisecky, 1997). 
Regardless of state, nonpolar side-chasins of protein molecules are the primary sites of 
lipid protein interactions; thus hydrophobic and, potentially water-insoluble, proteins 
should have a higher capacity to bind fat (Zayas, 1997).  
The use of one or more hydrophobic probes may aid in determining if MPC 
manufactured without NaCl addition to DF water exhibits increased hydrophobicity; if so 
then this would lend additional evidence to the hypothesis that there are increased lipid-
protein interactions occurring in MPC manufactured without the addition of NaCl to 
retentate. 
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6. CONCLUSIONS AND SIGNIFICANCE 
The main objective of this thesis was to test a manufacturing process utilizing the 
addition of sodium chloride to diafiltration water, which ultimately yields a spray-dried 
milk protein concentrate powder with improved solubility over a powder which is not 
manufactured with the addition of sodium chloride to diafiltration water. 
Milk protein concentrate manufactured utilizing the addition of sodium chloride 
to diafiltration water showed improved solubility under a variety of solubilizing 
conditions. For example, it was observed that under conditions of reconstitution for 1h at 
23 °C ± 1 °C, mean MPC solubility was improved from 59.81 %  (when no NaCl was 
incorporated into DF water) to 96.52 % (when 150 mM NaCl was incorporated into DF 
water). Under these testing conditions, significant increases in mean solubility were 
observed at every NaCl treatment level tested. In addition, it was observed under 
conditions of reconstitution for 30 min at 30 °C using an overhead stirrer, the addition of 
150 mM NaCl into DF water improved mean solubility to 96.2 %, a significant increase 
from the control level’s mean solubility of 46.1 %. In each solubility test performed, the 
solubility of milk protein concentrate manufactured utilizing sodium chloride in DF water 
was significantly higher than that of the control. These results demonstrate that milk 
protein concentrate manufactured by this process was significantly more soluble in water 
than milk protein concentrate that had been manufactured without such NaCl addition. 
Analysis of retentate products obtained by ultrafiltration and diafiltration, as well as of 
the final powders, showed significant increases in sodium content in both retentate and 
powder as sodium chloride treatment level increased 
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Analysis of particle size revealed no significant differences in dry powder particle 
size or particle size upon reconstitution due to sodium chloride treatment level. However, 
using light microscopy, some differences in rehydrated particle structure could be 
observed between treatment levels. These differences may partially explain differences in 
milk protein concentrate solubility between treatment levels.  
This thesis project provides a preliminary foundation for future studies 
investigating the effect of sodium chloride addition on particle structure, and the cause of 
such increases in solubility as sodium chloride treatment level increased. These insights 
may assist milk protein concentrate manufacturers in producing powders with 
consistently high water solubility. 
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7. DIRECTIONS FOR FUTURE RESEARCH 
Additional research into the relationship between milk protein concentrate 
manufacturing methods involving the addition of sodium chloride into the diafiltration 
water and its impact on the solubility of the final powder may broaden our understanding 
of the mechanism by which sodium addition yields a more highly soluble milk protein 
concentrate powder. Possible research directions are as follows: 
1. Investigate the location and state of added minerals by quantifying the 
concentrations of minerals bound to proteins versus the concentrations of 
minerals existing as ions upon reconstitution 
2. Isolate the effect of sodium addition on the solubility of the final powder from 
the effect of calcium depletion 
3. Further investigate the relationship between mineral salt addition during the 
MPC manufacture process and changes in particle size and structure that 
occur during reconstitution of the powder 
4. Determine changes in protein conformation and hydrophobic interactions that 
occur as MPC retentate is gradually replenished with sodium 
5. Perform MPC manufacturing trials as described in this thesis utilizing other 
mineral salts which dissociate to yield monovalent or divalent cations, such as 
potassium chloride or calcium chloride 
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Appendix A: Calculation of Statistical Power 
 
  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Figure 56: Equations utilized to calculate statistical power when “Power and 
Sample Size for One-Way Anova” command is invoked in Minitab v.15.1 
(Anonymous, 2010d), where df = degrees of freedom, a = number of factor levels, 
n = sample size per factor level, d = maximum difference between means, σ = 
overall standard deviation, and α = significance level 
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Appendix B: Temperature and pH of Products Obtained by 
MPC Manufacture 
Table 9: pH and temperature of each product obtained from MPC manufacture 
 
 
Block Treatment Sample pH Temperature (°C) 
1 1 SM 6.85 5.1 
1 1 UF 6.75 17.2 
1 1 DF1 6.81 23.0 
1 1 DF2 6.87 27.4 
1 1 DF3 7.14 28.2 
1 2 SM 6.85 5.3 
1 2 UF 6.77 19.0 
1 2 DF1 6.81 27.4 
1 2 DF2 6.87 29.0 
1 2 DF3 7.14 30.7 
1 3 SM 6.84 8.3 
1 3 UF 6.66 18.3 
1 3 DF1 6.75 27.1 
1 3 DF2 6.95 31.1 
1 3 DF3 7.15 30.4 
1 4 SM 6.84 5.0 
1 4 UF 6.66 19.1 
1 4 DF1 6.75 27.1 
1 4 DF2 6.95 31.1 
1 4 DF3 7.15 30.4 
2 1 SM 6.87 7.1 
2 1 UF 6.71 18.4 
2 1 DF1 6.83 25.3 
2 1 DF2 6.98 29.8 
2 1 DF3 7.09 30.3 
2 2 SM 6.87 7.2 
2 2 UF 6.72 19.1 
2 2 DF1 6.84 25.7 
2 2 DF2 6.97 31.1 
2 2 DF3 7.16 31.0 
2 3 SM 6.84 5.20 
2 3 UF 6.68 22.5 
2 3 DF1 6.76 29.4 
2 3 DF2 6.97 31.1 
2 3 DF3 7.18 31.5 
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Table 7; continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Statistical Analysis to Determine if pH differed significantly due to Treatment, 
sliced by Process 
 
The Mixed 
Procedure 
 
 
Block Treatment Sample pH Temperature (°C) 
2 4 SM 6.83 4.90 
2 4 UF 6.67 20.9 
2 4 DF1 6.78 26.7 
2 4 DF2 6.97 29.9 
2 4 DF3 7.23 29.5 
3 1 SM 6.85 5.0 
3 1 UF 6.77 21.8 
3 1 DF1 6.84 26.3 
3 1 DF2 6.95 28.8 
3 1 DF3 7.10 30.5 
3 2 SM 6.87 7.4 
3 2 UF 6.75 19.1 
3 2 DF1 6.87 25.7 
3 2 DF2 7.03 31.2 
3 2 DF3 7.22 29.9 
3 3 SM 6.90 5.5 
3 3 UF 6.74 20.7 
3 3 DF1 6.84 26.9 
3 3 DF2 7.04 30.4 
3 3 DF3 7.31 29.4 
3 4 SM 6.84 4.8 
3 4 UF 6.76 20.2 
3 4 DF1 6.87 24.9 
3 4 DF2 7.09 28.2 
3 4 DF3 7.27 33.6 
 137
Model Information 
Data Set WORK.PH_TEMP 
Dependent Variable pH 
Covariance Structure Variance 
Components 
Subject Effect block*treatment 
Estimation Method REML 
Residual Variance Method Parameter 
Fixed Effects SE Method Model-Based 
Degrees of Freedom 
Method 
Containment 
 
 
Class Level Information 
Class 
Level
s Values 
process 5 DF1 DF2 DF3 SM UF 
sample 12 1 2 3 4 5 6 7 8 9 10 
11 12 
block 3 1 2 3 
treatmen
t 
4 1 2 3 4 
 
 
Dimensions 
Covariance 
Parameters 
3 
Columns in X 30 
Columns in Z 15 
Subjects 1 
Max Obs Per Subject 60 
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Number of Observations 
Number of Observations Read 60 
Number of Observations Used 60 
Number of Observations Not 
Used 
0 
 
 
Iteration History 
Iteratio
n 
Evaluation
s -2 Res Log Like Criterion 
0 1 -
107.13146999 
 
1 1 -
130.11163270 
0.000000
00 
 
 
Convergence criteria 
met. 
 
 
Estimated R Matrix for block*treatment 1 1 
Row Col1 Col2 Col3 Col4 Col5 
1 0.0009
94 
    
2  0.0009
94 
   
3   0.0009
94 
  
4    0.0009
94 
 
5     0.0009
94 
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Estimated R Correlation Matrix for 
block*treatment 1 1 
Row Col1 Col2 Col3 Col4 Col5 
1 1.00
00 
    
2  1.00
00 
   
3   1.00
00 
  
4    1.00
00 
 
5     1.000
0 
 
 
Covariance Parameter Estimates 
Cov Parm Subject 
Estimat
e 
block  0.00110
0 
block*treatme
nt 
 0.00022
8 
process block*treat
ment 
0.00099
4 
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Fit Statistics 
-2 Res Log Likelihood -
130.
1 
AIC (smaller is better) -
124.
1 
AICC (smaller is 
better) 
-
123.
4 
BIC (smaller is better) -
126.
8 
 
 
Type 3 Tests of Fixed Effects 
Effect 
Num 
DF 
De
n 
DF F Value Pr > F 
treatment 3 6 0.62 0.628
5 
process 4 32 375.19 <.000
1 
process*treatme
nt 
12 32 3.49 0.002
3 
 
 
Least Squares Means 
Effect 
proces
s 
treatmen
t 
Estimat
e 
Standar
d Error DF 
t Valu
e 
Pr > 
|t| 
process*treatme
nt 
DF1 1 6.8267 0.02782 32 245.4
0 
<.000
1 
process*treatme
nt 
DF1 2 6.8400 0.02782 32 245.8
8 
<.000
1 
process*treatme
nt 
DF1 3 6.7833 0.02782 32 243.8
4 
<.000
1 
process*treatme
nt 
DF1 4 6.8000 0.02782 32 244.4
4 
<.000
1 
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Least Squares Means 
Effect 
proces
s 
treatmen
t 
Estimat
e 
Standar
d Error DF 
t Valu
e 
Pr > 
|t| 
process*treatme
nt 
DF2 1 6.9333 0.02782 32 249.2
3 
<.000
1 
process*treatme
nt 
DF2 2 6.9567 0.02782 32 250.0
7 
<.000
1 
process*treatme
nt 
DF2 3 6.9867 0.02782 32 251.1
5 
<.000
1 
process*treatme
nt 
DF2 4 7.0033 0.02782 32 251.7
5 
<.000
1 
process*treatme
nt 
DF3 1 7.1100 0.02782 32 255.5
8 
<.000
1 
process*treatme
nt 
DF3 2 7.1733 0.02782 32 257.8
6 
<.000
1 
process*treatme
nt 
DF3 3 7.2133 0.02782 32 259.3
0 
<.000
1 
process*treatme
nt 
DF3 4 7.2167 0.02782 32 259.4
2 
<.000
1 
process*treatme
nt 
SM 1 6.8567 0.02782 32 246.4
8 
<.000
1 
process*treatme
nt 
SM 2 6.8633 0.02782 32 246.7
2 
<.000
1 
process*treatme
nt 
SM 3 6.8600 0.02782 32 246.6
0 
<.000
1 
process*treatme
nt 
SM 4 6.8367 0.02782 32 245.7
6 
<.000
1 
process*treatme
nt 
UF 1 6.7433 0.02782 32 242.4
0 
<.000
1 
process*treatme
nt 
UF 2 6.7467 0.02782 32 242.5
2 
<.000
1 
process*treatme
nt 
UF 3 6.6933 0.02782 32 240.6
0 
<.000
1 
process*treatme
nt 
UF 4 6.6967 0.02782 32 240.7
2 
<.000
1 
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Tests of Effect Slices 
Effect process 
Num 
DF 
Den 
DF F Value Pr > F 
process*treatment DF1 3 32 1.61 0.2069 
process*treatment DF2 3 32 2.38 0.0877 
process*treatment DF3 3 32 6.05 0.0022 
process*treatment SM 3 32 0.35 0.7876 
process*treatment UF 3 32 2.06 0.1258 
 
Statistical Analysis to Determine if Temperature differed significantly due to 
Treatment 
 
The Mixed 
Procedure 
 
Model Information 
Data Set WORK.PH_TEMP 
Dependent Variable Temp 
Covariance Structures Variance Components, 
Autoregressive 
Subject Effect block*treatment 
Estimation Method REML 
Residual Variance Method Profile 
Fixed Effects SE Method Model-Based 
Degrees of Freedom 
Method 
Containment 
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Class Level Information 
Class 
Level
s Values 
process 5 DF1 DF2 DF3 SM UF 
sample 12 1 2 3 4 5 6 7 8 9 10 
11 12 
block 3 1 2 3 
treatmen
t 
4 1 2 3 4 
 
 
Dimensions 
Covariance 
Parameters 
4 
Columns in X 30 
Columns in Z 15 
Subjects 1 
Max Obs Per Subject 60 
 
 
Number of Observations 
Number of Observations Read 60 
Number of Observations Used 60 
Number of Observations Not 
Used 
0 
 
 
Iteration History 
Iteratio
n 
Evaluation
s -2 Res Log Like Criterion 
0 1 159.81993823  
1 3 156.15140861 0.003584
41 
2 2 155.99373285 0.000042
55 
3 1 155.99196528 0.000000
01 
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Convergence criteria 
met. 
 
 
Estimated R Matrix for block*treatment 1 1 
Row Col1 Col2 Col3 Col4 Col5 
1 1.4933 -
0.5629 
0.212
2 
-
0.0799
7 
0.0301
4 
2 -
0.5629 
1.4933 -
0.562
9 
0.2122 -
0.0799
7 
3 0.2122 -
0.5629 
1.493
3 
-
0.5629 
0.2122 
4 -
0.0799
7 
0.2122 -
0.562
9 
1.4933 -
0.5629 
5 0.0301
4 
-
0.0799
7 
0.212
2 
-
0.5629 
1.4933 
 
 
Estimated R Correlation Matrix for 
block*treatment 1 1 
Row Col1 Col2 Col3 Col4 Col5 
1 1.0000 -
0.3769 
0.142
1 
-
0.0535
5 
0.0201
9 
2 -
0.3769 
1.0000 -
0.376
9 
0.1421 -
0.0535
5 
3 0.1421 -
0.3769 
1.000
0 
-
0.3769 
0.1421 
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Estimated R Correlation Matrix for 
block*treatment 1 1 
Row Col1 Col2 Col3 Col4 Col5 
4 -
0.0535
5 
0.1421 -
0.376
9 
1.0000 -
0.3769 
5 0.0201
9 
-
0.0535
5 
0.142
1 
-
0.3769 
1.0000 
 
 
Covariance Parameter Estimates 
Cov Parm Subject 
Estimat
e 
block  0.03548 
block*treatme
nt 
 0.3058 
AR(1) block*treat
ment 
-0.3769 
Residual  1.4933 
 
 
Fit Statistics 
-2 Res Log Likelihood 156.
0 
AIC (smaller is better) 164.
0 
AICC (smaller is 
better) 
165.
1 
BIC (smaller is better) 160.
4 
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Type 3 Tests of Fixed Effects 
Effect 
Num 
DF 
De
n 
DF F Value Pr > F 
treatment 3 6 2.72 0.137
6 
process 4 32 1108.5
1 
<.000
1 
process*treatme
nt 
12 32 0.92 0.540
4 
 
 
Least Squares Means 
Effect 
proces
s 
Estimat
e 
Standar
d Error DF 
t Valu
e 
Pr > 
|t| 
proces
s 
DF1 26.2917 0.4022 32 65.37 <.000
1 
proces
s 
DF2 29.9250 0.4022 32 74.41 <.000
1 
proces
s 
DF3 30.4500 0.4022 32 75.71 <.000
1 
proces
s 
SM 5.9000 0.4022 32 14.67 <.000
1 
proces
s 
UF 19.6917 0.4022 32 48.96 <.000
1 
 
 
Differences of Least Squares Means 
Effect 
proces
s 
_proces
s 
Estimat
e 
Standar
d Error DF 
t Valu
e 
Pr > 
|t| Adjustment Adj P 
proces
s 
DF1 DF2 -3.6333 0.5854 32 -6.21 <.000
1 
Tukey-
Kramer 
<.000
1 
proces
s 
DF1 DF3 -4.1583 0.4621 32 -9.00 <.000
1 
Tukey-
Kramer 
<.000
1 
proces
s 
DF1 SM 20.3917 0.5121 32 39.82 <.000
1 
Tukey-
Kramer 
<.000
1 
proces
s 
DF1 UF 6.6000 0.4938 32 13.37 <.000
1 
Tukey-
Kramer 
<.000
1 
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Differences of Least Squares Means 
Effect 
proces
s 
_proces
s 
Estimat
e 
Standar
d Error DF 
t Valu
e 
Pr > 
|t| Adjustment Adj P 
proces
s 
DF2 DF3 -0.5250 0.5854 32 -0.90 0.376
5 
Tukey-
Kramer 
0.896
0 
proces
s 
DF2 SM 24.0250 0.4621 32 51.99 <.000
1 
Tukey-
Kramer 
<.000
1 
proces
s 
DF2 UF 10.2333 0.5121 32 19.98 <.000
1 
Tukey-
Kramer 
<.000
1 
proces
s 
DF3 SM 24.5500 0.5854 32 41.94 <.000
1 
Tukey-
Kramer 
<.000
1 
proces
s 
DF3 UF 10.7583 0.4621 32 23.28 <.000
1 
Tukey-
Kramer 
<.000
1 
proces
s 
SM UF -
13.7917 
0.5854 32 -23.56 <.000
1 
Tukey-
Kramer 
<.000
1 
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Appendix C: Data and Minitab Output for Solubility (1h) 
Table 10: Solubility after one hour (1h) reconstitution on laboratory stage mixer. 
Means and standard deviations were calculated from two measurements. 
Block Treatment Replicate Solubility (%) pH Temperature (°C) 
1 1 1 58.72 ± 0.47 7.49 23.5 
1 2 1 68.45 ± 0.87 7.69 24.6 
1 3 1 92.03 ± 0.46 7.73 23.5 
1 4 1 97.50 ± 0.70 7.74 22.7 
2 1 1 57.65 ± 1.03 7.48 22.8 
2 2 1 69.82 ± 0.40 7.70 24.3 
2 3 1 92.99 ± 0.11 7.73 22.4 
2 4 1 95.98 ± 1.14 7.73 23.4 
3 1 1 62.45 ± 1.53 7.51 21.7 
3 2 1 66.31 ± 1.73 7.70 23.4 
3 3 1 93.56 ± 1.09 7.72 22.9 
3 4 1 95.42± 0.69 7.72 21.8 
1 1 2 56.22 ± 0.81 7.51 23.0 
1 2 2 66.68 ± 0.98 7.71 23.7 
1 3 2 92.45 ± 0.52 7.73 24.6 
1 4 2 96.94 ± 0.76 7.75 22.1 
2 1 2 59.21 ± 0.93 7.50 23.0 
2 2 2 67.65 ± 0.51 7.69 23.8 
2 3 2 92.91 ± 0.49 7.72 22.6 
2 4 2 95.87 ± 0.68 7.73 22.0 
3 1 2 64.59 ± 0.75 7.50 22.3 
3 2 2 69.41 ± 1.12 7.70 24.0 
3 3 2 91.23 ± 0.68 7.72 23.3 
3 4 2 97.43±  0.91 7.73 22.9 
 
Minitab Output Solubility (1h) 
 
General Linear Model: solubility_1hr versus block, treatment  
 
Factor     Type    Levels  Values 
block      random       3  1, 2, 3 
treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for solubility_1hr, using Adjusted SS for Tests 
 
Source           DF   Seq SS   Adj SS   Adj MS       F      P 
block             2     8.71     8.71     4.35    0.70  0.533 
treatment         3  5868.53  5868.53  1956.18  314.45  0.000 
block*treatment   6    37.33    37.33     6.22    3.67  0.026 
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Error            12    20.35    20.35     1.70 
Total            23  5934.91 
 
S = 1.30212   R-Sq = 99.66%   R-Sq(adj) = 99.34% 
 
Minitab Output for no Interaction between block and treatment 
 
General Linear Model: solubility_1hr versus block, treatment  
 
Factor     Type    Levels  Values 
block      random       3  1, 2, 3 
treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for solubility_1hr, using Adjusted SS for Tests 
 
Source     DF  Seq SS  Adj SS  Adj MS       F      P 
block       2     8.7     8.7     4.4    1.36  0.282 
treatment   3  5868.5  5868.5  1956.2  610.54  0.000 
Error      18    57.7    57.7     3.2 
Total      23  5934.9 
 
 
S = 1.78998   R-Sq = 99.03%   R-Sq(adj) = 98.76% 
 
 
Unusual Observations for solubility_1hr 
 
Obs  solubility_1hr      Fit  SE Fit  Residual  St Resid 
 21         64.5900  60.6287  0.8950    3.9613      2.56 R 
 
R denotes an observation with a large standardized residual. 
 
 
Least Squares Means for solubility_1hr 
 
treatment   Mean 
1          59.81 
2          68.05 
3          92.53 
4          96.52 
 
 
Grouping Information Using Tukey Method and 99.0% Confidence 
 
treatment  N  Mean  Grouping 
4          6  96.5  A 
3          6  92.5    B 
2          6  68.1      C 
1          6  59.8        D 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 99.0% Simultaneous Confidence Intervals 
Response Variable solubility_1hr 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
treatment   Lower  Center  Upper  +---------+---------+---------+------ 
2           4.527   8.247  11.97      (--*--) 
 150
3          29.002  32.722  36.44                          (--*--) 
4          32.997  36.717  40.44                             (---*--) 
                                  +---------+---------+---------+------ 
                                  0        12        24        36 
 
 
treatment = 2  subtracted from: 
 
treatment  Lower  Center  Upper  +---------+---------+---------+------ 
3          20.76   24.48  28.19                   (--*--) 
4          24.75   28.47  32.19                       (--*--) 
                                 +---------+---------+---------+------ 
                                 0        12        24        36 
 
 
treatment = 3  subtracted from: 
 
treatment   Lower  Center  Upper  +---------+---------+---------+------ 
4          0.2755   3.995  7.715  (--*--) 
                                  +---------+---------+---------+------ 
                                  0        12        24        36 
 
 
Tukey Simultaneous Tests 
Response Variable solubility_1hr 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
2               8.247       1.033    7.980    0.0000 
3              32.722       1.033   31.663    0.0000 
4              36.717       1.033   35.528    0.0000 
 
 
treatment = 2  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
3               24.48       1.033    23.68    0.0000 
4               28.47       1.033    27.55    0.0000 
 
 
treatment = 3  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
4               3.995       1.033    3.866    0.0057 
 
Regression Analysis: solubility_1hr versus pH_1hr  
 
The regression equation is 
solubility_1hr = - 915 + 130 pH_1hr 
 
 
Predictor    Coef  SE Coef      T      P 
Constant   -914.7    160.2  -5.71  0.000 
pH_1hr     129.69    20.90   6.21  0.000 
 
 
S = 9.90324   R-Sq = 63.6%   R-Sq(adj) = 62.0% 
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Analysis of Variance 
 
Source          DF      SS      MS      F      P 
Regression       1  3777.3  3777.3  38.51  0.000 
Residual Error  22  2157.6    98.1 
Total           23  5934.9 
 
General Linear Model: pH_1hr versus treatment  
 
Factor     Type   Levels  Values 
treatment  fixed       4  1, 2, 3, 4 
 
 
Analysis of Variance for pH_1hr, using Adjusted SS for Tests 
 
Source     DF    Seq SS    Adj SS    Adj MS       F      P 
treatment   3  0.222913  0.222913  0.074304  900.66  0.000 
Error      20  0.001650  0.001650  0.000082 
Total      23  0.224563 
 
 
S = 0.00908295   R-Sq = 99.27%   R-Sq(adj) = 99.16% 
 
 
Unusual Observations for pH_1hr 
 
Obs   pH_1hr      Fit   SE Fit  Residual  St Resid 
  5  7.48000  7.49833  0.00371  -0.01833     -2.21 R 
 16  7.75000  7.73333  0.00371   0.01667      2.01 R 
 
R denotes an observation with a large standardized residual. 
 
 
Least Squares Means for pH_1hr 
 
treatment   Mean   SE Mean 
1          7.498  0.003708 
2          7.698  0.003708 
3          7.725  0.003708 
4          7.733  0.003708 
 
 
Grouping Information Using Tukey Method and 99.0% Confidence 
 
treatment  N  Mean  Grouping 
4          6   7.7  A 
3          6   7.7  A 
2          6   7.7    B 
1          6   7.5      C 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 99.0% Simultaneous Confidence Intervals 
Response Variable pH_1hr 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
treatment   Lower  Center   Upper   -+---------+---------+---------+----- 
2          0.1814  0.2000  0.2186                           (-*-) 
3          0.2081  0.2267  0.2453                              (-*--) 
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4          0.2164  0.2350  0.2536                               (-*--) 
                                    -+---------+---------+---------+----- 
                                   0.000     0.080     0.160     0.240 
 
 
treatment = 2  subtracted from: 
 
treatment     Lower   Center    Upper   -+---------+---------+---------+----- 
3          0.008052  0.02667  0.04528     (-*--) 
4          0.016385  0.03500  0.05361      (-*--) 
                                        -+---------+---------+---------+----- 
                                       0.000     0.080     0.160     0.240 
 
 
treatment = 3  subtracted from: 
 
treatment     Lower    Center    Upper   -+---------+---------+---------+----- 
4          -0.01028  0.008333  0.02695   (-*-) 
                                         -+---------+---------+---------+----- 
                                        0.000     0.080     0.160     0.240 
 
 
Tukey Simultaneous Tests 
Response Variable pH_1hr 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
2              0.2000    0.005244    38.14    0.0000 
3              0.2267    0.005244    43.22    0.0000 
4              0.2350    0.005244    44.81    0.0000 
 
 
treatment = 2  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
3             0.02667    0.005244    5.085    0.0003 
4             0.03500    0.005244    6.674    0.0000 
 
 
treatment = 3  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
4            0.008333    0.005244    1.589    0.4069z 
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Figure 57: Residual plots for solubility at 1h; Top Left: Normal probability plot for 
solubility at 1 h (p = 0.225); Top Right: Residuals versus fitted values; Bottom Left: 
Histogram of Residuals; Bottom Right: Residuals versus order 
 
 
4
3
2
1
6543210
tr
e
a
tm
e
n
t
95% Bonferroni Confidence Intervals for StDevs
Test Statistic 5.71
P-Value 0.127
Test Statistic 1.38
P-Value 0.278
Bartlett's Test
Levene's Test
Test for Equal Variances for TRES3
 
Figure 58: Plot of Variance for Solubility 1h reconstitution; Bartlett’s Test statistic 
= 5.71, p-value = 0.127; Levene’s Test statistic = 1.38, p-value = 0.278 
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General Regression Analysis: solubility_1hr versus conc-75, block  
 
Regression Equation 
 
block 
1      solubility_1hr  =  78.6238 + 0.26925 conc-75 
 
2      solubility_1hr  =  79.01 + 0.26925 conc-75 
 
3      solubility_1hr  =  80.05 + 0.26925 conc-75 
 
 
Coefficients 
 
Term         Coef  SE Coef        T      P        95% CI 
Constant  79.2279  1.00937  78.4924  0.000  (77.1224, 81.3334) 
conc-75    0.2693  0.01806  14.9118  0.000  ( 0.2316,  0.3069) 
block 
  1       -0.6042  1.42747  -0.4232  0.677  (-3.5818,  2.3735) 
  2       -0.2179  1.42747  -0.1527  0.880  (-3.1956,  2.7597) 
 
 
Summary of Model 
 
S = 4.94489      R-Sq = 91.76%        R-Sq(adj) = 90.52% 
PRESS = 672.714  R-Sq(pred) = 88.67% 
 
 
Analysis of Variance 
 
Source         DF   Seq SS   Adj SS   Adj MS        F         P 
Regression      3  5445.87  5445.87  1815.29   74.239  0.000000 
  conc-75       1  5437.17  5437.17  5437.17  222.362  0.000000 
  block         2     8.71     8.71     4.35    0.178  0.838225 
Error          20   489.04   489.04    24.45 
  Lack-of-Fit   8   468.69   468.69    58.59   34.554  0.000000 
  Pure Error   12    20.35    20.35     1.70 
Total          23  5934.91 
 
 
Fits and Diagnostics for Unusual Observations 
 
 
No unusual observations 
 
  
 155
Appendix D: Data and Minitab Output for Solubility (3h) 
Table 11: Solubility after three hours (3h) reconstitution on laboratory stage mixer. 
Means and standard deviations were calculated from two replicates 
Block Treatment Replicate Solubility (%) pH Temperature (°C) 
1 1 1 67.00 ± 0.56 7.35 23.0 
1 2 1 95.34 ± 0.97 7.57 23.8 
1 3 1 99.45 ± 0.34 7.62 22.5 
1 4 1 99.43 ± 0.65 7.67 24.1 
2 1 1 62.92 ± 1.45 7.32 23.2 
2 2 1 96.75 ± 0.76 7.55 22.3 
2 3 1 97.85 ± 0.43 7.62 21.4 
2 4 1 97.21 ± 0.60 7.69 23.0 
3 1 1 63.11 ± 1.91 7.29 21.5 
3 2 1 92.44 ± 0.56 7.52 22.6 
3 3 1 96.75 ± 0.85 7.59 23.4 
3 4 1 99.48 ± 0.34 7.65 23.4 
1 1 2 63.68 ± 1.43 7.33 21.5 
1 2 2 94.20 ± 0.60 7.56 24.0 
1 3 2 97.18 ± 0.52 7.63 22.0 
1 4 2 98.01 ± 0.31 7.66 23.2 
2 1 2 60.18 ± 1.21 7.30 21.1 
2 2 2 94.91 ± 0.51 7.57 24.3 
2 3 2 99.56 ± 0.12 7.64 23.5 
2 4 2 98.24 ± 0.42 7.67 24.5 
3 1 2 67.72 ± 1.58 7.29 23.4 
3 2 2 92.98 ± 0.56 7.56 23.2 
3 3 2 97.04 ± 0.45 7.58 21.5 
3 4 2 98.24 ± 0.51 7.63 22.9 
 
Minitab Output for block*treatment Interaction 
 
General Linear Model: solubility_3hr versus block, treatment  
 
Factor     Type    Levels  Values 
block      random       3  1, 2, 3 
treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for solubility_3hr, using Adjusted SS for Tests 
 
Source           DF   Seq SS   Adj SS   Adj MS       F      P 
block             2     3.63     3.63     1.82    0.35  0.718 
treatment         3  4912.30  4912.30  1637.43  315.53  0.000 
block*treatment   6    31.14    31.14     5.19    2.16  0.120 
Error            12    28.77    28.77     2.40 
Total            23  4975.83 
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S = 1.54832   R-Sq = 99.42%   R-Sq(adj) = 98.89% 
 
 
Unusual Observations for solubility_3hr 
 
Obs  solubility_3hr      Fit  SE Fit  Residual  St Resid 
  9         63.1100  65.4150  1.0948   -2.3050     -2.11 R 
 21         67.7200  65.4150  1.0948    2.3050      2.11 R 
 
R denotes an observation with a large standardized residual. 
 
Minitab Output for no Interaction between block and treatment 
 
General Linear Model: solubility_3h versus block, treatment  
 
Factor     Type    Levels  Values 
block      random       3  1, 2, 3 
treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for solubility_3h, using Adjusted SS for Tests 
 
Source     DF   Seq SS   Adj SS   Adj MS       F      P 
block       2     3.63     3.63     1.82    0.55  0.589 
treatment   3  4912.30  4912.30  1637.43  492.02  0.000 
Error      18    59.90    59.90     3.33 
Total      23  4975.83 
 
 
S = 1.82428   R-Sq = 98.80%   R-Sq(adj) = 98.46% 
 
 
Unusual Observations for solubility_3h 
 
Obs  solubility_3h      Fit  SE Fit  Residual  St Resid 
 17        60.1800  63.8179  0.9121   -3.6379     -2.30 R 
 21        67.7200  63.8354  0.9121    3.8846      2.46 R 
 
R denotes an observation with a large standardized residual. 
 
 
Least Squares Means for solubility_3h 
 
treatment   Mean 
1          64.10 
2          94.44 
3          97.97 
4          98.44 
 
 
Grouping Information Using Tukey Method and 99.0% Confidence 
 
treatment  N  Mean  Grouping 
4          6  98.4  A 
3          6  98.0  A B 
2          6  94.4    B 
1          6  64.1      C 
 
Means that do not share a letter are significantly different. 
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Tukey 99.0% Simultaneous Confidence Intervals 
Response Variable solubility_3h 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
treatment  Lower  Center  Upper  ---+---------+---------+---------+--- 
2          26.54   30.34  34.13                           (--*--) 
3          30.08   33.87  37.66                              (--*--) 
4          30.54   34.33  38.12                              (---*--) 
                                 ---+---------+---------+---------+--- 
                                    0        12        24        36 
 
 
treatment = 2  subtracted from: 
 
treatment    Lower  Center  Upper  ---+---------+---------+---------+--- 
3          -0.2558   3.535  7.326     (--*--) 
4           0.2075   3.998  7.789     (--*--) 
                                   ---+---------+---------+---------+--- 
                                      0        12        24        36 
 
 
treatment = 3  subtracted from: 
 
treatment   Lower  Center  Upper  ---+---------+---------+---------+--- 
4          -3.327  0.4633  4.254  (--*---) 
                                  ---+---------+---------+---------+--- 
                                     0        12        24        36 
 
 
Tukey Simultaneous Tests 
Response Variable solubility_3h 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
2               30.34       1.053    28.80    0.0000 
3               33.87       1.053    32.16    0.0000 
4               34.33       1.053    32.60    0.0000 
 
 
treatment = 2  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
3               3.535       1.053    3.356    0.0169 
4               3.998       1.053    3.796    0.0066 
 
 
treatment = 3  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
4              0.4633       1.053   0.4399    0.9707 
 
Regression Analysis: solubility_3h versus pH_3h  
 
The regression equation is 
solubility_3h = - 689 + 103 pH_3h 
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Predictor     Coef  SE Coef       T      P 
Constant   -688.81    41.53  -16.58  0.000 
pH_3h      103.180    5.511   18.72  0.000 
 
 
S = 3.65446   R-Sq = 94.1%   R-Sq(adj) = 93.8% 
 
Analysis of Variance 
 
Source          DF      SS      MS       F      P 
Regression       1  4682.0  4682.0  350.58  0.000 
Residual Error  22   293.8    13.4 
Total           23  4975.8 
 
Unusual Observations 
 
Obs  pH_3h  solubility_3h      Fit  SE Fit  Residual  St Resid 
  8   7.69         97.210  104.643   1.131    -7.433     -2.14R 
 
R denotes an observation with a large standardized residual. 
 
General Linear Model: pH_3h versus treatment  
 
Factor     Type   Levels  Values 
treatment  fixed       4  1, 2, 3, 4 
 
 
Analysis of Variance for pH_3h, using Adjusted SS for Tests 
 
Source     DF   Seq SS   Adj SS   Adj MS       F      P 
treatment   3  0.43028  0.43028  0.14343  301.95  0.000 
Error      20  0.00950  0.00950  0.00048 
Total      23  0.43978 
 
 
S = 0.0217945   R-Sq = 97.84%   R-Sq(adj) = 97.52% 
 
 
Least Squares Means for pH_3h 
 
treatment   Mean   SE Mean 
1          7.313  0.008898 
2          7.555  0.008898 
3          7.613  0.008898 
4          7.662  0.008898 
 
 
Grouping Information Using Tukey Method and 99.0% Confidence 
 
treatment  N  Mean  Grouping 
4          6   7.7  A 
3          6   7.6    B 
2          6   7.6      C 
1          6   7.3        D 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 99.0% Simultaneous Confidence Intervals 
Response Variable pH_3h 
All Pairwise Comparisons among Levels of treatment 
 159
treatment = 1  subtracted from: 
 
treatment   Lower  Center   Upper    +---------+---------+---------+------ 
2          0.1970  0.2417  0.2863                    (---*---) 
3          0.2553  0.3000  0.3447                         (---*---) 
4          0.3037  0.3483  0.3930                             (---*---) 
                                     +---------+---------+---------+------ 
                                   0.00      0.12      0.24      0.36 
 
 
treatment = 2  subtracted from: 
 
treatment    Lower   Center   Upper    +---------+---------+---------+------ 
3          0.01367  0.05833  0.1030     (---*---) 
4          0.06200  0.10667  0.1513         (---*---) 
                                       +---------+---------+---------+------ 
                                     0.00      0.12      0.24      0.36 
 
 
treatment = 3  subtracted from: 
 
treatment     Lower   Center    Upper    +---------+---------+---------+------ 
4          0.003668  0.04833  0.09300    (---*---) 
                                         +---------+---------+---------+------ 
                                       0.00      0.12      0.24      0.36 
 
 
Tukey Simultaneous Tests 
Response Variable pH_3h 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
2              0.2417     0.01258    19.21    0.0000 
3              0.3000     0.01258    23.84    0.0000 
4              0.3483     0.01258    27.68    0.0000 
 
 
treatment = 2  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
3             0.05833     0.01258    4.636    0.0009 
4             0.10667     0.01258    8.477    0.0000 
 
 
treatment = 3  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
4             0.04833     0.01258    3.841    0.0052 
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Figure 59: Residual plots for solubility at 3h; Top Left: Normal probability plot for 
solubility at 3 h (p = 0.055); Top Right: Residuals versus fitted values; Bottom 
Left: Histogram of Residuals; Bottom Right: Residuals versus order 
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Figure 60: Plot of Variance for Solubility 3h reconstitution; Bartlett’s Test statistic 
= 8.27, p-value = 0.041; Levene’s Test statistic = 1.37, p-value = 0.281 
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General Regression Analysis: solubility_3hr versus log2(conc+1), block  
 
Regression Equation 
 
block 
1      solubility_3hr  =  65.0903 + 4.94575 log2(conc+1) 
 
2      solubility_3hr  =  64.2566 + 4.94575 log2(conc+1) 
 
3      solubility_3hr  =  64.2741 + 4.94575 log2(conc+1) 
 
 
Coefficients 
 
Term             Coef   SE Coef        T      P        99% CI            VIF 
Constant      64.5403  0.920702  70.0991  0.000  (61.9206, 67.1601) 
log2(conc+1)   4.9458  0.162188  30.4940  0.000  ( 4.4843,  5.4072)  1.00000 
block 
  1            0.5500  0.660463   0.8327  0.415  (-1.3292,  2.4292)  1.33333 
  2           -0.2837  0.660463  -0.4296  0.672  (-2.1630,  1.5955)  1.33333 
 
 
Summary of Model 
 
S = 2.28791      R-Sq = 97.90%        R-Sq(adj) = 97.58% 
PRESS = 156.441  R-Sq(pred) = 96.86% 
 
 
Analysis of Variance 
 
Source          DF   Seq SS   Adj SS   Adj MS        F         P 
Regression       3  4871.14  4871.14  1623.71  310.192  0.000000 
  log2(conc+1)   1  4867.51  4867.51  4867.51  929.883  0.000000 
  block          2     3.63     3.63     1.82    0.347  0.711078 
Error           20   104.69   104.69     5.23 
  Lack-of-Fit    8    75.92    75.92     9.49    3.959  0.016253 
  Pure Error    12    28.77    28.77     2.40 
Total           23  4975.83 
 
 
Fits and Diagnostics for Unusual Observations 
 
Obs  solubility_3hr      Fit   SE Fit  Residual  St Resid 
  6           96.75  92.3110  0.81874   4.43900   2.07779  R 
 17           60.18  64.2566  1.13309  -4.07660  -2.05099  R 
 
R denotes an observation with a large standardized residual. 
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Appendix E: Data and Minitab Output for Insolubility Index 
Table 12: Solubility as determined by ISI method. Means and standard deviations 
were calculated from two measurements. 
Block Treatment ISI (ml sediment) 
1 1 9.25 ± 0.35  
1 2 6.25 ± 0.35 
1 3 2.20 ± 0.28 
1 4 0.50 ± 0.00 
2 1 9.70 ± 0.21 
2 2 7.50 ± 0.71 
2 3  3.30± 0.42 
2 4 0.50 ± 0.00 
3 1 11.25 ± 0.35 
3 2 7.40 ± 0.14 
3 3 2.25 ± 0.35 
3 4 0.75 ± 0.35 
 
Minitab output for Insolubility Index 
 
General Linear Model: ISI (ml) versus block, treatment  
 
Factor     Type    Levels  Values 
block      random       3  1, 2, 3 
treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for ISI (ml), using Adjusted SS for Tests 
 
Source     DF   Seq SS   Adj SS  Adj MS       F      P 
block       2    1.680    1.680   0.840    2.19  0.193 
treatment   3  165.602  165.602  55.201  144.03  0.000 
Error       6    2.300    2.300   0.383 
Total      11  169.582 
 
 
S = 0.619083   R-Sq = 98.64%   R-Sq(adj) = 97.51% 
 
 
Least Squares Means for ISI (ml) 
 
treatment     Mean 
1          10.0667 
2           7.0500 
3           2.5833 
4           0.5833 
 
 
Grouping Information Using Tukey Method and 99.0% Confidence 
 
treatment  N  Mean  Grouping 
1          3  10.1  A 
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2          3   7.0    B 
3          3   2.6      C 
4          3   0.6      C 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 99.0% Simultaneous Confidence Intervals 
Response Variable ISI (ml) 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
treatment   Lower  Center   Upper  ----+---------+---------+---------+-- 
2           -5.53  -3.017  -0.504                    (------*-------) 
3          -10.00  -7.483  -4.971       (-------*------) 
4          -12.00  -9.483  -6.971  (------*------) 
                                   ----+---------+---------+---------+-- 
                                   -10.5      -7.0      -3.5       0.0 
 
 
treatment = 2  subtracted from: 
 
treatment   Lower  Center   Upper  ----+---------+---------+---------+-- 
3          -6.979  -4.467  -1.954                (------*------) 
4          -8.979  -6.467  -3.954          (-------*------) 
                                   ----+---------+---------+---------+-- 
                                   -10.5      -7.0      -3.5       0.0 
 
 
treatment = 3  subtracted from: 
 
treatment   Lower  Center   Upper  ----+---------+---------+---------+-- 
4          -4.513  -2.000  0.5127                       (------*------) 
                                   ----+---------+---------+---------+-- 
                                   -10.5      -7.0      -3.5       0.0 
 
 
Tukey Simultaneous Tests 
Response Variable ISI (ml) 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
2              -3.017      0.5055    -5.97    0.0040 
3              -7.483      0.5055   -14.80    0.0000 
4              -9.483      0.5055   -18.76    0.0000 
 
 
treatment = 2  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
3              -4.467      0.5055    -8.84    0.0005 
4              -6.467      0.5055   -12.79    0.0001 
 
 
treatment = 3  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
4              -2.000      0.5055   -3.957    0.0286 
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Figure 61: Residual plots for ISI; Top Left: Normal probability plot for ISI (p = 
0.834); Top Right: Residuals versus fitted values; Bottom Left: Histogram of 
Residuals; Bottom Right: Residuals versus order 
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Figure 62: Plot of Variance for ISI; Bartlett’s Test statistic = 4.41, p-value = 0.221; 
Levene’s Test statistic = 0.49, p-value = 0.701 
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General Regression Analysis: ISI (ml) versus concentration, block  
 
Regression Equation 
 
block 
1      ISI (ml)  =  9.4875 - 0.0658333 concentration 
 
2      ISI (ml)  =  10.1875 - 0.0658333 concentration 
 
3      ISI (ml)  =  10.35 - 0.0658333 concentration 
 
 
Coefficients 
 
Term              Coef   SE Coef         T      P         95% CI            VIF 
Constant       10.0083  0.395974   25.2753  0.000  ( 9.09522, 10.9215) 
concentration  -0.0658  0.004233  -15.5519  0.000  (-0.07559, -0.0561)  1.00000 
block 
  1            -0.5208  0.334659   -1.5563  0.158  (-1.29256,  0.2509)  1.33333 
  2             0.1792  0.334659    0.5354  0.607  (-0.59256,  0.9509)  1.33333 
 
 
Summary of Model 
 
S = 0.819743     R-Sq = 96.83%        R-Sq(adj) = 95.64% 
PRESS = 11.8352  R-Sq(pred) = 93.02% 
 
 
Analysis of Variance 
 
Source           DF   Seq SS   Adj SS   Adj MS        F         P 
Regression        3  164.206  164.206   54.735   81.454  0.000002 
  concentration   1  162.526  162.526  162.526  241.862  0.000000 
  block           2    1.680    1.680    0.840    1.250  0.336889 
Error             8    5.376    5.376    0.672 
Total            11  169.582 
 
 
Fits and Diagnostics for Unusual Observations 
 
Obs  ISI (ml)      Fit    SE Fit  Residual  St Resid 
 11      2.25  3.76667  0.423314  -1.51667  -2.16054  R 
 
R denotes an observation with a large standardized residual. 
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Appendix F: Data and Minitab Output for Anema et al. (2006) 
Table 13: Solubility as determined by method of Anema et al. (2006). Means and 
standard deviations were calculated from two measurements. 
Block Treatment Solubility (%) 
1 1 48.16 ± 1.47  
1 2 59.47 ± 0.77 
1 3 83.71 ± 1.81 
1 4 97.40 ± 0.52 
2 1 48.02 ± 1.10 
2 2 63.77 ± 1.85 
2 3 81.61 ± 1.06 
2 4 93.56 ± 0.24 
3 1 42.22 ± 2.19 
3 2 54.02 ± 1.83 
3 3 91.84 ± 1.04 
3 4 97.64 ± 0.73 
 
Minitab output for Solubility using method of Anema et al. (2006) 
 
General Linear Model: solubility_an versus block, treatment  
 
Factor     Type    Levels  Values 
block      random       3  1, 2, 3 
treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for solubility_an, using Adjusted SS for Tests 
 
Source     DF   Seq SS   Adj SS   Adj MS      F      P 
block       2     1.15     1.15     0.58   0.02  0.975 
treatment   3  4828.60  4828.60  1609.53  69.75  0.000 
Error       6   138.45   138.45    23.08 
Total      11  4968.20 
 
 
S = 4.80365   R-Sq = 97.21%   R-Sq(adj) = 94.89% 
 
 
Least Squares Means for solubility_an 
 
treatment   Mean 
1          46.13 
2          59.09 
3          85.72 
4          96.20 
 
 
Grouping Information Using Tukey Method and 99.0% Confidence 
 
treatment  N  Mean  Grouping 
4          3  96.2  A 
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3          3  85.7  A 
2          3  59.1    B 
1          3  46.1    B 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 99.0% Simultaneous Confidence Intervals 
Response Variable solubility_an 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
treatment   Lower  Center  Upper  ----+---------+---------+---------+-- 
2          -6.544   12.95  32.45   (-------*-------) 
3          20.090   39.59  59.08              (-------*-------) 
4          30.570   50.07  69.56                  (-------*-------) 
                                  ----+---------+---------+---------+-- 
                                      0        25        50        75 
 
 
treatment = 2  subtracted from: 
 
treatment   Lower  Center  Upper  ----+---------+---------+---------+-- 
3           7.136   26.63  46.13         (-------*------) 
4          17.616   37.11  56.61             (-------*-------) 
                                  ----+---------+---------+---------+-- 
                                      0        25        50        75 
 
 
treatment = 3  subtracted from: 
 
treatment   Lower  Center  Upper  ----+---------+---------+---------+-- 
4          -9.017   10.48  29.98  (-------*-------) 
                                  ----+---------+---------+---------+-- 
                                      0        25        50        75 
 
 
Tukey Simultaneous Tests 
Response Variable solubility_an 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
2               12.95       3.922    3.303    0.0602 
3               39.59       3.922   10.093    0.0002 
4               50.07       3.922   12.765    0.0001 
 
 
treatment = 2  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
3               26.63       3.922    6.790    0.0020 
4               37.11       3.922    9.462    0.0003 
 
 
treatment = 3  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
4               10.48       3.922    2.672    0.1277 
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Figure 63: Residual plots for Solubility according to method of Anema et al. 
(2006); Top Left: Normal probability plot (p = 0.530); Top Right: Residuals versus 
fitted values; Bottom Left: Histogram of Residuals; Bottom Right: Residuals versus 
order 
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Figure 64: Plot of Variance for Solubility according to method of Anema et al. 
(2006); Bartlett’s Test statistic = 1.31, p-value = 0.726; Levene’s Test statistic = 
0.28, p-value = 0.835 
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General Regression Analysis: solubility versus concentration, block  
 
Regression Equation 
 
block 
1      solubility  =  45.66 + 0.353667 concentration 
 
2      solubility  =  45.215 + 0.353667 concentration 
 
3      solubility  =  44.905 + 0.353667 concentration 
 
 
Coefficients 
 
Term              Coef  SE Coef        T      P        95% CI            VIF 
Constant       45.2600  2.84004  15.9364  0.000  (38.7109, 51.8091) 
concentration   0.3537  0.03036  11.6486  0.000  ( 0.2837,  0.4237)  1.00000 
block 
  1             0.4000  2.40027   0.1666  0.872  (-5.1350,  5.9350)  1.33333 
  2            -0.0450  2.40027  -0.0187  0.986  (-5.5800,  5.4900)  1.33333 
 
 
Summary of Model 
 
S = 5.87944      R-Sq = 94.43%        R-Sq(adj) = 92.35% 
PRESS = 555.811  R-Sq(pred) = 88.81% 
 
 
Analysis of Variance 
 
Source           DF   Seq SS   Adj SS   Adj MS        F         P 
Regression        3  4691.66  4691.66  1563.89   45.241  0.000023 
  concentration   1  4690.50  4690.50  4690.50  135.690  0.000003 
  block           2     1.15     1.15     0.58    0.017  0.983506 
Error             8   276.54   276.54    34.57 
Total            11  4968.20 
 
 
Fits and Diagnostics for Unusual Observations 
 
Obs  solubility      Fit   SE Fit  Residual  St Resid 
 11       91.84  80.2717  3.03613   11.5683   2.29765  R 
 
R denotes an observation with a large standardized residual. 
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Appendix G: Data and Minitab Output for Solubility After 
Adjustment to Treatment Level 4 pH 
Table 14: Solubility after three hours (3h) reconstitution on laboratory stage mixer, 
when adjusted to treatment 4 pH after 1h mixing. Means and standard deviations 
were calculated from two replicates. 
Block Treatment Solubility (%) pH (initial) pH (final) Temperature (°C) 
1 1 66.98 ± 1.36  7.52 ± 0.01 7.68 ± 0.02 23.1 ± 0.28 
1 2 90.39 ± 1.27 7.63 ± 0.01 7.67 ± 0.03 23.0 ± 0.35 
1 3 96.72 ± 1.88 7.69 ± 0.01 7.66 ± 0.01 23.3 ± 0.14 
1 4 95.98 ± 1.30 7.73 ± 0.01 7.67 ± 0.00 22.9 ± 0.49 
2 1 68.30 ± 2.39 7.52 ± 0.01 7.67 ± 0.01 22.8 ± 0.28 
2 2 95.88 ± 2.21 7.63 ± 0.01 7.68 ± 0.01 23.0 ± 0.42 
2 3 99.57 ± 0.45 7.68 ± 0.01 7.68 ± 0.01 22.3 ± 0.21 
2 4 97.81 ± 1.45 7.72 ± 0.01 7.67 ± 0.00 23.0 ± 0.21 
3 1 62.09 ± 1.18 7.52 ± 0.01 7.69 ± 0.01 22.4 ± 0.35 
3 2 92.51 ± 2.67 7.63 ± 0.01 7.67 ± 0.02 23.2 ± 0.77 
3 3 95.46 ± 1.12 7.69 ± 0.01 7.67 ± 0.01 23.1 ± 0.35 
3 4 99.36 ± 0.42 7.73 ± 0.01 7.67 ± 0.00 23.5 ± 1.06 
 
Minitab Output for Solubility After Adjustment to Treatment Level 4 pH 
General Linear Model: solubility versus block, treatment  
 
Factor     Type    Levels  Values 
block      random       3  1, 2, 3 
treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for solubility, using Adjusted SS for Tests 
 
Source     DF   Seq SS   Adj SS  Adj MS       F      P 
block       2    23.32    23.32   11.66    2.50  0.163 
treatment   3  2090.47  2090.47  696.82  149.26  0.000 
Error       6    28.01    28.01    4.67 
Total      11  2141.80 
 
 
S = 2.16066   R-Sq = 98.69%   R-Sq(adj) = 97.60% 
 
 
Least Squares Means for solubility 
 
treatment   Mean 
1          65.79 
2          92.93 
3          97.25 
4          97.72 
 
 
Grouping Information Using Tukey Method and 99.0% Confidence 
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treatment  N  Mean  Grouping 
4          3  97.7  A 
3          3  97.2  A 
2          3  92.9  A 
1          3  65.8    B 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 99.0% Simultaneous Confidence Intervals 
Response Variable solubility 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
treatment  Lower  Center  Upper  ------+---------+---------+---------+ 
2          18.37   27.14  35.91                    (-----*-----) 
3          22.69   31.46  40.23                       (-----*-----) 
4          23.16   31.93  40.70                       (-----*-----) 
                                 ------+---------+---------+---------+ 
                                       0        15        30        45 
 
 
treatment = 2  subtracted from: 
 
treatment   Lower  Center  Upper  ------+---------+---------+---------+ 
3          -4.446   4.323  13.09     (-----*-----) 
4          -3.980   4.790  13.56     (-----*-----) 
                                  ------+---------+---------+---------+ 
                                        0        15        30        45 
 
 
treatment = 3  subtracted from: 
 
treatment   Lower  Center  Upper  ------+---------+---------+---------+ 
4          -8.303  0.4667  9.236  (-----*-----) 
                                  ------+---------+---------+---------+ 
                                        0        15        30        45 
 
 
Tukey Simultaneous Tests 
Response Variable solubility 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
2               27.14       1.764    15.38    0.0000 
3               31.46       1.764    17.83    0.0000 
4               31.93       1.764    18.10    0.0000 
 
 
treatment = 2  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
3               4.323       1.764    2.451    0.1668 
4               4.790       1.764    2.715    0.1212 
 
 
treatment = 3  subtracted from: 
 
           Difference       SE of           Adjusted 
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treatment    of Means  Difference  T-Value   P-Value 
4              0.4667       1.764   0.2645    0.9928 
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Figure 65: Residual plots for Solubility after adjustment to Treatment level 4 pH; 
Top Left: Normal probability plot (p = 0.785); Top Right: Residuals versus fitted 
values; Bottom Left: Histogram of Residuals; Bottom Right: Residuals versus order 
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Figure 66: Plot of Variance for Solubility after adjustment to Treatment level 4 pH; 
Bartlett’s Test statistic = 0.81, p-value = 0.848; Levene’s Test statistic = 0.18, p-
value = 0.908 
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Appendix H: Data and Minitab Output for Solubility After 
Adjustment to Control Level 4 pH 
Table 15: Solubility after three hours (3h) reconstitution on laboratory stage mixer, 
when  adjusted to Control pH after 1h mixing. Means and standard deviations were 
calculated from two replicates 
Block Treatment Solubility (%) pH (initial) pH (final) Temperature (°C) 
1 1 62.70 ± 2.96  7.53 ± 0.01 7.41 ± 0.00 24.0 ± 0.35 
1 2 80.04 ± 1.35 7.62 ± 0.01 7.41 ± 0.02 24.3 ± 0.21 
1 3 94.83 ± 1.52 7.69 ± 0.01 7.42 ± 0.01 23.7 ± 0.42 
1 4 97.95 ± 2.01 7.73 ± 0.01 7.40 ± 0.02 24.1 ± 0.21 
2 1 60.27 ± 1.04 7.52 ± 0.01 7.41 ± 0.01 23.2 ± 0.77 
2 2 85.40 ± 1.21 7.63 ± 0.01 7.42 ± 0.02 23.6 ± 1.06 
2 3 96.21 ± 1.28 7.68 ± 0.01 7.41 ± 0.02 22.5 ± 0.84 
2 4 99.11 ± 0.31 7.72 ± 0.01 7.41 ± 0.01 22.2 ± 0.92 
3 1 66.86 ± 1.18 7.53 ± 0.01 7.41 ± 0.01 23.8 ± 0.70 
3 2 85.94 ± 1.13 7.63 ± 0.01 7.42 ± 0.03 23.5 ± 0.35 
3 3 99.68 ± 0.49 7.69 ± 0.01 7.40 ± 0.02 24.0 ± 0.49 
3 4 99.56 ± 0.22 7.73 ± 0.01 7.43 ± 0.02 24.2 ± 0.07 
 
Minitab Output for Solubility After Adjustment to Control Level pH 
General Linear Model: solubility versus block, treatment  
 
Factor     Type    Levels  Values 
block      random       3  1, 2, 3 
treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for solubility, using Adjusted SS for Tests 
 
Source     DF   Seq SS   Adj SS  Adj MS       F      P 
block       2    35.41    35.41   17.71    4.84  0.056 
treatment   3  2416.70  2416.70  805.57  220.22  0.000 
Error       6    21.95    21.95    3.66 
Total      11  2474.06 
 
 
S = 1.91259   R-Sq = 99.11%   R-Sq(adj) = 98.37% 
 
 
Least Squares Means for solubility 
 
treatment   Mean 
1          63.28 
2          83.79 
3          96.91 
4          98.87 
 
 
Grouping Information Using Tukey Method and 99.0% Confidence 
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treatment  N  Mean  Grouping 
4          3  98.9  A 
3          3  96.9  A 
2          3  83.8    B 
1          3  63.3      C 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 99.0% Simultaneous Confidence Intervals 
Response Variable solubility 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
treatment  Lower  Center  Upper  ----+---------+---------+---------+-- 
2          12.75   20.52  28.28               (----*----) 
3          25.87   33.63  41.39                       (----*-----) 
4          27.83   35.60  43.36                         (----*----) 
                                 ----+---------+---------+---------+-- 
                                     0        15        30        45 
 
 
treatment = 2  subtracted from: 
 
treatment  Lower  Center  Upper  ----+---------+---------+---------+-- 
3          5.351   13.11  20.88          (----*----) 
4          7.317   15.08  22.84           (----*----) 
                                 ----+---------+---------+---------+-- 
                                     0        15        30        45 
 
 
treatment = 3  subtracted from: 
 
treatment   Lower  Center  Upper  ----+---------+---------+---------+-- 
4          -5.796   1.967  9.729  (----*----) 
                                  ----+---------+---------+---------+-- 
                                      0        15        30        45 
 
 
Tukey Simultaneous Tests 
Response Variable solubility 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
2               20.52       1.562    13.14    0.0001 
3               33.63       1.562    21.54    0.0000 
4               35.60       1.562    22.79    0.0000 
 
 
treatment = 2  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
3               13.11       1.562    8.397    0.0007 
4               15.08       1.562    9.657    0.0003 
 
 
treatment = 3  subtracted from: 
 
           Difference       SE of           Adjusted 
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treatment    of Means  Difference  T-Value   P-Value 
4               1.967       1.562    1.259    0.6167 
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Figure 67: Residual plots for Solubility after adjustment to Control pH; Top Left: 
Normal probability plot (p = 0.452); Top Right: Residuals versus fitted values; 
Bottom Left: Histogram of Residuals; Bottom Right: Residuals versus order 
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Figure 68: Plot of Variance for Solubility after adjustment to Control pH; Bartlett’s 
Test statistic = 2.73, p-value = 0.436; Levene’s Test statistic = 0.39, p-value = 0.761 
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Appendix I: Proximate Analysis as Determined by FOSS Milkoscan FT2 
Table 16: Proximate analysis of products obtained by UF and DF processes during MPC manufacture, determined by FOSS 
Milkoscan FT2. Means and standard deviations were obtained from duplicate measurements. 
Sample Block Treatment Fat Protein Casein Lactose TS 
Milk 1 1 0.22 ± 0.00 3.43 ± 0.01 2.69 ± 0.01 5.10 ± 0.01 9.43 ± 0.01 
Milk 1 2 0.21 ± 0.00 3.43 ± 0.00 2.61 ± 0.01 5.09 ± 0.00 9.42 ± 0.01 
Milk 1 3 0.22 ± 0.00 3.40 ± 0.00 2.59 ± 0.01 5.06 ± 0.00 9.37 ± 0.00 
Milk 1 4 0.21 ± 0.00 3.44 ± 0.01 2.63 ± 0.01 5.09 ± 0.00 9.44 ± 0.00 
Milk 2 1 0.17 ± 0.00 3.40 ± 0.01 2.64 ± 0.01 5.06 ± 0.01 9.32 ± 0.01 
Milk 2 2 0.21 ± 0.00 3.43 ± 0.00 2.61 ± 0.01 5.09 ± 0.00 9.42 ± 0.03 
Milk 2 3 0.23 ± 0.00 3.43 ± 0.00 2.69 ± 0.01 5.12 ± 0.00 9.47 ± 0.01 
Milk 2 4 0.17 ± 0.00 3.37 ± 0.01 2.63 ± 0.01 5.06 ± 0.00 9.29 ± 0.01 
Milk 3 1 0.17 ± 0.00 3.44 ± 0.01 2.65 ± 0.01 5.12 ± 0.00 9.40 ± 0.00 
Milk 3 2 0.17 ± 0.00 3.41 ± 0.00 2.61 ± 0.01 5.09 ± 0.00 9.33 ± 0.01 
Milk 3 3 0.18 ± 0.00 3.43 ± 0.01 2.66 ± 0.01 5.14 ± 0.00 9.43 ± 0.01 
Milk 3 4 0.17 ± 0.00 3.37 ± 0.00 2.61 ± 0.01 5.05 ± 0.00 9.28 ± 0.01 
UF 1 1 0.60 ± 0.01 12.78 ± 0.00 10.23 ± 0.00 4.19 ± 0.00 18.52 ± 0.01 
UF 1 2 0.71 ± 0.01 12.53 ± 0.00 10.03 ± 0.01 4.22 ± 0.00 18.47 ± 0.00 
UF 1 3 0.78 ± 0.01 13.51 ± 0.01 10.80 ± 0.00 4.15 ± 0.00 19.49 ± 0.04 
UF 1 4 0.69 ± 0.00 13.16 ± 0.01 10.48 ± 0.01 4.18 ± 0.00 19.09 ± 0.00 
UF 2 1 0.51 ± 0.00 12.45 ± 0.01 9.94 ± 0.01 4.18 ± 0.00 18.06 ± 0.00 
UF 2 2 0.50 ± 0.00 12.66 ± 0.01 10.10 ± 0.04 4.18 ± 0.00 18.26 ± 0.03 
UF 2 3 0.79 ± 0.00 13.44 ± 0.01 10.77 ± 0.04 4.18 ± 0.00 19.38 ± 0.01 
UF 2 4 0.51 ± 0.00 12.16 ± 0.01 9.72 ± 0.07 4.19 ± 0.00 17.76 ± 0.01 
UF 3 1 0.54 ± 0.00 13.61 ± 0.01 10.89 ± 0.01 4.18 ± 0.04 19.29 ± 0.03 
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Table 14; continued 
 
Sample Block Treatment Fat Protein Casein Lactose TS 
UF 3 2 0.51 ± 0.00 12.25 ± 0.01 9.81 ± 0.00 4.22 ± 0.00 17.88 ± 0.01 
UF 3 3 0.51 ± 0.00 12.24 ± 0.01 9.85 ± 0.03 4.22 ± 0.01 17.85 ± 0.00 
UF 3 4 0.52 ± 0.01 12.64 ± 0.02 10.14 ± 0.01 4.19 ± 0.00 16.41 ± 0.03 
DF1 1 1 0.91 ± 0.00 13.69 ± 0.00 10.19 ± 0.01 1.04 ± 0.00 16.41 ± 0.03 
DF1 1 2 1.09 ± 0.00 14.03 ± 0.01 10.28 ± 0.01 0.92 ± 0.00 16.86 ± 0.01 
DF1 1 3 1.00 ± 0.00 12.44 ± 0.01 9.12 ± 0.01 1.01 ± 0.00 15.29 ± 0.01 
DF1 1 4 1.01 ± 0.01 14.14 ± 0.01 10.67 ± 0.01 1.00 ± 0.00 17.07 ± 0.00 
DF1 2 1 0.81 ± 0.01 13.58 ± 0.01 9.94 ± 0.00 1.15 ± 0.01 16.19 ± 0.03 
DF1 2 2 0.85 ± 0.00 15.36 ± 0.02 11.32 ± 0.01 1.00 ± 0.00 17.91 ± 0.01 
DF1 2 3 1.02 ± 0.00 12.64 ± 0.00 9.41 ± 0.02 1.08 ± 0.00 15.52 ± 0.03 
DF1 2 4 0.79 ± 0.00 12.88 ± 0.01 9.75 ± 0.01 1.11 ± 0.00 15.56 ± 0.04 
DF1 3 1 0.87 ± 0.00 14.80 ± 0.01 10.90 ± 0.01 1.05 ± 0.00 17.38 ± 0.04 
DF1 3 2 0.91 ± 0.00 13.69 ± 0.00 10.19 ± 0.04 1.04 ± 0.00 16.41 ± 0.01 
DF1 3 3 0.83 ± 0.00 14.06 ± 0.01 10.68 ± 0.03 1.10 ± 0.00 16.76 ± 0.01 
DF1 3 4 0.79 ± 0.00 12.94 ± 0.02 9.81 ± 0.01 1.04 ± 0.01 15.57 ± 0.01 
DF2 1 1 1.06 ± 0.00 12.63 ± 0.01 8.75 ± 0.00 0.64  ± 0.00 14.86 ± 0.03 
DF2 1 2 0.95 ± 0.00 14.03 ± 0.00 10.23 ± 0.00 0.59 ± 0.00 16.27 ± 0.00 
DF2 1 3 1.07 ± 0.00 13.17 ± 0.01 9.58 ± 0.01 0.56 ± 0.01 15.62 ± 0.01 
DF2 1 4 1.03 ± 0.00 13.93 ± 0.00 10.31 ± 0.00 0.51 ± 0.00 16.39 ± 0.01 
DF2 2 1 0.91 ± 0.00 15.33 ± 0.01 11.09 ± 0.00 0.67 ± 0.00 17.43 ± 0.04 
DF2 2 2 0.84 ± 0.00 14.12 ± 0.01 10.11 ± 0.01 0.60 ± 0.01 16.15 ± 0.04 
DF2 2 3 1.18 ± 0.00 14.62 ± 0.02 10.83 ± 0.00 0.56 ± 0.00 17.11 ± 0.01 
DF2 2 4 0.83 ± 0.00 12.97 ± 0.01 9.57 ± 0.00 0.59 ± 0.00 15.15 ± 0.05 
DF2 3 1 0.94 ± 0.01 16.18 ± 0.01 11.84 ± 0.01 0.63 ± 0.01 18.31 ± 0.04 
DF2 3 2 0.85 ± 0.00 13.44 ± 0.04 9.65 ± 0.01 0.62 ± 0.01 15.52 ± 0.01 
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Table 14; continued 
 
Sample Block Treatment Fat Protein Casein Lactose TS 
DF2 3 3 0.84 ± 0.00 13.29 ± 0.01 9.75 ± 0.00 0.61 ± 0.00 15.45 ± 0.01 
DF2 3 4 0.90 ± 0.00 14.74 ± 0.01 11.07 ± 0.01 0.52 ± 0.01 17.01 ± 0.01 
DF3 1 1 0.86 ± 0.00 14.02 ± 0.01 9.85 ± 0.01 0.61 ± 0.00 15.98 ± 0.05 
DF3 1 2 0.90 ± 0.00 13.23 ± 0.00 9.53 ± 0.01 0.57 ± 0.00 15.39 ± 0.01 
DF3 1 3 1.06 ± 0.00 12.72 ± 0.00 9.12 ± 0.01 0.47 ± 0.01 15.04 ± 0.01 
DF3 1 4 1.07 ± 0.00 14.91 ± 0.02 10.78 ± 0.01 0.34 ± 0.01 17.25 ± 0.04 
DF3 2 1 0.84 ± 0.01 13.60 ± 0.04 9.59 ± 0.06 0.62 ± 0.00 15.51 ± 0.04 
DF3 2 2 0.79 ± 0.00 12.82 ± 0.01 8.96 ± 0.01 0.52 ± 0.00 14.69 ± 0.03 
DF3 2 3 1.03 ± 0.00 11.79 ± 0.01 8.47 ± 0.01 0.54 ± 0.00 14.03 ± 0.00 
DF3 2 4 0.79 ± 0.00 11.60 ± 0.01 8.43 ± 0.01 0.51 ± 0.00 13.67 ± 0.02 
DF3 3 1 0.90 ± 0.00 13.23 ± 0.00 9.53 ± 0.00 0.57 ± 0.00 15.39 ± 0.01 
DF3 3 2 0.87 ± 0.00 14.19 ± 0.02 10.20 ± 0.06 0.50 ± 0.01 16.19 ± 0.02 
DF3 3 3 0.83 ± 0.00 14.09 ± 0.01 10.67 ± 0.03 1.10 ± 0.00 16.78 ± 0.05 
DF3 3 4 0.84 ± 0.00 12.63 ± 0.01 9.24 ± 0.03 0.48 ± 0.00 14.74 ± 0.02 
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Appendix J: Protein Content as Determined by rapidN 
Table 17: Protein content of skim milk and products obtained from UF and DF as 
determined by rapidN 
Sample Block Treatment Protein 
Milk 1 1 4.18 ± 0.03 
Milk 1 2 3.64 ± 0.04 
Milk 1 3 3.75 ± 0.05 
Milk 1 4 4.10 ± 0.35 
Milk 2 1 3.94 ± 0.03  
Milk 2 2 3.57 ± 0.09 
Milk 2 3 3.96 ± 0.01 
Milk 2 4 4.14 ± 0.19  
Milk 3 1 4.31 ± 0.09 
Milk 3 2 4.04 ± 0.13 
Milk 3 3 4.01 ± 0.11 
Milk 3 4 4.06 ± 0.08 
UF 1 1 12.52 ± 0.11 
UF 1 2 12.75 ± 0.10 
UF 1 3 13.86 ± 0.07 
UF 1 4 14.13 ± 0.14 
UF 2 1 12.39 ± 0.05 
UF 2 2 12.72 ± 0.05 
UF 2 3 13.27 ± 0.12 
UF 2 4 12.48 ± 0.10 
UF 3 1 13.97 ± 0.04 
UF 3 2 12.50 ± 0.06 
UF 3 3 12.57 ± 0.10 
UF 3 4 13.08 ± 0.09 
DF1 1 1 13.81 ± 1.17 
DF1 1 2 14.40 ± -0.03 
DF1 1 3 12.53± 0.12 
DF1 1 4 15.39 ± 0.26 
DF1 2 1 13.66 ± 0.15 
DF1 2 2 14.98 ± 0.09 
DF1 2 3 12.52 ± 0.08 
DF1 2 4 12.96 ± 0.03 
DF1 3 1 15.21 ± 0.02 
DF1 3 2 14.66 ± 0.03 
DF1 3 3 14.38 ± 0.10 
DF1 3 4 13.09 ± 0.21 
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 Table 15; continued 
 
Sample Block Treatment Protein 
DF2 1 2 14.39 ± 0.19 
DF2 1 3 13.48 ± 0.28 
DF2 1 4 13.89 ± 0.74 
DF2 2 1 15.36 ± 0.06 
DF2 2 2 13.96 ± 0.06 
DF2 2 3 14.96 ± 0.08 
DF2 2 4 13.56 ± 0.23 
DF2 3 1 16.52 ± 0.15 
DF2 3 2 14.05 ± 0.63 
DF2 3 3 13.45 ± 0.06 
DF2 3 4 15.06 ± 0.41 
DF3 1 1 16.81 ± 0.08 
DF3 1 2 13.45 ± 0.26 
DF3 1 3 13.67 ± 0.13 
DF3 1 4 15.46 ± 0.01 
DF3 2 1 13.45 ± 0.08 
DF3 2 2 12.83 ± 0.09 
DF3 2 3 12.37 ± 0.02 
DF3 2 4 12.10 ± 0.02 
DF3 3 1 13.72 ± 0.22 
DF3 3 2 14.44 ± 0.09 
DF3 3 3 14.50 ± 0.24 
DF3 3 4 13.01 ± 0.16 
 
  
 181
Protein in Spray-dried MPC as Determined by rapidN 
 
Table 18: Protein analysis of dry MPC, as determined by Elementar rapidN. Means 
and standard deviations were calculated from two measurements 
 
Sample Block Treatment Protein 
MPC 1 1 84.73 ± 0.26 
MPC 1 2 82.42 ± 0.18 
MPC 1 3 81.70 ± 0.28 
MPC 1 4 81.37 ± 0.19 
MPC 2 1 84.90 ± 0.02  
MPC 2 2 85.15 ± 0.08 
MPC 2 3 81.13 ± 0.71 
MPC 2 4 81.46 ± 0.69  
MPC 3 1 85.33 ± 0.08 
MPC 3 2 84.95 ± 0.23 
MPC 3 3 81.93 ± 0.15 
MPC 3 4 81.78 ± 0.06 
 
Minitab Output for Protein in Spray-dried MPC as Determined by rapidN 
General Linear Model: protein versus block, treatment  
 
Factor     Type    Levels  Values 
block      random       3  1, 2, 3 
treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for protein, using Adjusted SS for Tests 
 
Source     DF   Seq SS   Adj SS  Adj MS      F      P 
block       2   1.8243   1.8243  0.9122   1.60  0.278 
treatment   3  28.3270  28.3270  9.4423  16.52  0.003 
Error       6   3.4304   3.4304  0.5717 
Total      11  33.5817 
 
 
S = 0.756125   R-Sq = 89.79%   R-Sq(adj) = 81.27% 
 
 
Unusual Observations for protein 
 
Obs  protein      Fit  SE Fit  Residual  St Resid 
  2  82.4200  83.6575  0.5347   -1.2375     -2.31 R 
 
R denotes an observation with a large standardized residual. 
 
 
Least Squares Means for protein 
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treatment   Mean 
1          84.99 
2          84.17 
3          81.59 
4          81.54 
 
 
Grouping Information Using Tukey Method and 99.0% Confidence 
 
treatment  N  Mean  Grouping 
1          3  85.0  A 
2          3  84.2  A B 
3          3  81.6    B 
4          3  81.5    B 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 99.0% Simultaneous Confidence Intervals 
Response Variable protein 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
treatment   Lower  Center    Upper   --+---------+---------+---------+---- 
2          -3.882  -0.813   2.2556            (---------*----------) 
3          -6.469  -3.400  -0.3311   (----------*---------) 
4          -6.519  -3.450  -0.3811   (---------*----------) 
                                     --+---------+---------+---------+---- 
                                    -6.0      -3.0       0.0       3.0 
 
 
treatment = 2  subtracted from: 
 
treatment   Lower  Center   Upper   --+---------+---------+---------+---- 
3          -5.656  -2.587  0.4823      (---------*----------) 
4          -5.706  -2.637  0.4323      (---------*---------) 
                                    --+---------+---------+---------+---- 
                                   -6.0      -3.0       0.0       3.0 
 
 
treatment = 3  subtracted from: 
 
treatment   Lower    Center  Upper   --+---------+---------+---------+---- 
4          -3.119  -0.05000  3.019               (---------*---------) 
                                     --+---------+---------+---------+---- 
                                    -6.0      -3.0       0.0       3.0 
 
 
Tukey Simultaneous Tests 
Response Variable protein 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
2              -0.813      0.6174   -1.317    0.5857 
3              -3.400      0.6174   -5.507    0.0061 
4              -3.450      0.6174   -5.588    0.0056 
 
 
treatment = 2  subtracted from: 
 
           Difference       SE of           Adjusted 
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treatment    of Means  Difference  T-Value   P-Value 
3              -2.587      0.6174   -4.190    0.0223 
4              -2.637      0.6174   -4.271    0.0204 
 
 
treatment = 3  subtracted from: 
 
           Difference       SE of            Adjusted 
treatment    of Means  Difference   T-Value   P-Value 
4            -0.05000      0.6174  -0.08099    0.9998 
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Figure 69: Residual plots for protein of dry MPC as determined by Elementar rapid 
N; Top Left: Normal probability plot (p = 0.400); Top Right: Residuals versus 
fitted values; Bottom Left: Histogram of Residuals; Bottom Right: Residuals versus 
order 
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Figure 70: Plot of Variance for protein of dry MPC as determined by Elementar 
rapid N; Bartlett’s Test statistic = 7.73, p-value = 0.052; Levene’s Test statistic = 
0.72, p-value = 0.566 
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Appendix K: Comparison of FOSS Milkoscan FT2 and rapidN 
in Determination of Protein Content of Products Obtained 
from UF/DF Processes 
 
The Mixed 
Procedure 
 
Model Information 
Data Set GUALCO.FT2_RN 
Dependent Variable protein 
Covariance Structure Variance Components 
Estimation Method REML 
Residual Variance Method Profile 
Fixed Effects SE Method Prasad-Rao-Jeske-Kackar-
Harville 
Degrees of Freedom 
Method 
Kenward-Roger 
 
 
Class Level Information 
Class 
Level
s Values 
process 5 DF1 DF2 DF3 Milk UF 
sample 24 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
21 22 23 24 
block 3 1 2 3 
treatme
nt 
4 1 2 3 4 
test 2 1 2 
 
 
Dimensions 
Covariance 
Parameters 
4 
Columns in X 90 
Columns in Z 75 
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Dimensions 
Subjects 1 
Max Obs Per Subject 120 
 
 
Number of Observations 
Number of Observations Read 120 
Number of Observations Used 120 
Number of Observations Not 
Used 
0 
 
 
Iteration History 
Iteratio
n 
Evaluation
s -2 Res Log Like Criterion 
0 1 255.83107178  
1 1 197.99255796 0.000000
00 
 
 
Convergence criteria 
met. 
 
 
Covariance Parameter 
Estimates 
Cov Parm 
Estimat
e 
block 0.00318
7 
block*treatment 0.04540 
proces*block*treat
me 
0.6742 
Residual 0.1048 
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Fit Statistics 
-2 Res Log Likelihood 198.
0 
AIC (smaller is better) 206.
0 
AICC (smaller is 
better) 
206.
5 
BIC (smaller is better) 202.
4 
 
 
Type 3 Tests of Fixed Effects 
Effect 
Nu
m 
DF 
De
n 
DF 
F 
Value Pr > F 
treatment 3 6 0.94 0.477
8 
process 4 32 327.81 <.000
1 
process*treatment 12 32 0.54 0.874
8 
test 1 40 41.05 <.000
1 
treatment*test 3 40 0.89 0.457
0 
process*test 4 40 1.78 0.151
4 
process*treatme*te
st 
12 40 0.72 0.721
9 
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Appendix L: Ca, Mg, K, Na Analysis of Skim Milk, UF/DF 
Products (Wet Basis) 
Table 19: Minerals analysis (Ca, Mg, K, and Na) of skim milk and all products 
obtained by UF and DF, as determined by ICP-MS (wet basis) 
Sample Block Treatment Ca mg/L Mg mg/L K mg/L Na mg/L 
Milk 1 1 1113.0 85.1 1368.0 393.4 
Milk 1 2 1137.0 87.8 1468.0 402.7 
Milk 1 3 1041.0 83.6 1324.0 383.4 
Milk 1 4 1088.0 80.1 1282.0 360.9 
Milk 2 1 1224.0 96.0 1560.0 438.0 
Milk 2 2 1251.0 110.1 1696.0 491.5 
Milk 2 3 1156.0 84.9 1460.0 398.9 
Milk 2 4 1551.0 84.9 1950.0 651.2 
Milk 3 1 1138.0 84.8 1376.0 417.6 
Milk 3 2 1191.0 91.3 1517.0 469.7 
Milk 3 3 1465.0 112.7 1807.0 601.9 
Milk 3 4 1092.0 85.5 1362.0 407.0 
UF 1 1 4123.0 204.6 1682.0 536.4 
UF 1 2 3551.0 170.6 1559.0 423.1 
UF 1 3 3242.0 180.7 1534.0 439.8 
UF 1 4 3544.0 157.5 1432.0 384.2 
UF 2 1 3837.0 187.7 1611.0 467.8 
UF 2 2 3951.0 194.5 1764.0 486.6 
UF 2 3 3911.0 186.7 1530.0 444.4 
UF 2 4 4090.0 202.0 1730.0 517.0 
UF 3 1 3749.0 176.4 1419.0 432.5 
UF 3 2 3721.0 187.1 1775.0 469.7 
UF 3 3 3273.0 154.4 1432.0 456.6 
UF 3 4 3552.0 179.3 1552.0 462.2 
DF1 1 1 4035.0 203.8 255.2 181.7 
DF1 1 2 2964.0 146.9 211.1 1643.0 
DF1 1 3 3242.0 151.0 234.7 1962.0 
DF1 1 4 3230.0 139.8 209.9 2457.0 
DF1 2 1 3811.0 205.6 364.1 209.5 
DF1 2 2 4088.0 188.9 245.3 1086.0 
DF1 2 3 3461.0 170.3 259.1 2014.0 
DF1 2 4 3504.0 171.7 259.9 2867.0 
DF1 3 1 3833.0 206.2 316.8 120.9 
DF1 3 2 3310.0 164.0 273.8 559.0 
DF1 3 3 3326.0 159.0 248.9 1784.0 
DF1 3 4 3547.0 165.6 236.0 282.0 
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Table 17, continued 
 
Sample Block Treatment Ca mg/L Mg mg/L K mg/L Na mg/L 
DF2 1 1 3252.0 209.9 26.6 116.3 
DF2 1 2 3531.0 196.5 9.5 1144.0 
DF2 1 3 3051.0 164.8 25.0 1987.0 
DF2 1 4 2794.0 142.8 6.9 2680.0 
DF2 2 1 4363.0 286.1 55.2 149.2 
DF2 2 2 3591.0 200.4 19.2 1277.0 
DF2 2 3 3622.0 177.8 8.8 2196.0 
DF2 2 4 3151.0 166.2 17.1 3125.0 
DF2 3 1 4294.0 274.3 85.3 118.3 
DF2 3 2 3256.0 181.2 25.9 963.3 
DF2 3 3 2897.0 164.3 6.8 2024.0 
DF2 3 4 3181.0 165.9 ND 2757.0 
DF3 1 1 3490.0 249.7 ND 54.7 
DF3 1 2 2699.0 176.6 ND 2176.0 
DF3 1 3 2911.0 175.4 ND 2297.0 
DF3 1 4 3016.0 171.1 ND 2926.0 
DF3 2 1 3781.0 295.4 ND 61.9 
DF3 2 2 2960.0 206.6 ND 1109.0 
DF3 2 3 2654.0 167.4 ND 1993.0 
DF3 2 4 2795.0 178.4 ND 3591.0 
DF3 3 1 4333.0 313.3 ND 71.2 
DF3 3 2 3724.0 233.0 ND 1313.0 
DF3 3 3 3595.0 210.7 ND 2024.0 
DF3 3 4 2802.0 165.8 ND 3228.0 
 
PROC Mixed to Determine Differences Between DF1, DF2, DF3 Processes and 
UF Process 
 
Ca Difference Between DF1, DF2, DF3 Processes and UF Process 
 
The Mixed Procedure 
  
Model Information 
Data Set GUALCO.MPC4 
Dependent Variable DIFF_Ca 
Covariance Structures Variance Components, Autoregressive 
Subject Effects Sample, Sample 
Estimation Method REML 
Residual Variance Method Profile 
Fixed Effects SE Method Model-Based 
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Degrees of Freedom Method Containment 
  
  
Class Level Information 
Class Levels Values 
Process 3 DF1 DF2 DF3 
Sample 12 1 2 3 4 5 6 7 8 9 10 11 12 
Block 3 1 2 3 
Treatment 4 1 2 3 4 
  
  
Dimensions 
Covariance Parameters 3 
Columns in X 2
0 
Columns in Z Per Subject 3 
Subjects 1
2 
Max Obs Per Subject 3 
  
  
Number of Observations 
Number of Observations Read 3
6 
Number of Observations Used 3
6 
Number of Observations Not Used 0 
  
  
Iteration History 
Iteration Evaluations -2 Res Log Like Criterion 
0 1 375.81066595   
1 2 374.04996866 0.00000001 
2 1 374.04996658 0.00000000 
  
  
Convergence criteria met. 
  
  
Covariance Parameter Estimates 
Cov Parm Subject Estimate 
Block Sample 60779 
AR(1) Sample 0.001135 
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Residual   152766 
  
  
Fit Statistics 
-2 Res Log Likelihood 374.
0 
AIC (smaller is better) 380.
0 
AICC (smaller is better) 381.
2 
BIC (smaller is better) 381.
5 
  
  
Type 3 Tests of Fixed Effects 
Effect Num 
DF 
Den 
DF 
F 
Value 
Pr > F 
Process 2 16 1.79 0.1985 
Treatment 3 16 1.80 0.1875 
Process*Treatment 6 16 0.33 0.9137 
 
K Difference Between DF1, DF2, DF3 Processes and UF Process 
The Mixed Procedure 
  
Model Information 
Data Set GUALCO.MPC4 
Dependent Variable DIFF_K 
Covariance Structures Variance Components, Autoregressive 
Subject Effects Sample, Sample 
Estimation Method REML 
Residual Variance Method Profile 
Fixed Effects SE Method Model-Based 
Degrees of Freedom Method Containment 
  
  
Class Level Information 
Class Levels Values 
Process 3 DF1 DF2 DF3 
Sample 12 1 2 3 4 5 6 7 8 9 10 11 12 
Block 3 1 2 3 
Treatment 4 1 2 3 4 
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Dimensions 
Covariance Parameters 3 
Columns in X 2
0 
Columns in Z Per Subject 3 
Subjects 1
2 
Max Obs Per Subject 3 
  
  
Number of Observations 
Number of Observations Read 3
6 
Number of Observations Used 3
6 
Number of Observations Not Used 0 
  
  
Iteration History 
Iteration Evaluations -2 Res Log Like Criterion 
0 1 311.72410402   
1 2 275.69049709 2059.6268490 
2 1 270.87053030 500.73405620 
3 1 266.57830772 113.77264947 
4 1 262.90179901 22.23647227 
5 2 259.73026528 1.14031119 
6 2 259.47831939 0.19884516 
7 2 259.42850547 0.00138714 
8 3 259.40625178 . 
9 1 259.40577828 0.00000000 
  
  
Convergence criteria met. 
  
  
Covariance Parameter Estimates 
Cov Parm Subject Estimate 
Block Sample 0 
AR(1) Sample 0.9797 
Residual   14255 
  
  
Fit Statistics 
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-2 Res Log Likelihood 259.
4 
AIC (smaller is better) 263.
4 
AICC (smaller is better) 264.
0 
BIC (smaller is better) 264.
4 
  
  
Type 3 Tests of Fixed Effects 
Effect Num 
DF 
Den 
DF 
F 
Value 
Pr > F 
Process 2 16 583.7
2 
<.0001 
Treatment 3 16 1.63 0.2220 
Process*Treatment 6 16 1.76 0.1719 
 
Mg Difference Between DF1, DF2, DF3 Processes and UF Process 
The Mixed Procedure 
  
Model Information 
Data Set GUALCO.MPC4 
Dependent Variable DIFF_Mg 
Covariance Structures Variance Components, Autoregressive 
Subject Effects Sample, Sample 
Estimation Method REML 
Residual Variance Method Profile 
Fixed Effects SE Method Model-Based 
Degrees of Freedom Method Containment 
  
  
Class Level Information 
Class Levels Values 
Process 3 DF1 DF2 DF3 
Sample 12 1 2 3 4 5 6 7 8 9 10 11 12 
Block 3 1 2 3 
Treatment 4 1 2 3 4 
  
  
Dimensions 
Covariance Parameters 3 
Columns in X 2
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0 
Columns in Z Per Subject 3 
Subjects 1
2 
Max Obs Per Subject 3 
  
  
Number of Observations 
Number of Observations Read 3
6 
Number of Observations Used 3
6 
Number of Observations Not Used 0 
  
  
Iteration History 
Iteration Evaluations -2 Res Log Like Criterion 
0 1 239.73138362   
1 3 231.76721108 0.00004451 
2 1 231.76299899 0.00000013 
3 1 231.76298647 0.00000000 
  
  
Convergence criteria met. 
  
  
Covariance Parameter Estimates 
Cov Parm Subject Estimate 
Block Sample 321.61 
AR(1) Sample 0.2950 
Residual   405.25 
  
  
Fit Statistics 
-2 Res Log Likelihood 231.
8 
AIC (smaller is better) 237.
8 
AICC (smaller is better) 239.
0 
BIC (smaller is better) 239.
2 
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Type 3 Tests of Fixed Effects 
Effect Num 
DF 
Den 
DF 
F 
Value 
Pr > F 
Process 2 16 12.52 0.0005 
Treatment 3 16 6.52 0.0043 
Process*Treatment 6 16 2.08 0.1136 
  
  
Least Squares Means 
Effect Proces
s 
Treatment Estimate Standard 
Error 
D
F 
t Value Pr > |t| 
Process DF1   -9.0583 7.7828 1
6 
-1.16 0.2615 
Process DF2   12.3917 7.7828 1
6 
1.59 0.1309 
Process DF3   30.1583 7.7828 1
6 
3.87 0.0013 
Treatment   1 59.8000 13.1362 1
6 
4.55 0.0003 
Treatment   2 4.1667 13.1362 1
6 
0.32 0.7552 
Treatment   3 -2.7444 13.1362 1
6 
-0.21 0.8371 
Treatment   4 -16.5667 13.1362 1
6 
-1.26 0.2253 
 
Differences of Least Squares Means 
Effect Pro
ces
s 
Treat
ment 
Pro
ces
s 
Tre
atm
ent 
Estim
ate 
Standar
d Error 
D
F 
t V
alu
e 
Pr 
> 
|t| 
Adjust
ment 
Adj P 
Proce
ss 
DF
1 
  DF
2 
  -
21.45
00 
6.9003 1
6 
-
3.1
1 
0.
0
0
6
8 
Tukey-
Krame
r 
0.0175 
Proce
ss 
DF
1 
  DF
3 
  -
39.21
67 
7.8526 1
6 
-
4.9
9 
0.
0
0
0
1 
Tukey-
Krame
r 
0.0004 
Proce
ss 
DF
2 
  DF
3 
  -
17.76
67 
6.9003 1
6 
-
2.5
7 
0.
0
2
Tukey-
Krame
r 
0.0505 
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0
4 
Treat
ment 
  1   2 55.63
33 
18.577
4 
1
6 
2.9
9 
0.
0
0
8
6 
Tukey 0.0386 
Treat
ment 
  1   3 62.54
44 
18.577
4 
1
6 
3.3
7 
0.
0
0
3
9 
Tukey 0.0185 
Treat
ment 
  1   4 76.36
67 
18.577
4 
1
6 
4.1
1 
0.
0
0
0
8 
Tukey 0.0041 
Treat
ment 
  2   3 6.911
1 
18.577
4 
1
6 
0.3
7 
0.
7
1
4
8 
Tukey 0.9818 
Treat
ment 
  2   4 20.73
33 
18.577
4 
1
6 
1.1
2 
0.
2
8
0
9 
Tukey 0.6852 
Treat
ment 
  3   4 13.82
22 
18.577
4 
1
6 
0.7
4 
0.
4
6
7
6 
Tukey 0.8778 
 
  
Na Difference Between DF1, DF2, DF3 Processes and UF Process 
The Mixed Procedure 
  
Model Information 
Data Set GUALCO.MPC4 
Dependent Variable DIFF_Na 
Covariance Structures Variance Components, Unstructured 
Subject Effects Sample, Sample 
Estimation Method REML 
Residual Variance Method None 
 197
Fixed Effects SE Method Model-Based 
Degrees of Freedom Method Containment 
  
  
Class Level Information 
Class Levels Values 
Process 3 DF1 DF2 DF3 
Sample 12 1 2 3 4 5 6 7 8 9 10 11 12 
Block 3 1 2 3 
Treatment 4 1 2 3 4 
  
  
Dimensions 
Covariance Parameters 7 
Columns in X 2
0 
Columns in Z Per Subject 3 
Subjects 1
2 
Max Obs Per Subject 3 
  
  
Number of Observations 
Number of Observations Read 3
6 
Number of Observations Used 3
6 
Number of Observations Not Used 0 
  
  
Iteration History 
Iteration Evaluations -2 Res Log Like Criterion 
0 1 377.95673596   
1 1 355.29144012 0.00000000 
  
  
Convergence criteria met but final hessian is not positive definite. 
  
  
Covariance Parameter Estimates 
Cov Parm Subject Estimate 
Block Sample 11388 
UN(1,1) Sample 554907 
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UN(2,1) Sample 43236 
UN(2,2) Sample 6853.40 
UN(3,1) Sample 75580 
UN(3,2) Sample 0 
UN(3,3) Sample 104628 
  
  
Fit Statistics 
-2 Res Log Likelihood 355.
3 
AIC (smaller is better) 369.
3 
AICC (smaller is better) 376.
3 
BIC (smaller is better) 372.
7 
  
  
Type 3 Tests of Fixed Effects 
Effect Num 
DF 
Den 
DF 
F 
Value 
Pr > F 
Process 2 16 3.57 0.0523 
Treatment 3 16 32.76 <.0001 
Process*Treatment 6 16 1.70 0.1849 
  
  
Least Squares Means 
Effect Treatment Estimate Standard 
Error 
D
F 
t Value Pr > |t| 
Treatment 1 -358.49 193.08 1
6 
-1.86 0.0819 
Treatment 2 792.46 193.08 1
6 
4.10 0.0008 
Treatment 3 1584.29 193.08 1
6 
8.21 <.0001 
Treatment 4 2202.53 193.08 1
6 
11.41 <.0001 
 
Differences of Least Squares Means 
Effect Treatm
ent 
Treatm
ent 
Estim
ate 
Standa
rd 
Error 
D
F 
t Val
ue 
Pr 
> 
|t| 
Adjustm
ent 
Adj P 
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Treatm
ent 
1 2 -
1150.
94 
273.05 1
6 
-
4.22 
0.0
00
7 
Tukey 0.0033 
Treatm
ent 
1 3 -
1942.
78 
273.05 1
6 
-
7.12 
<.0
00
1 
Tukey <.0001 
Treatm
ent 
1 4 -
2561.
02 
273.05 1
6 
-
9.38 
<.0
00
1 
Tukey <.0001 
Treatm
ent 
2 3 -
791.8
3 
273.05 1
6 
-
2.90 
0.0
10
4 
Tukey 0.0464 
Treatm
ent 
2 4 -
1410.
08 
273.05 1
6 
-
5.16 
<.0
00
1 
Tukey 0.0005 
Treatm
ent 
3 4 -
618.2
4 
273.05 1
6 
-
2.26 
0.0
37
8 
Tukey 0.1484 
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Appendix M: Ca, Mg, K, and Na Analysis of Skim Milk, 
UF/DF Products (Dry Basis) 
 
Ca Difference Between DF1, DF2, DF3 Processes and UF Process 
 
The Mixed 
Procedure 
 
Model Information 
Data Set WORK.DRY_BASIS 
Dependent Variable DIFF_ca 
Covariance Structures Variance Components, 
Autoregressive 
Subject Effects sample, sample 
Estimation Method REML 
Residual Variance Method Profile 
Fixed Effects SE Method Model-Based 
Degrees of Freedom 
Method 
Containment 
 
 
Class Level Information 
Class 
Level
s Values 
process 3 DF1 DF2 DF3 
sample 12 1 2 3 4 5 6 7 8 9 10 
11 12 
block 3 1 2 3 
treatmen
t 
4 1 2 3 4 
 
 
Dimensions 
Covariance Parameters 3 
Columns in X 20 
Columns in Z Per 
Subject 
3 
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Dimensions 
Subjects 12 
Max Obs Per Subject 3 
 
 
Number of Observations 
Number of Observations Read 36 
Number of Observations Used 36 
Number of Observations Not 
Used 
0 
 
 
Iteration History 
Iteratio
n 
Evaluation
s -2 Res Log Like Criterion 
0 1 3.95812742  
1 4 2.02016066 0.000314
25 
2 1 2.01363299 0.000000
12 
3 1 2.01363056 0.000000
00 
 
 
Convergence criteria 
met. 
 
 
Covariance Parameter 
Estimates 
Cov Parm 
Subjec
t 
Estimat
e 
block sampl
e 
1.89E-
19 
AR(1) sampl
e 
0.3722 
Residual  0.04061 
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Fit Statistics 
-2 Res Log Likelihood 2.0 
AIC (smaller is better) 6.0 
AICC (smaller is 
better) 
6.6 
BIC (smaller is better) 7.0 
 
 
Type 3 Tests of Fixed Effects 
Effect 
Num 
DF 
De
n 
DF F Value Pr > F 
process 2 16 0.43 0.654
7 
treatment 3 16 4.92 0.013
1 
process*treatme
nt 
6 16 1.23 0.343
1 
 
 
Least Squares Means 
Effect 
proces
s 
treatmen
t 
Estimat
e 
Standar
d Error DF 
t Valu
e 
Pr > 
|t| 
process DF1  0.1277 0.05817 16 2.19 0.043
3 
process DF2  0.06897 0.05817 16 1.19 0.253
1 
process DF3  0.07241 0.05817 16 1.24 0.231
1 
treatmen
t 
 1 0.2899 0.08466 16 3.42 0.003
5 
treatmen
t 
 2 0.01288 0.08466 16 0.15 0.881
0 
treatmen
t 
 3 0.1894 0.08466 16 2.24 0.039
9 
treatmen
t 
 4 -0.1334 0.08466 16 -1.58 0.134
6 
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Differences of Least Squares Means 
Effect 
proc
ess 
treat
ment 
_pr
oc
ess 
_treatm
ent Estimate 
Standar
d Error DF t Value Pr > |t| 
Adjustm
ent Adj P 
proces
s 
DF1  DF
2 
 0.05871 0.06518 16 0.90 0.3811 Tukey-
Kramer 
0.647
6 
proces
s 
DF1  DF
3 
 0.05526 0.07635 16 0.72 0.4796 Tukey-
Kramer 
0.753
2 
proces
s 
DF2  DF
3 
 -0.00345 0.06518 16 -0.05 0.9585 Tukey-
Kramer 
0.998
5 
treat
ment 
 1  2 0.2770 0.1197 16 2.31 0.0343 Tukey 0.136
3 
treat
ment 
 1  3 0.1005 0.1197 16 0.84 0.4135 Tukey 0.834
9 
treat
ment 
 1  4 0.4233 0.1197 16 3.54 0.0027 Tukey 0.013
2 
treat
ment 
 2  3 -0.1765 0.1197 16 -1.47 0.1599 Tukey 0.474
8 
treat
ment 
 2  4 0.1463 0.1197 16 1.22 0.2394 Tukey 0.622
4 
treat
ment 
 3  4 0.3228 0.1197 16 2.70 0.0159 Tukey 0.068
3 
 
Na Difference Between DF1, DF2, DF3 Processes and UF Process 
 
The Mixed 
Procedure 
 
Model Information 
Data Set WORK.DRY_BASIS 
Dependent Variable DIFF_mg 
Covariance Structures Variance Components, 
Autoregressive 
Subject Effects sample, sample 
Estimation Method REML 
Residual Variance Method Profile 
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Model Information 
Fixed Effects SE Method Model-Based 
Degrees of Freedom 
Method 
Containment 
 
 
Class Level Information 
Class 
Level
s Values 
process 3 DF1 DF2 DF3 
sample 12 1 2 3 4 5 6 7 8 9 10 
11 12 
block 3 1 2 3 
treatmen
t 
4 1 2 3 4 
 
 
Dimensions 
Covariance Parameters 3 
Columns in X 20 
Columns in Z Per 
Subject 
3 
Subjects 12 
Max Obs Per Subject 3 
 
 
Number of Observations 
Number of Observations Read 36 
Number of Observations Used 36 
Number of Observations Not 
Used 
0 
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Iteration History 
Iteratio
n 
Evaluation
s -2 Res Log Like Criterion 
0 1 -4.33208256  
1 2 -90.43885417 0.436097
49 
2 1 -90.53165496 0.000060
94 
3 1 -90.53554938 0.000005
73 
4 1 -90.53593703 0.000000
01 
 
 
Convergence criteria 
met. 
 
 
Covariance Parameter 
Estimates 
Cov Parm 
Subjec
t 
Estimat
e 
block sampl
e 
0.02759 
AR(1) sampl
e 
0.8344 
Residual  0.00039
3 
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Fit Statistics 
-2 Res Log Likelihood -
90.5 
AIC (smaller is better) -
84.5 
AICC (smaller is 
better) 
-
83.3 
BIC (smaller is better) -
83.1 
 
 
Type 3 Tests of Fixed Effects 
Effect 
Num 
DF 
De
n 
DF F Value Pr > F 
process 2 16 27.00 <.000
1 
treatment 3 16 1.55 0.239
3 
process*treatme
nt 
6 16 3.42 0.022
8 
 
 
Least Squares Means 
Effect 
proces
s 
treatmen
t 
Estimat
e 
Standar
d Error DF 
t Valu
e 
Pr > 
|t| 
process DF1  -1.9197 0.04829 16 -39.75 <.000
1 
process DF2  -1.9062 0.04829 16 -39.47 <.000
1 
process DF3  -1.8873 0.04829 16 -39.08 <.000
1 
treatmen
t 
 1 -1.9453 0.09649 16 -20.16 <.000
1 
treatmen
t 
 2 -1.9388 0.09649 16 -20.09 <.000
1 
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Least Squares Means 
Effect 
proces
s 
treatmen
t 
Estimat
e 
Standar
d Error DF 
t Valu
e 
Pr > 
|t| 
treatmen
t 
 3 -1.7294 0.09649 16 -17.92 <.000
1 
treatmen
t 
 4 -2.0041 0.09649 16 -20.77 <.000
1 
 
 
Differences of Least Squares Means 
Effect 
proc
ess 
treatm
ent 
_proc
ess 
_treatm
ent 
Estim
ate 
Standa
rd 
Error 
D
F 
t Val
ue 
Pr > 
|t| 
Adjust
ment 
Adj 
P 
proces
s 
DF1  DF2  -
0.013
55 
0.003
293 
1
6 
-
4.11 
0.00
08 
Tukey-
Kramer 
0.00
22 
proces
s 
DF1  DF3  -
0.032
41 
0.004
461 
1
6 
-
7.27 
<.00
01 
Tukey-
Kramer 
<.00
01 
proces
s 
DF2  DF3  -
0.018
86 
0.003
293 
1
6 
-
5.73 
<.00
01 
Tukey-
Kramer 
<.00
01 
treatm
ent 
 1  2 -
0.006
54 
0.136
5 
1
6 
-
0.05 
0.96
24 
Tukey 1.00
00 
treatm
ent 
 1  3 -
0.215
9 
0.136
5 
1
6 
-
1.58 
0.13
32 
Tukey 0.41
56 
treatm
ent 
 1  4 0.058
78 
0.136
5 
1
6 
0.43 0.67
24 
Tukey 0.97
23 
treatm
ent 
 2  3 -
0.209
4 
0.136
5 
1
6 
-
1.53 
0.14
45 
Tukey 0.44
14 
treatm
ent 
 2  4 0.065
32 
0.136
5 
1
6 
0.48 0.63
86 
Tukey 0.96
27 
treatm
ent 
 3  4 0.274
7 
0.136
5 
1
6 
2.01 0.06
13 
Tukey 0.22
43 
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K Difference Between DF1, DF2, DF3 Processes and UF Process 
 
The Mixed 
Procedure 
 
Model Information 
Data Set WORK.DRY_BASI
S 
Dependent Variable DIFF_k 
Covariance Structure Variance 
Components 
Subject Effects sample, sample 
Estimation Method REML 
Residual Variance Method Parameter 
Fixed Effects SE Method Model-Based 
Degrees of Freedom 
Method 
Containment 
 
 
Class Level Information 
Class 
Level
s Values 
process 3 DF1 DF2 DF3 
sample 12 1 2 3 4 5 6 7 8 9 10 
11 12 
block 3 1 2 3 
treatmen
t 
4 1 2 3 4 
 
 
Dimensions 
Covariance Parameters 2 
Columns in X 20 
Columns in Z Per 
Subject 
3 
Subjects 12 
Max Obs Per Subject 3 
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Number of Observations 
Number of Observations Read 36 
Number of Observations Used 36 
Number of Observations Not 
Used 
0 
 
 
Iteration History 
Iteratio
n 
Evaluation
s -2 Res Log Like Criterion 
0 1 -3.43961829  
1 1 -75.53850632 0.000000
00 
 
 
Convergence criteria 
met. 
 
 
Covariance Parameter 
Estimates 
Cov Parm 
Subjec
t 
Estimat
e 
block sampl
e 
0.02910 
process sampl
e 
0.00018
7 
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Fit Statistics 
-2 Res Log Likelihood -
75.5 
AIC (smaller is better) -
71.5 
AICC (smaller is 
better) 
-
71.0 
BIC (smaller is better) -
70.6 
 
 
Type 3 Tests of Fixed Effects 
Effect 
Num 
DF 
De
n 
DF F Value Pr > F 
process 2 16 493.11 <.000
1 
treatment 3 16 1.60 0.229
3 
process*treatme
nt 
6 16 1.75 0.173
7 
 
 
Least Squares Means 
Effect 
proces
s 
treatmen
t 
Estimat
e 
Standar
d Error DF 
t Valu
e 
Pr > 
|t| 
process DF1  -1.8665 0.04941 16 -37.78 <.000
1 
process DF2  -2.0108 0.04941 16 -40.70 <.000
1 
process DF3  -2.0251 0.04941 16 -40.99 <.000
1 
treatmen
t 
 1 -2.0249 0.09860 16 -20.54 <.000
1 
treatmen
t 
 2 -2.0043 0.09860 16 -20.33 <.000
1 
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Least Squares Means 
Effect 
proces
s 
treatmen
t 
Estimat
e 
Standar
d Error DF 
t Valu
e 
Pr > 
|t| 
treatmen
t 
 3 -1.7834 0.09860 16 -18.09 <.000
1 
treatmen
t 
 4 -2.0572 0.09860 16 -20.86 <.000
1 
 
 
Differences of Least Squares Means 
Effect 
proc
ess 
treatm
ent 
_proc
ess 
_treatm
ent 
Estim
ate 
Standa
rd 
Error 
D
F 
t Val
ue 
Pr > 
|t| 
Adjust
ment 
Adj 
P 
proces
s 
DF1  DF2  0.144
2 
0.005
584 
1
6 
25.8
3 
<.00
01 
Tukey-
Kramer 
<.00
01 
proces
s 
DF1  DF3  0.158
5 
0.005
584 
1
6 
28.3
9 
<.00
01 
Tukey-
Kramer 
<.00
01 
proces
s 
DF2  DF3  0.014
30 
0.005
584 
1
6 
2.56 0.02
09 
Tukey-
Kramer 
0.05
19 
treatm
ent 
 1  2 -
0.020
59 
0.139
4 
1
6 
-
0.15 
0.88
45 
Tukey 0.99
88 
treatm
ent 
 1  3 -
0.241
5 
0.139
4 
1
6 
-
1.73 
0.10
25 
Tukey 0.34
04 
treatm
ent 
 1  4 0.032
29 
0.139
4 
1
6 
0.23 0.81
98 
Tukey 0.99
54 
treatm
ent 
 2  3 -
0.220
9 
0.139
4 
1
6 
-
1.58 
0.13
27 
Tukey 0.41
46 
treatm
ent 
 2  4 0.052
88 
0.139
4 
1
6 
0.38 0.70
95 
Tukey 0.98
08 
treatm
ent 
 3  4 0.273
8 
0.139
4 
1
6 
1.96 0.06
72 
Tukey 0.24
23 
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Na Difference Between DF1, DF2, DF3 Processes and UF Process 
 
The Mixed 
Procedure 
 
Model Information 
Data Set WORK.DRY_BASI
S 
Dependent Variable DIFF_na 
Covariance Structure Variance 
Components 
Subject Effects sample, sample 
Estimation Method REML 
Residual Variance Method Parameter 
Fixed Effects SE Method Model-Based 
Degrees of Freedom 
Method 
Containment 
 
 
Class Level Information 
Class 
Level
s Values 
process 3 DF1 DF2 DF3 
sample 12 1 2 3 4 5 6 7 8 9 10 
11 12 
block 3 1 2 3 
treatmen
t 
4 1 2 3 4 
 
 
Dimensions 
Covariance Parameters 2 
Columns in X 20 
Columns in Z Per 
Subject 
3 
Subjects 12 
Max Obs Per Subject 3 
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Number of Observations 
Number of Observations Read 36 
Number of Observations Used 36 
Number of Observations Not 
Used 
0 
 
 
Iteration History 
Iteratio
n 
Evaluation
s -2 Res Log Like Criterion 
0 1 31.64004511  
1 1 27.59411495 0.000000
00 
 
 
Convergence criteria 
met. 
 
 
Covariance Parameter 
Estimates 
Cov Parm 
Subjec
t 
Estimat
e 
block sampl
e 
0.05443 
process sampl
e 
0.07190 
 
 
Fit Statistics 
-2 Res Log Likelihood 27.6 
AIC (smaller is better) 31.6 
AICC (smaller is 
better) 
32.2 
BIC (smaller is better) 32.6 
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Type 3 Tests of Fixed Effects 
Effect 
Num 
DF 
De
n 
DF F Value Pr > F 
process 2 16 5.68 0.013
7 
treatment 3 16 21.31 <.000
1 
process*treatme
nt 
6 16 2.36 0.079
4 
 
 
Least Squares Means 
Effect 
proces
s 
treatmen
t 
Estimat
e 
Standar
d Error DF 
t Valu
e 
Pr > 
|t| 
process DF1  -1.2468 0.1026 16 -12.15 <.000
1 
process DF2  -1.0645 0.1026 16 -10.37 <.000
1 
process DF3  -0.8778 0.1026 16 -8.56 <.000
1 
treatmen
t 
 1 -2.0249 0.1617 16 -12.53 <.000
1 
treatmen
t 
 2 -1.2763 0.1617 16 -7.89 <.000
1 
treatmen
t 
 3 -0.5423 0.1617 16 -3.35 0.004
0 
treatmen
t 
 4 -0.4086 0.1617 16 -2.53 0.022
4 
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Differences of Least Squares Means 
Effect 
proc
ess 
treatm
ent 
_proc
ess 
_treatm
ent 
Estim
ate 
Stand
ard 
Error 
D
F 
t Val
ue 
Pr > 
|t| 
Adjust
ment 
Adj 
P 
proces
s 
DF1  DF2  -
0.182
3 
0.109
5 
1
6 
-
1.67 
0.11
53 
Tukey-
Kramer 
0.24
85 
proces
s 
DF1  DF3  -
0.369
0 
0.109
5 
1
6 
-
3.37 
0.00
39 
Tukey-
Kramer 
0.01
03 
proces
s 
DF2  DF3  -
0.186
7 
0.109
5 
1
6 
-
1.71 
0.10
75 
Tukey-
Kramer 
0.23
37 
treatm
ent 
 1  2 -
0.748
7 
0.228
6 
1
6 
-
3.27 
0.00
48 
Tukey 0.02
22 
treatm
ent 
 1  3 -
1.482
7 
0.228
6 
1
6 
-
6.49 
<.00
01 
Tukey <.00
01 
treatm
ent 
 1  4 -
1.616
4 
0.228
6 
1
6 
-
7.07 
<.00
01 
Tukey <.00
01 
treatm
ent 
 2  3 -
0.734
0 
0.228
6 
1
6 
-
3.21 
0.00
55 
Tukey 0.02
53 
treatm
ent 
 2  4 -
0.867
7 
0.228
6 
1
6 
-
3.80 
0.00
16 
Tukey 0.00
78 
treatm
ent 
 3  4 -
0.133
7 
0.228
6 
1
6 
-
0.58 
0.56
68 
Tukey 0.93
52 
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General Regression Analysis: CaMgRatio versus conc-75, (conc-75)2, Block  
 
Regression Equation 
 
Block 
1      CaMgRatio  =  16.3193 + 0.021788 conc-75 - 0.000143511 (conc-75)2 
 
2      CaMgRatio  =  15.1105 + 0.021788 conc-75 - 0.000143511 (conc-75)2 
 
3      CaMgRatio  =  16.3922 + 0.021788 conc-75 - 0.000143511 (conc-75)2 
 
 
Coefficients 
 
Term           Coef   SE Coef        T      P 
Constant    15.9407  0.160372  99.3979  0.000 
conc-75      0.0218  0.001792  12.1575  0.000 
(conc-75)2  -0.0001  0.000040  -3.5812  0.009 
Block 
  1          0.3786  0.141681   2.6724  0.032 
  2         -0.8302  0.141681  -5.8596  0.001 
 
 
Summary of Model 
 
S = 0.347047     R-Sq = 96.54%        R-Sq(adj) = 94.56% 
PRESS = 2.61286  R-Sq(pred) = 89.26% 
 
 
Analysis of Variance 
 
Source        DF   Seq SS   Adj SS   Adj MS        F          P 
Regression     4  23.4925  23.4925   5.8731   48.763  0.0000339 
  conc-75      1  17.8019  17.8019  17.8019  147.806  0.0000058 
  (conc-75)2   1   1.5447   1.5447   1.5447   12.825  0.0089619 
  Block        2   4.1459   4.1459   2.0730   17.211  0.0019838 
Error          7   0.8431   0.8431   0.1204 
Total         11  24.3356 
 
 
Fits and Diagnostics for Unusual Observations 
 
 
No unusual observations 
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Appendix N: Mineral Content of Dry MPC 
Table 20: Mineral analysis of dry MPC, as determined by ICP-MS. Means are 
shown and were calculated from three measurements, ND (not detected) values 
were below the instrument detection limit (0.1 mg/g) and were assumed to be 0 in 
the statistical analysis. 
Sample 
 
Block Treatment 
Ca 
mg/g 
Mg 
mg/g K mg/g 
Na 
mg/g 
Pdr  1 1 8.02 1.567 ND ND 
Pdr  1 2 8.384 1.311 ND 5.97 
Pdr  1 3 6.309 0.9886 ND 9.86 
Pdr  1 4 6.594 0.9383 ND 13.32 
Pdr  2 1 9.69 1.845 ND ND 
Pdr  2 2 7.579 1.291 ND 5.174 
Pdr  2 3 6.732 0.9169 ND 10.35 
Pdr  2 4 5.818 0.811 ND 14.16 
Pdr  3 1 7.987 1.788 ND ND 
Pdr  3 2 7.515 1.142 ND 6.21 
Pdr  3 3 6.87 0.9631 ND 10.74 
Pdr  3 4 6.19 0.90 ND 15.03 
 
Minitab Output for Mineral Content of Dry MPC 
General Linear Model: Ca, Mg, Na versus block, treatment  
 
Factor     Type   Levels  Values 
block      fixed       3  1, 2, 3 
treatment  fixed       4  1, 2, 3, 4 
 
 
Analysis of Variance for Ca, using Adjusted SS for Tests 
 
Source     DF   Seq SS   Adj SS  Adj MS     F      P 
block       2   0.1998   0.1998  0.0999  0.23  0.803 
treatment   3  10.5794  10.5794  3.5265  8.02  0.016 
Error       6   2.6382   2.6382  0.4397 
Total      11  13.4174 
 
 
S = 0.663101   R-Sq = 80.34%   R-Sq(adj) = 63.95% 
 
 
Unusual Observations for Ca 
 
Obs       Ca      Fit   SE Fit  Residual  St Resid 
  5  9.69000  8.71308  0.46888   0.97692      2.08 R 
 
R denotes an observation with a large standardized residual. 
 
 
Analysis of Variance for Mg, using Adjusted SS for Tests 
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Source     DF   Seq SS   Adj SS   Adj MS      F      P 
block       2  0.00072  0.00072  0.00036   0.03  0.970 
treatment   3  1.33952  1.33952  0.44651  37.93  0.000 
Error       6  0.07063  0.07063  0.01177 
Total      11  1.41087 
 
 
S = 0.108499   R-Sq = 94.99%   R-Sq(adj) = 90.82% 
 
 
Unusual Observations for Mg 
 
Obs       Mg      Fit   SE Fit  Residual  St Resid 
  1  1.56700  1.72940  0.07672  -0.16240     -2.12 R 
 
R denotes an observation with a large standardized residual. 
 
 
Analysis of Variance for Na, using Adjusted SS for Tests 
 
Source     DF   Seq SS   Adj SS   Adj MS       F      P 
block       2    1.132    1.132    0.566    2.59  0.154 
treatment   3  334.823  334.823  111.608  511.21  0.000 
Error       6    1.310    1.310    0.218 
Total      11  337.265 
 
 
S = 0.467247   R-Sq = 99.61%   R-Sq(adj) = 99.29% 
 
 
MANOVA for block 
s = 2    m = 0.0    n = 1.0 
 
                       Test             DF 
Criterion         Statistic      F  Num  Denom      P 
Wilks'              0.34646  0.932    6      8  0.521 
Lawley-Hotelling    1.84896  0.924    6      6  0.537 
Pillai's            0.66650  0.833    6     10  0.571 
Roy's               1.82851 
 
 
SSCP Matrix (adjusted) for block 
 
         Ca        Mg       Na 
Ca   0.1998   0.01067  -0.3939 
Mg   0.0107   0.00072  -0.0137 
Na  -0.3939  -0.01373   1.1325 
 
 
SSCP Matrix (adjusted) for Error 
 
        Ca        Mg        Na 
Ca  2.6382   0.26788   0.43134 
Mg  0.2679   0.07063  -0.09092 
Na  0.4313  -0.09092   1.30992 
 
 
Partial Correlations for the Error SSCP Matrix 
 
         Ca        Mg        Na 
Ca  1.00000   0.62056   0.23203 
Mg  0.62056   1.00000  -0.29889 
Na  0.23203  -0.29889   1.00000 
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EIGEN Analysis for block 
 
 
Eigenvalue  1.8285  0.02045  0.00000 
Proportion  0.9889  0.01106  0.00000 
Cumulative  0.9889  1.00000  1.00000 
 
 
Eigenvector        1       2        3 
Ca           -0.6681  0.5204  -0.4218 
Mg            3.7773  0.5274   4.4931 
Na            1.0819  0.1952  -0.0922 
 
 
MANOVA for treatment 
s = 3    m = -0.5    n = 1.0 
 
                       Test                DF 
Criterion         Statistic  Approx F  Num  Denom      P 
Wilks'              0.00089    18.550    9      9  0.000 
Lawley-Hotelling  345.98873   102.515    9      8  0.000 
Pillai's            1.74204     2.770    9     18  0.031 
Roy's             343.92102 
 
 
SSCP Matrix (adjusted) for treatment 
 
        Ca      Mg      Na 
Ca   10.58    3.63  -58.79 
Mg    3.63    1.34  -20.65 
Na  -58.79  -20.65  334.82 
 
 
EIGEN Analysis for treatment 
 
 
Eigenvalue  343.921  1.980  0.088 
Proportion    0.994  0.006  0.000 
Cumulative    0.994  1.000  1.000 
 
 
Eigenvector        1       2      3 
Ca           -0.4793   0.581  0.573 
Mg            2.3445  -5.403  0.207 
Na            1.0733  -0.229  0.113 
 
 
 
General Linear Model: Na versus block, treatment  
 
Factor     Type    Levels  Values 
block      random       3  1, 2, 3 
treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for Na, using Adjusted SS for Tests 
 
Source     DF   Seq SS   Adj SS  Adj MS       F      P 
block       2    0.821    0.821   0.411    1.10  0.391 
treatment   3  235.332  235.332  78.444  210.83  0.000 
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Error       6    2.232    2.232   0.372 
Total      11  238.386 
 
 
S = 0.609975   R-Sq = 99.06%   R-Sq(adj) = 98.28% 
 
 
Unusual Observations for Na 
 
Obs       Na      Fit  SE Fit  Residual  St Resid 
  4  13.3200  12.3274  0.4313    0.9926      2.30 R 
 
R denotes an observation with a large standardized residual. 
 
 
Least Squares Means for Na 
 
treatment     Mean 
1           0.0302 
2           4.9890 
3           8.3043 
4          12.0800 
 
 
Grouping Information Using Tukey Method and 99.0% Confidence 
 
treatment  N  Mean  Grouping 
4          3  12.1  A 
3          3   8.3    B 
2          3   5.0      C 
1          3   0.0        D 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 99.0% Simultaneous Confidence Intervals 
Response Variable Na 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
treatment  Lower  Center   Upper  --------+---------+---------+-------- 
2          2.483   4.959   7.435      (-----*------) 
3          5.798   8.274  10.750              (------*-----) 
4          9.574  12.050  14.526                        (-----*-----) 
                                  --------+---------+---------+-------- 
                                        4.0       8.0      12.0 
 
 
treatment = 2  subtracted from: 
 
treatment   Lower  Center  Upper  --------+---------+---------+-------- 
3          0.8396   3.315  5.791  (-----*-----) 
4          4.6153   7.091  9.567            (-----*-----) 
                                  --------+---------+---------+-------- 
                                        4.0       8.0      12.0 
 
 
treatment = 3  subtracted from: 
 
treatment  Lower  Center  Upper  --------+---------+---------+-------- 
4          1.300   3.776  6.251   (-----*------) 
                                 --------+---------+---------+-------- 
                                       4.0       8.0      12.0 
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Tukey Simultaneous Tests 
Response Variable Na 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
2               4.959      0.4980    9.957    0.0003 
3               8.274      0.4980   16.613    0.0000 
4              12.050      0.4980   24.194    0.0000 
 
 
treatment = 2  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
3               3.315      0.4980    6.657    0.0023 
4               7.091      0.4980   14.238    0.0000 
 
 
treatment = 3  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
4               3.776      0.4980    7.581    0.0011 
 
 
Calculation of Mineral Content 
 
Treatment Level 2 Powders: 
 
4.98 mgg Na S 
1g
10mg   0.00498 S 100  0.498 % Na 
 
100 g of this MPC would be expected to contain 0.498 g Na; therefore: 
 
0.498g Na S mol22.99g  0.021 mol Na per 100 g powder 
 
there exists 0.021 mol per 84.17g protein; per 100 g protein: 
 
0.021 mol
84.19 g   
%
100 g 
 
x = 0.026 mol Na 
 
 
 
Treatment Level 3 Powders: 
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8.30 mgg Na S 
1g
10mg   0.0083 S 100  0.83 % Na 
 
100 g of this MPC would be expected to contain 0.83 g Na; therefore: 
 
0.83g Na S mol22.99g  0.036 mol Na per 100 g powder 
 
there exists 0.036 mol per 81.59g protein; per 100 g protein: 
 
0.036 mol
81.59 g   
%
100 g 
 
x = 0.044 mol Na 
 
Treatment Level 4 Powders: 
 
12.08 mgg Na S 
1g
10mg   0.01208 S 100  1.208 % Na 
 
100 g of this MPC would be expected to contain 1.208 g Na; therefore: 
 
1.208g Na S mol22.99g  0.0525 mol Na per 100 g powder 
 
there exists 0.0525 mol per 81.54g protein; per 100 g protein: 
 
0.0525 mol
81.54 g   
%
100 g 
 
x = 0.064 mol Na 
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Figure 71: Residual plots for univariate ANOVA of Na content in dry MPC; Top 
Left: Normal probability plot (p = 0.453); Top Right: Residuals versus fitted 
values; Bottom Left: Histogram of Residuals; Bottom Right: Residuals versus order 
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Figure 72: Residual plots for univariate ANOVA of Ca content in dry MPC; Top 
Left: Normal probability plot (p = 0.366); Top Right: Residuals versus fitted 
values; Bottom Left: Histogram of Residuals; Bottom Right: Residuals versus order 
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Figure 73: Residual plots for univariate ANOVA of Na content in dry MPC; Top 
Left: Normal probability plot (p = 0.124); Top Right: Residuals versus fitted 
values; Bottom Left: Histogram of Residuals; Bottom Right: Residuals versus order 
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Appendix O: Moisture Content of Dry MPC 
 
Table 21: Moisture content of MPC powders as determined by AOAC 925.23 
Sample Block Treatment 
Moisture 
(%) 
MPC 1 1 8.01 
MPC 1 2 6.69 
MPC 1 3 5.38 
MPC 1 4 6.28 
MPC 2 1 7.04 
MPC 2 2 5.79 
MPC 2 3 6.15 
MPC 2 4 6.90 
MPC 3 1 6.35 
MPC 3 2 5.63 
MPC 3 3 5.86 
MPC 3 4 6.52 
 
 
Minitab Output for Moisture Analysis of MPC powders 
 
General Linear Model: moisture versus block, treatment  
 
Factor     Type    Levels  Values 
block      random       3  1, 2, 3 
treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for moisture, using Adjusted SS for Tests 
 
Source     DF  Seq SS  Adj SS  Adj MS     F      P 
block       2  0.5446  0.5446  0.2723  0.81  0.487 
treatment   3  3.1759  3.1759  1.0586  3.17  0.107 
Error       6  2.0064  2.0064  0.3344 
Total      11  5.7268 
 
 
S = 0.578275   R-Sq = 64.96%   R-Sq(adj) = 35.77% 
 
 
Grouping Information Using Tukey Method and 99.0% Confidence 
 
treatment  N  Mean  Grouping 
1          3   7.1  A 
4          3   6.6  A 
2          3   6.0  A 
3          3   5.8  A 
 
Means that do not share a letter are significantly different. 
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Means that do not share a letter are significantly different. 
 
 
Tukey 99.0% Simultaneous Confidence Intervals 
Response Variable moisture 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
treatment   Lower  Center  Upper  --------+---------+---------+-------- 
2          -3.441  -1.094  1.253   (-----------*----------) 
3          -3.684  -1.337  1.010  (----------*-----------) 
4          -2.914  -0.567  1.780     (-----------*-----------) 
                                  --------+---------+---------+-------- 
                                       -2.0       0.0       2.0 
 
 
treatment = 2  subtracted from: 
 
treatment   Lower   Center  Upper  --------+---------+---------+-------- 
3          -2.590  -0.2429  2.104       (-----------*-----------) 
4          -1.820   0.5268  2.874           (-----------*----------) 
                                   --------+---------+---------+-------- 
                                        -2.0       0.0       2.0 
 
 
treatment = 3  subtracted from: 
 
treatment   Lower  Center  Upper  --------+---------+---------+-------- 
4          -1.577  0.7698  3.117            (-----------*-----------) 
                                  --------+---------+---------+-------- 
                                       -2.0       0.0       2.0 
 
 
Tukey Simultaneous Tests 
Response Variable moisture 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
2              -1.094      0.4722   -2.317    0.1959 
3              -1.337      0.4722   -2.831    0.1053 
4              -0.567      0.4722   -1.201    0.6481 
 
 
treatment = 2  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
3             -0.2429      0.4722  -0.5145    0.9526 
4              0.5268      0.4722   1.1158    0.6941 
 
 
treatment = 3  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
4              0.7698      0.4722    1.630    0.4301 
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Appendix P: Particle Size of Dry Powder 
Table 22: Measured particle size of MPC powders. Means and standard deviations 
were obtained from triplicate measurements. 
Block Treatment Mean 
Standard 
Deviation d10 d50 d90 
1 1 133.00 117.10 49.50 104.70 218.80 
1 2 76.41 78.35 29.06 65.25 109.70 
1 3 158.20 184.90 39.15 92.50 448.90 
1 4 135.00 163.40 36.16 82.72 322.50 
2 1 81.79 40.65 34.36 78.81 130.50 
2 2 89.25 65.36 33.43 79.87 142.50 
2 3 98.42 109.80 29.08 68.31 170.20 
2 4 89.28 89.89 30.27 69.01 136.20 
3 1 109.80 98.57 39.42 89.06 174.50 
3 2 171.10 213.70 45.78 100.4 413.30 
3 3 116.80 134.50 32.52 79.39 200.40 
3 4 83.18 69.680 29.14 71.81 135.10 
 
Minitab Output for Particle Size Distribution Analysis (d90) of Dry MPC 
 
General Linear Model: d90 versus Block, Treatment  
 
Factor     Type    Levels  Values 
Block      random       3  1, 2, 3 
Treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for d90, using Adjusted SS for Tests 
 
Source     DF  Seq SS  Adj SS  Adj MS     F      P 
Block       2   35031   35031   17516  1.11  0.388 
Treatment   3   16018   16018    5339  0.34  0.798 
Error       6   94450   94450   15742 
Total      11  145499 
 
 
S = 125.466   R-Sq = 35.09%   R-Sq(adj) = 0.00% 
 
 
Term         Coef  SE Coef      T      P 
Constant   216.88    36.22   5.99  0.001 
Block 
1           58.09    51.22   1.13  0.300 
2          -72.03    51.22  -1.41  0.209 
Treatment 
1          -42.28    62.73  -0.67  0.525 
2            4.95    62.73   0.08  0.940 
3           56.28    62.73   0.90  0.404 
 
 
Unusual Observations for d90 
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Obs      d90      Fit  SE Fit  Residual  St Resid 
 10  413.300  235.775  88.718   177.525      2.00 R 
 
R denotes an observation with a large standardized residual. 
 
 
Least Squares Means for d90 
 
Treatment   Mean 
1          174.6 
2          221.8 
3          273.2 
4          197.9 
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Figure 74: Residual plots for particle size distribution (d90) as determined by 
Coulter LS 230; Top Left: Normal probability plot (p = 0.743); Top Right: 
Residuals versus fitted values; Bottom Left: Histogram of Residuals; Bottom Right: 
Residuals versus order 
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Figure 75: Plot of Variance for protein of dry MPC as determined by Elementar 
rapid N; Bartlett’s Test statistic = 2.55, p-value = 0.467; Levene’s Test statistic = 
0.24, p-value = 0.864 
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General Linear Model: Mean versus Block, Treatment  
 
Factor     Type    Levels  Values 
Block      random       3  1, 2, 3 
Treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for Mean, using Adjusted SS for Tests 
 
Source     DF  Seq SS  Adj SS  Adj MS     F      P 
Block       2    3007    3007    1504  1.28  0.345 
Treatment   3     782     782     261  0.22  0.878 
Error       6    7064    7064    1177 
Total      11   10853 
 
 
S = 34.3121   R-Sq = 34.91%   R-Sq(adj) = 0.00% 
 
 
Term          Coef  SE Coef      T      P 
Constant   111.853    9.905  11.29  0.000 
Block 
1            13.80    14.01   0.99  0.363 
2           -22.17    14.01  -1.58  0.165 
Treatment 
1            -3.66    17.16  -0.21  0.838 
2             0.40    17.16   0.02  0.982 
3            12.62    17.16   0.74  0.490 
 
 
Unusual Observations for Mean 
 
Obs     Mean      Fit  SE Fit  Residual  St Resid 
  2   76.410  126.053  24.262   -49.643     -2.05 R 
 10  171.100  120.621  24.262    50.479      2.08 R 
 
R denotes an observation with a large standardized residual. 
 
 
Least Squares Means for Mean 
 
Treatment   Mean 
1          108.2 
2          112.3 
3          124.5 
4          102.5 
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Figure 76: Residual plots for particle size distribution (mean size) of dry MPC as 
determined by Coulter LS 230; Top Left: Normal probability plot (p = 0.694); Top 
Right: Residuals versus fitted values; Bottom Left: Histogram of Residuals; Bottom 
Right: Residuals versus order 
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Figure 77: Plot of Variance for particle size distribution (mean size) of dry MPC as 
determined by Coulter LS 230; Bartlett’s Test statistic = 1.08, p-value = 0.781; 
Levene’s Test statistic = 0.18, p-value = 0.910 
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General Linear Model: d80 versus Block, Treatment  
 
Factor     Type    Levels  Values 
Block      random       3  1, 2, 3 
Treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for d80, using Adjusted SS for Tests 
 
Source     DF   Seq SS   Adj SS  Adj MS     F      P 
Block       2   2622.6   2622.6  1311.3  3.01  0.124 
Treatment   3  10346.3  10346.3  3448.8  7.92  0.017 
Error       6   2612.7   2612.7   435.4 
Total      11  15581.6 
 
 
S = 20.8674   R-Sq = 83.23%   R-Sq(adj) = 69.26% 
 
 
Least Squares Means for d80 
 
Treatment    Mean 
1          141.55 
2          112.53 
3           72.64 
4           71.41 
 
 
Grouping Information Using Tukey Method and 99.0% Confidence 
 
Treatment  N   Mean  Grouping 
1          3  141.6  A 
2          3  112.5  A 
3          3   72.6  A 
4          3   71.4  A 
 
Means that do not share a letter are significantly different. 
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Appendix Q: Particle Size of MPC During Reconstitution 
Table 23: Measured particle size of particles during reconstitution. Means and 
standard deviations were obtained from duplicate measurements. 
Block Treatment Mean 
Standard 
Deviation d10 d50 d90 
1 1 95.51 57.65 25.94 90.16 165.50 
1 2 94.84 40.22 39.59 97.11 143.50 
1 3 111.70 26.18 79.18 112.60 144.60 
1 4 102.00 22.40 75.20 102.90 130.10 
2 1 100.10 65.87 30.10 87.33 181.20 
2 2 43.91 41.77 11.76 30.51 90.64 
2 3 77.20 28.94 42.48 79.55 108.50 
2 4 79.54 21.75 52.53 81.39 105.80 
3 1 86.51 56.66 22.60 78.15 156.60 
3 2 84.70 65.36 13.00 75.78 167.80 
3 3 78.41 33.97 37.02 75.83 123.50 
3 4 81.68 40.23 28.44 80.25 134.50 
 
 
Minitab Output for Particle Size Distribution Analysis (Mean) of MPC During 
Reconstitution 
 
General Linear Model: Mean versus Block, Treatment  
 
Factor     Type    Levels  Values 
Block      random       3  1, 2, 3 
Treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for Mean, using Adjusted SS for Tests 
 
Source     DF  Seq SS  Adj SS  Adj MS     F      P 
Block       2    3007    3007    1504  1.28  0.345 
Treatment   3     782     782     261  0.22  0.878 
Error       6    7064    7064    1177 
Total      11   10853 
 
 
S = 34.3121   R-Sq = 34.91%   R-Sq(adj) = 0.00% 
 
 
Term          Coef  SE Coef      T      P 
Constant   111.853    9.905  11.29  0.000 
Block 
1            13.80    14.01   0.99  0.363 
2           -22.17    14.01  -1.58  0.165 
Treatment 
1            -3.66    17.16  -0.21  0.838 
2             0.40    17.16   0.02  0.982 
3            12.62    17.16   0.74  0.490 
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Unusual Observations for Mean 
 
Obs     Mean      Fit  SE Fit  Residual  St Resid 
  2   76.410  126.053  24.262   -49.643     -2.05 R 
 10  171.100  120.621  24.262    50.479      2.08 R 
 
R denotes an observation with a large standardized residual. 
 
 
Least Squares Means for Mean 
 
Treatment   Mean 
1          108.2 
2          112.3 
3          124.5 
4          102.5 
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Figure 78: Residual plots for particle size distribution (mean size) of dry MPC as 
determined by Coulter LS 230; Top Left: Normal probability plot (p = 0.694); Top 
Right: Residuals versus fitted values; Bottom Left: Histogram of Residuals; Bottom 
Right: Residuals versus order 
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Figure 79: Plot of Variance for particle size distribution (mean size) of dry MPC as 
determined by Coulter LS 230; Bartlett’s Test statistic = 1.08, p-value = 0.781; 
Levene’s Test statistic = 0.18, p-value = 0.910 
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Minitab Output for Particle Size Distribution Analysis (d90) of  MPC During 
Reconstitution 
 
General Linear Model: d90 versus block, treatment  
 
Factor     Type    Levels  Values 
block      random       3  1, 2, 3 
treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for d90, using Adjusted SS for Tests 
 
Source     DF  Seq SS  Adj SS  Adj MS     F      P 
block       2  1565.5  1565.5   782.7  1.57  0.283 
treatment   3  3805.4  3805.4  1268.5  2.54  0.152 
Error       6  2993.2  2993.2   498.9 
Total      11  8364.1 
 
 
S = 22.3355   R-Sq = 64.21%   R-Sq(adj) = 34.39% 
 
Least Squares Means for d90 
 
treatment   Mean 
1          167.8 
2          134.0 
3          125.5 
4          123.5 
 
 
Tukey Simultaneous Tests 
Response Variable d90 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
2              -33.79       18.24   -1.853    0.3373 
3              -42.23       18.24   -2.316    0.1962 
4              -44.30       18.24   -2.429    0.1712 
 
 
treatment = 2  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
3               -8.45       18.24  -0.4632    0.9645 
4              -10.51       18.24  -0.5765    0.9356 
 
 
treatment = 3  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
4              -2.067       18.24  -0.1133    0.9994 
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Figure 80: Residual plots for particle size distribution (d90) of MPC during 
reconstitution as determined by Coulter LS 230; Top Left: Normal probability plot 
(p = 0.488); Top Right: Residuals versus fitted values; Bottom Left: Histogram of 
Residuals; Bottom Right: Residuals versus order 
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Figure 81: Plot of Variance for particle size distribution (d90) of dry MPC as 
determined by Coulter LS 230; Bartlett’s Test statistic = 2.84, p-value = 0.417; 
Levene’s Test statistic = 0.74, p-value = 0.556 
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Minitab Output for Particle Size Distribution Analysis (Mean) of MPC During 
Reconstitution 
 
General Linear Model: mean versus block, treatment  
 
Factor     Type    Levels  Values 
block      random       3  1, 2, 3 
treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for mean, using Adjusted SS for Tests 
 
Source     DF  Seq SS  Adj SS  Adj MS     F      P 
block       2  1408.1  1408.1   704.0  3.48  0.099 
treatment   3   628.4   628.4   209.5  1.03  0.442 
Error       6  1215.0  1215.0   202.5 
Total      11  3251.4 
 
 
S = 14.2301   R-Sq = 62.63%   R-Sq(adj) = 31.49% 
 
Least Squares Means for mean 
 
treatment   Mean 
1          94.04 
2          74.48 
3          89.10 
4          87.74 
 
 
Tukey Simultaneous Tests 
Response Variable mean 
All Pairwise Comparisons among Levels of treatment 
treatment = 1  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
2              -19.56       11.62   -1.683    0.4066 
3               -4.94       11.62   -0.425    0.9721 
4               -6.30       11.62   -0.542    0.9453 
 
 
treatment = 2  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
3               14.62       11.62    1.258    0.6173 
4               13.26       11.62    1.141    0.6806 
 
 
treatment = 3  subtracted from: 
 
           Difference       SE of           Adjusted 
treatment    of Means  Difference  T-Value   P-Value 
4              -1.363       11.62  -0.1173    0.9994 
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Figure 82: Residual plots for particle size distribution (mean) of MPC during 
reconstitution as determined by Coulter LS 230; Top Left: Normal probability plot 
(p = 0.976); Top Right: Residuals versus fitted values; Bottom Left: Histogram of 
Residuals; Bottom Right: Residuals versus order 
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Figure 83: Plot of Variance for particle size distribution (d90) of dry MPC as 
determined by Coulter LS 230; Bartlett’s Test statistic = 2.87, p-value = 0.413; 
Levene’s Test statistic = 0.37, p-value = 0.780 
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Minitab Output for Particle Size Distribution Analysis (d80) of MPC During 
Reconstitution 
 
General Linear Model: d80 versus Block, Treatment  
 
Factor     Type    Levels  Values 
Block      random       3  1, 2, 3 
Treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for d80, using Adjusted SS for Tests 
 
Source     DF   Seq SS   Adj SS  Adj MS     F      P 
Block       2   2622.6   2622.6  1311.3  3.01  0.124 
Treatment   3  10346.3  10346.3  3448.8  7.92  0.017 
Error       6   2612.7   2612.7   435.4 
Total      11  15581.6 
 
 
S = 20.8674   R-Sq = 83.23%   R-Sq(adj) = 69.26% 
 
 
Least Squares Means for d80 
 
Treatment    Mean 
1          141.55 
2          112.53 
3           72.64 
4           71.41 
 
 
Grouping Information Using Tukey Method and 99.0% Confidence 
 
Treatment  N   Mean  Grouping 
1          3  141.6  A 
2          3  112.5  A 
3          3   72.6  A 
4          3   71.4  A 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 99.0% Simultaneous Confidence Intervals 
Response Variable d80 
All Pairwise Comparisons among Levels of Treatment 
Treatment = 1  subtracted from: 
 
Treatment   Lower  Center  Upper   --+---------+---------+---------+---- 
2          -113.7  -29.02  55.67         (-----------*-----------) 
3          -153.6  -68.91  15.78   (-----------*-----------) 
4          -154.8  -70.14  14.55   (-----------*-----------) 
                                   --+---------+---------+---------+---- 
                                  -140       -70         0        70 
 
 
Treatment = 2  subtracted from: 
 
Treatment   Lower  Center  Upper   --+---------+---------+---------+---- 
3          -124.6  -39.89  44.81       (-----------*-----------) 
4          -125.8  -41.12  43.58       (-----------*-----------) 
                                   --+---------+---------+---------+---- 
 241
                                  -140       -70         0        70 
 
 
Treatment = 3  subtracted from: 
 
Treatment   Lower  Center  Upper   --+---------+---------+---------+---- 
4          -85.93  -1.230  83.47             (-----------*-----------) 
                                   --+---------+---------+---------+---- 
                                  -140       -70         0        70 
 
 
Tukey Simultaneous Tests 
Response Variable d80 
All Pairwise Comparisons among Levels of Treatment 
Treatment = 1  subtracted from: 
 
           Difference       SE of           Adjusted 
Treatment    of Means  Difference  T-Value   P-Value 
2              -29.02       17.04   -1.703    0.3978 
3              -68.91       17.04   -4.045    0.0260 
4              -70.14       17.04   -4.117    0.0241 
 
 
Treatment = 2  subtracted from: 
 
           Difference       SE of           Adjusted 
Treatment    of Means  Difference  T-Value   P-Value 
3              -39.89       17.04   -2.341    0.1903 
4              -41.12       17.04   -2.413    0.1745 
 
 
Treatment = 3  subtracted from: 
 
           Difference       SE of            Adjusted 
Treatment    of Means  Difference   T-Value   P-Value 
4              -1.230       17.04  -0.07219    0.9998 
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Figure 84: Residual plots for particle size distribution (d80) of dry MPC as 
determined by Coulter LS 230; Top Left: Normal probability plot (p = 0.822); Top 
Right: Residuals versus fitted values; Bottom Left: Histogram of Residuals; Bottom 
Right: Residuals versus order 
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Minitab Output for Particle Size Distribution Analysis (d90-d50) of MPC 
During Reconstitution 
 
 
General Linear Model: d90-d50 versus Block, Treatment  
 
Factor     Type    Levels  Values 
Block      random       3  1, 2, 3 
Treatment  fixed        4  1, 2, 3, 4 
 
 
Analysis of Variance for d90-d50, using Adjusted SS for Tests 
 
Source     DF  Seq SS  Adj SS  Adj MS      F      P 
Block       2  1107.7  1107.7   553.8   3.57  0.095 
Treatment   3  4877.9  4877.9  1626.0  10.49  0.008 
Error       6   930.3   930.3   155.0 
Total      11  6915.9 
 
 
S = 12.4516   R-Sq = 86.55%   R-Sq(adj) = 75.34% 
 
 
Grouping Information Using Tukey Method and 99.0% Confidence 
 
Treatment  N  Mean  Grouping 
1          3  82.6  A 
2          3  66.2  A 
3          3  36.2  A 
4          3  35.3  A 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 99.0% Simultaneous Confidence Intervals 
Response Variable d90-d50 
All Pairwise Comparisons among Levels of Treatment 
Treatment = 1  subtracted from: 
 
Treatment   Lower  Center   Upper  ----+---------+---------+---------+-- 
2          -66.91  -16.37  34.165         (------------*------------) 
3          -96.88  -46.35   4.192  (-----------*------------) 
4          -97.80  -47.27   3.272  (-----------*------------) 
                                   ----+---------+---------+---------+-- 
                                     -80       -40         0        40 
 
 
Treatment = 2  subtracted from: 
 
Treatment   Lower  Center  Upper  ----+---------+---------+---------+-- 
3          -80.51  -29.97  20.56      (------------*-----------) 
4          -81.43  -30.89  19.64      (-----------*------------) 
                                  ----+---------+---------+---------+-- 
                                    -80       -40         0        40 
 
 
Treatment = 3  subtracted from: 
 
Treatment   Lower   Center  Upper  ----+---------+---------+---------+-- 
4          -51.46  -0.9200  49.62             (------------*-----------) 
                                   ----+---------+---------+---------+-- 
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                                     -80       -40         0        40 
 
 
Tukey Simultaneous Tests 
Response Variable d90-d50 
All Pairwise Comparisons among Levels of Treatment 
Treatment = 1  subtracted from: 
 
           Difference       SE of           Adjusted 
Treatment    of Means  Difference  T-Value   P-Value 
2              -16.37       10.17   -1.610    0.4392 
3              -46.35       10.17   -4.559    0.0151 
4              -47.27       10.17   -4.649    0.0138 
 
 
Treatment = 2  subtracted from: 
 
           Difference       SE of           Adjusted 
Treatment    of Means  Difference  T-Value   P-Value 
3              -29.97       10.17   -2.948    0.0915 
4              -30.89       10.17   -3.039    0.0822 
 
 
Treatment = 3  subtracted from: 
 
           Difference       SE of            Adjusted 
Treatment    of Means  Difference   T-Value   P-Value 
4             -0.9200       10.17  -0.09049    0.9997 
